|20216|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Flies null for Hsr-omega mostly die at embryonic stage, and the surviving flies are weak, sterile and die within a few days of emergence (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17020918\">Jolly (2006)</a>).\n\nTranscribed from a locus involved in the heat shock response in Drosophila. hsr-omega-n nuclear transcripts form complexes with various hnRNP proteins and related proteins in nucleoplasmic omega-speckles, distributed in the interchromatin space in close proximity to the chromatin (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17114940\">Sengupta (2007)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/1704862\">Bendena (1991)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/10984439\">Prasanth (2000)</a>).\n\nMany proteins are found associated with the hsr-omega-n transcripts, including: (i) various hnRNPs Hrp40 (hnRNP A), Hrb87F (hnRNP A1/A2), Hrb57A (hnRNP K), Hrb98DE (44); (ii) other nuclear RNA-binding proteins like NonA, PEP, Sxl, nuclear non-histone proteins recognized by Q14, Q16, T29, P75 antibodies; (iii) Snf; (iv) Hsp83 and (v) Tpr (see <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17020918\">Jolly (2006)</a> for review and references).\n\nOmega speckles disappear after heat shock, except from the hsr-omega/93D locus, and speckled distribution of associated hnRNPs is disrupted in hsr-omega nullosomics (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/10984439\">Prasanth (2000)</a>). It is suggested that the ncRNA may regulate the availability of hnRNPs in active (chromatin bound) and inactive (in omega-speckles) compartments and interfere with the processing of pre-mRNAs in cyst cells (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11910129\">Rajendra (2001)</a>).\n\nAltered expression of the hsr omega RNAs enhances poly-Q-induced neurotoxicity in Drosophila (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17114940\">Sengupta (2007)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19667761\">Mallik (2009)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11081516\">Fernandez-Funez (2000)</a>)."], ["Characteristics", "Product of the 93D (or hsr-omega) locus, one of the largest heat-shock puffs in Drosophila polytene chromosomes. This locus produces three major long transcripts (by alternative polyadenylation and splicing) in all Drosophila species examined (reviewed in <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17020918\">Jolly (2006)</a>). The locus spans 10\u201320 kb, composed of two small exons (~475 and 700 bp in Drosophila melanogaster) separated by a 700 bp intron, and followed by a long stretch (5\u201315 kb) of short (280 bp in D. melanogaster) tandem repeat units (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17020918\">Jolly (2006)</a>).\n\nLong noncoding transcripts produced include three major hsr-omega transcripts, which share the same 5' end (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/1704862\">Bendena (1991)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/3097014\">Garbe (1986)</a>):\n\nHsr-omega-n (omega-1) is >10kb-long and nuclear transcript that covers the entire length of the gene (including the tandem repeats), is polyadenylated, and retains the intron.\n\nHsr-omega-c (omega-3 ) is 1.2-kb, spliced and cytoplasmic. \n\nThe third common RNA, omega-pre-c (omega-2) is spliced to produce the mature omega-c transcript. It is 1.9kb-long and terminates at a first polyadenylation site located at the 3' end of exon 2."], ["Misc", "Heat shock puffs in Chironomus genus also produce non-conding transcripts analogous to Drosophila  hsr omega transcripts, and interaction of Hsp90 with puffs is dependent on transcription (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/8306827\">Morcillo (1993)</a>). Analogy is also drawn with non-related human heat-shock induced Satellite III (Sat III) transcripts (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17020918\">Jolly (2006)</a>).\n\nNatural variation in hsr-omega expression influence rates of protein synthesis in Drosophila lines (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19280368\">Johnson (2009)</a>).\n\nSmall open reading frames (ORFs) present in hsr-omega are poorly conserved in different Drosophila species. A short ORF of 23\u201327 amino acids present in the hsr-omega-c sequence of three examined Drosophila species is translatable, but the predicted protein has not been detected (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/2500443\">Fini (1989)</a>)."], ["Conservation", "The hsr-omega/93D locus and genomic organization is conserved among Drosophila species. However, the hsr-omega transcripts have poor sequence conservation among different Drosophila species (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/3097014\">Garbe (1986)</a>), but, similar to other ncRNAs, have short stretches of conservation."], ["NULL", "hsr omega: heat shock RNA omega"], ["Expression", "Transcripts are constitutively expressed at relatively high levels in many tissues, in almost all cell types analysed, and are developmentally regulated (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11255511\">Lakhotia (2001)</a>)(<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/1704862\">Bendena (1991)</a>)(<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/8641048\">Mutsuddi (1995)</a>).\n\nTranscripts were not detected in gonadal cell types such as male and female gonial cells and in follicle cells and oocytes in ovary. Polytenised tissues such as salivary glands, and certain regions of larval gut and the Malpighian tubules, showed a greater abundance of hsr-omega transcripts with a strong hybridization in nuclei (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/1704862\">Bendena (1991)</a>). \n\nExpression is stress-induced, being highly active after heat exposure, but also responsive to other stresses such as amides benzamide and colchicine (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9364937\">Tapadia (1997)</a>).\n\nNuclear hsr-omega-n is localized in nuclear granules called omega-speckles (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17114940\">Sengupta (2007)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/1704862\">Bendena (1991)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/10984439\">Prasanth (2000)</a>)."]]|
|20217|;|Characteristics|;|0|;|1|;|0|;|[["Characteristics", "Analysis of a member (Pinci1-1) indicates a minimum size of 850 bases. Polyadenylated.\n\nThe described Pinci1 RNA family comprises more than 400 members with sequence homolgy (110 full-length and 297 single-domain homology), which are arranged in clusters of up to nine copies throughout the P. infestans genome."], ["Expression", "Identified in a suppression subtractive hybridization (SSH) screen for exprressed sequences upregulated during Phytophthora infestans of potato.\n\nExpression of members of five classes of Pinci1 transcripts was found markedly upregulated from 12 to 33h post-inoculation of potato with P. infestans, a period defining the biotrophic phase of the infection."], ["Name", "Pinci1: P. infestans non-coding infection-specific family\n"]]|
|20214|;|Characteristics|;|0|;|1|;|0|;|[["Function", "LincRNA-p21 acts to repress many genes transcriptionally regulated by p53.\n\nLincRNA-p21 gene repression is mediated (at least in part) by lincRNA binding to heterogeneous nuclear ribonucleoprotein K (hnRNP-K) through its 5' end. hnRNP-K associates with the promoters of many genes repressed by lincRNA-p21 in a lincRNA-p21 dependent manner.\n\nLincRNA-p21 is necessary for p53-dependent apoptotic induction, but not cell cycle arrest.\n"], ["Characteristics", "~3.1kb, spliced, 2 exon transcript. \n\nStarts ~15kb upstream and on the opposite strand to p21 (Cdkn1a) gene in mouse."], ["Conservation", "At least some sequences within lincRNA-p21 are well conserved in mammals."], ["Expression", "Transcriptional target of p53. P53 binds to the lincRNA-p21 promoter and up-regulates expression upon DNA damage and in various tumour cell lines.\n\nEnriched in nucleus.\n\nComplete length and structure of human lincRNA-p21 not defined, but it too appears to be regulated by p53.\n\nMouse RNA was stable with a half-life of 6.2 hr in in N2A (neuroblastoma) cells, well above the median lncRNA half-life (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/22406755\">Clark (2012)</a>)."], ["Misc", "Nb: Cdkn1a (p21) cell cycle regulator is also a p53 target gene."]]|
|20215|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Loss of At4 lead to increased shoot Pi content and an increase in the shoot:root Pi ratio under low Pi conditions suggesting At4 affects Pi distribution and plant growth (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16460506\">Shin (2006)</a>).\n\nCompeting endogenous RNA (ceRNA). At4 has complementarity to miR-399, but contains a central mismatch loop. Over-expression of At4 lead to a decrease in shoot Pi content suggesting that, like IPS1, At4 inhibits miR-399 through target mimicry thereby allowing activity of PHO2 (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17643101\">Franco-Zorrilla (2007)</a>).\n\nAt4 and IPS1 appear to be functionally redundant as overexpression of one gave same phenotypic change as overexpression of both (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17643101\">Franco-Zorrilla (2007)</a>)."], ["Characteristics", "At4: member of a family of RNAs induced by phosphate (Pi) starvation in plants that have a region of complementarity to miR-399 and short non-conserved ORFs (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9880366\">Burleigh (1999)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16460506\">Shin (2006)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17643101\">Franco-Zorrilla (2007)</a>).\n\nOther family members in Arabidopsis are At4-1, At4-2, At4-3 and <a href=\"http://www.lncrnadb.com/Detail.aspx?TKeyid=158\">IPS1</a> (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16460506\">Shin (2006)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17643101\">Franco-Zorrilla (2007)</a>).\n\nAt4 is ~750nuc (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9880366\">Burleigh (1999)</a>)."], ["Conservation", "At4 and IPS1 are paralogs in Arabidopsis.\n\nAt4 only shares homology with other family members (ie: At4-1 and At4-2, Mt4 in Medicago truncatula and Mt4-like in Glycine max) in the miR-399 complementarity region (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9880366\">Burleigh (1999)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16460506\">Shin (2006)</a>)."], ["Expression", "Expression of At4 family members is induced upon Pi starvation (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9880366\">Burleigh (1999)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17643101\">Franco-Zorrilla (2007)</a>).\n\nAt4 is expressed in roots (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9880366\">Burleigh (1999)</a>) and shoots (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11123795\">Mart\u00edn (2000)</a>).\n\nHormonal signaling by cytokinins and abscisic acid repressed At4 expression in the roots (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11123795\">Mart\u00edn (2000)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16460506\">Shin (2006)</a>)."], ["Misc", "Accession for other family members:\nAt4-1: AY536062; At4-2: AY334555; At4-3: AI995459"]]|
|20213|;|Characteristics|;|0|;|1|;|0|;|[["Function", "meiRNA specifically binds (both in-vivo and in-vitro) and is required for nuclear localisation of Mei2, which is an RNA-binding protein essential for premeiotic RNA synthesis and meiosis. Mei2p relocalises to nuclear granules/dot structures after binding to meiRNA, resulting in a cell switch from mitosis to meiosis.\n\nOverexpression of meiRNA suppresses a temperature-sensitive defect of mei2+.\n\nMei2-meiRNA complex functions specifically at Meiosis I, and loss of function of meiRNA blocks meiosis, but not premeiotic DNA synthesis. "], ["Characteristics", "~0.5kb. Unspliced, polyadenylated. Alternative polyadenylation may give rise to different isoforms of ~510 and ~440 nt (excluding polyA tail)."], ["Misc", "Mei2 may interact with other regulatory RNAs. A Mei2 defective in RNA binding cannot promote meiosis, and causes premeiotic DNA synthesis inhibition. In addition, the cytoplasmic function of Mei2, which is independent of meiRNA, is also abrogated in the RNA-binding mutant."], ["Expression", "Mainly cytoplasmic but when bound to Mei2p becomes mainly nuclear localised in the Mei2p nuclear granule/ dot structure.\n\nExpression of meiRNA is induced by nitrogen starvation in Schizosaccharomyces pombe, which causes a switch from the mitotic cell cycle to meiosis that is dependent on mei2.\n"]]|
|20218|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Probable competing endogenous RNA (ceRNA). KRASP1 is hypothesised to act as a decoy for miRNAs targeting KRAS, similar to how PTENP1 acts a decoy for PTEN (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20577206\">Poliseno (2010)</a>).\n\nExpression of the KRASP1 3'UTR sequence lead to de-repression of KRAS mRNA levels and increased cellular proliferation (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20577206\">Poliseno (2010)</a>).   "], ["Characteristics", "Processed pseudogene of KRAS oncogene on 6p12-p11 (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/6308466\">McGrath (1983)</a>)."], ["Conservation", "Pseudogene sequence at this locus only present in some primates."], ["Name", "KRAS Pseudogene 1"]]|
|20219|;|Characteristics|;|0|;|1|;|0|;|[["Features", "Together with the noncoding RNA BC040587 and the tumor suppressor gene LSAMP (limbic system-associated membrane protein), LOC285194 is present in the focal region of chr3q13.31 (osteo3q13.31), which is the most altered region in osteosarcomas. These genes are proposed to be cooperatively acting tumor suppressors.\n\nRecurrent focal copy-number changes and loss of heterozygosity (LOH), which usually involves loss of LOC285194 and BC040587 expression, implicate these ncRNAs in ostecosarcoma. Focal osteo3q13.31 CNAs and LOH are also common in cell lines from several other cancers (such as lung, autonomic and central nervous system, blood, endometrium, soft tissue, skin, gastrointestinal tract, urinary tract, and breast).\n\nDepletion of LOC285194 by siRNA promoted proliferation of normal osteoblasts (with a mild increase in the G1 population) by cell-cycle transcripts (Cyclin D1, VEGF, and VEGFR1 up-regulation, and cyclin A2 and cyclin B1 suppression) as well as regulation of apoptotic genes (such as suppression of BCL2 and BimEL pro-apoptotic genes).\n\nGenetic deletions of LOC285194 or BC040587 in  tumor DNA were also associated with dramatic decrease in survival of osteosarcoma patients."]]|
|20132|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Regulates RPS14 transcription.\n\nEach lncRNA can interact with the Rps14 gene loci to stimulate its expression in-trans.\n\nEach lncRNA is transcribed through a known enhancer with putative transcription factor binding abilities, suggesting the 'enhancer' may be the transcribed RNA, which could be recruiting transcription factors to the Rps14 gene. "], ["Characteristics", "Two overlapping antisense RNAs from intron 1 of the human ribosomal protein 14 (Rps14) gene, identified by RNase Protection Assay (RPA).\n\nRPA expression analysis using both cell extracts and cell-free transcription system indicates full-length sizes of 250 and 280 nt, respectively. Transcripts terminate at the same nucleotide, therefore alpha-250 overlaps alpha-280 along its whole length.\n\nTranscription of both RNAs is resistant to high concentrations of RNAPII inhibitor alpha-amanitin."], ["Expression", "Ubiquitously expressed in the human tissues and cell lines examined. \n\n Alpha-250 was almost exclusively cytoplasmic. Alpha- 280 was mostly in the nucleus."]]|
|20130|;|Characteristics|;|0|;|1|;|0|;|[["Characteristics", "Spliced ~1.7kb transcript. \n\nSequence contains multiple repeat elements."], ["Misc", "Found ~50kb from Cox2 (Ptgs2), which is also induced by NFkB."], ["Expression", "Reglulated by NFkB. Highly up-regulated upon Toll-like receptor 4 (TLR4) stimulation of CD11C+ bone-marrow-derived dendritic cells (BMDC)."]]|
|20137|;|Characteristics|;|0|;|1|;|0|;|[["Characteristics", "Several splice isoforms. Main isoform is a 6-7kb transcript.\n"], ["Conservation", "Also present in another honey bee species: Apis cerana. Sequence was highly conserved but putative ORFs were not.\n\nAt time of study, AncR-1 sequence did not show homology to sequences from any other organisms"], ["Expression", "Expressed in brain cortex (not ubiquitously expressed). Also differentially expressed between queens, drones and workers: detected in sex organs in queens and drones and in the hypopharyngeal glands and oenocytes of worker bees.\n\nLocalises to punctate foci in nucleus. Did not co-localise with the Ks-1 nuclear lncRNA."], ["Name", "Apis noncoding RNA-1"], ["Misc", "Nucleotide accessions of different isoforms: AB125322.1, AB125323.1, AB125324.1"]]|
|20136|;|Characteristics|;|0|;|1|;|0|;|[["Characteristics", "~17.5 kb, intronless transcript (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12088150\">Sawata (2002)</a>)."], ["Conservation", "Also present in another honey bee species: Apis cerana. Sequence was highly conserved but putative ORFs were not (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12088150\">Sawata (2002)</a>)."], ["Expression", "Expressed in honey bee brain, preferentially expressed in the small-type Kenyon cell neurons of the Mushroom bodies (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12088150\">Sawata (2002)</a>).\n\nLocalised exclusively in nuclei. Forms punctate nuclear foci which vary in number from 1-50 per nuclei (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12088150\">Sawata (2002)</a>). Ks-1 did not co-localise with a second nuclear lncRNA AncR-1 (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15208441\">Sawata (2004)</a>)."], ["Name", "Kenyon cell/smalltype preferential gene-1"]]|
|20138|;|Characteristics|;|0|;|1|;|0|;|[["Function", "LncRNAs contain a number of miRNAs and snoRNAs, little is known about the molecular function of the lncRNAs.\n\nRian transcript(s) bind to the PRC2 chromatin modifying complex in mouse embryonic stem cells (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21172659\">Zhao (2010)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21874018\">Guttman (2011)</a>). Rian was also found to interact with a number of other chromatin binding protein(s)/complexes in mouse embryonic stem cells including PRC1, JARID1B, JARID1C and CBX3, with the general pattern being interaction with repressors of gene expression (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21874018\">Guttman (2011)</a>).\n\nAberrant repression of Rian and other maternally expressed lncRNAs from the DLK1-Dio3 imprinting cluster is present in most induced pluripotent stem cell (iPSC) lines and is responsible for the failure of iPSCs to form viable mice, with embryos dying mid-gestation (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20418860\">Stadtfeld (2010)</a>)."], ["Name", "Rian: RNA Imprinted and Accumulated in Nucleus \nIrm: Imprinted RNA near Meg3/Gtl2\nMEG8: Maternally expressed gene 8"], ["Characteristics", "These overlapping but non-identical transcripts are found in the Dlk1-Dio3 imprinted region (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11481034\">Hatada (2001)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17507654\">Royo (2007)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19194500\">Hagan (2009)</a>) and should probably be viewed as different isoforms of the Rian gene. The human and mouse loci are quite similar, whereas the rat loci (Bsr gene) has undergone significant divergence and so has its own entry in the database.\n\nSpliced lncRNAs that contain a number of intronic snoRNAs and sometimes miRNAs (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12045206\">Cavaill\u00e9 (2002)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17507654\">Royo (2007)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19194500\">Hagan (2009)</a>). \n\nIn human and mouse, transcription of the Meg8 isoform can extend through the snoRNA clusters. Mouse Meg8 is ~4.4kb with over 20 exons. In mouse the ~2.5 kb Irm transcript contains the last 10 exons of Meg8 but has its own transcriptional start site. Mouse Meg8 contains intronic miRNAs not found in Irm (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19194500\">Hagan (2009)</a>).\n\nRNA sequencing confirms a large number of isoforms with alternative splicing and also retained introns exist at this locus though no evidence was found for Rian overlapping the Meg9/Mirg transcript (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20436462\">Guttman (2010)</a>). It is unclear if the Irm isoform exists in humans."], ["Misc", "Human UCSC browser link below is for Refseq Meg8, however it is clear from known human mRNAs that transcripts from the Meg8 locus can extend much further than the current Refseq annotation."], ["Summary", "Comparing human, mouse and rat: All contain ncRNA gene(s) with intronic snoRNAs at this locus. The snoRNAs vary between species, but there are some homologous snoRNAs between each suggesting an evolutionary history with species specific snoRNA addition and duplication (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12045206\">Cavaill\u00e9 (2002)</a>).\n\nThe expression profiles of Bsr, Rian/Irm/MEG8 and the snoRNAs they contain are similar between rat, human and mouse."], ["Conservation", "Bsr and Rian/MEG8/Irm are not highly conserved between species (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12045206\">Cavaill\u00e9 (2002)</a>). However, some Rian exons show good homology to Bsr and while many snoRNAs are specific to one species others are homologous (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11481034\">Hatada (2001)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12045206\">Cavaill\u00e9 (2002)</a>).\n\nRian gene is present in mammals."], ["Expression", "Imprinted: Maternally expressed (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11481034\">Hatada (2001)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11337479\">Charlier (2001)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12045206\">Cavaill\u00e9 (2002)</a>).\n\nExpressed predominately in brain (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11481034\">Hatada (2001)</a>), embryo and muscle (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11337479\">Charlier (2001)</a>) with generally weak expression in other tissues (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19194500\">Hagan (2009)</a>). Expressed in mouse embryonic stem cells (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21874018\">Guttman (2011)</a>). In mouse the longer 'Meg8' transcript is also expressed in skin whereas the shorter 3' 'Irm' is not (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19194500\">Hagan (2009)</a>).\n\nUp-regulated during differentiation of neuronal progenitors to GABAergic neurons in vitro (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20137068\">Mercer (2010)</a>).\n\nLocalised to the nucleus (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11481034\">Hatada (2001)</a>).\n\nIntronic snoRNAs also show brain and embryo imprinted expression (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12045206\">Cavaill\u00e9 (2002)</a>)."]]|
|20093|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Summary: Malat1 has been found to regulate alternative splicing of endogenous target genes, and it is implicated in cancer and a series of molecular and cellular phenotypes, as indicated below.\n\n\nIdentified as an oncogene that promotes tumorigensis. Expression of a Malat1 fragment in NIH 3T3 cells transformed cells (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19625619\">Li (2009)</a>). \n\nKnockdown inhibited cell mobility and lead to decreased expression of several genes (CTHRC1, CCT4, HMMR, or ROD1) that promoted cell migration (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20937273\">Tano (2010)</a>). This result may also explain why knockdown inhibited trophoblast-like cell invasion in-vitro, with MALAT1 hypothesised to regulate the level of trophoblast invasion into the uterus in vivo (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19690017\">Tseng (2009)</a>).\n\nMALAT1 depletion resulted in aberrant mitosis, with a large fraction of cells accumulating at G2/M boundary, and increased cell death (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20797886\">Tripathi (2010)</a>).\n\nDepletion of Malat1 in neuroblastoma cells indicated that Malat1 affects the expression of genes involved not only in the organization and the function of the nucleus, but also in synapse function and dendrite development. In cultured hippocampal neurons, knock-down of Malat1 decreased synaptic density, whereas its over-expression resulted in a cell-autonomous increase in synaptogenesis (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20729808\">Bernard (2010)</a>).\n\nThere is a significant enrichment for SRSF1 (SF2/ASF) binding sites within the 5' half of both human and mouse MALAT1, whose direct interaction has been demonstrated, and is dependent on its canonical RRM (RRM1) or the pseudo RRM (RRM2) domains (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19116412\">Sanford (2009)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20797886\">Tripathi (2010)</a>). Independent sequence elements in MALAT1 influence its distribution to nuclear speckles and the recruitment of SRSF1 (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20797886\">Tripathi (2010)</a>).\n\nAdditional interactions have been found between MALAT1 and SRSF1, SRSF2, and SRSF3 proteins, but only weak interactions with SRSF5 and PSP1 (an RNA-binding protein that is a component of paraspeckles) have been identified (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20797886\">Tripathi (2010)</a>).\n\nKnock-down of nuclear Malat1 in a transfected U2OS cell line showed that it modulates the recruitment of SR proteins (SRSF1 or SF2/ASF and SC35) to a transcriptionally active transgene array (stably integrated), indicating a role in the regulation of the association of pre-mRNA-splicing factors to transcription sites and control of post-transcriptional gene expression (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20729808\">Bernard (2010)</a>). Malat1 modulates the speckle association of a subset of pre-mRNA splicing factors, such as SF1, U2AF-65, SF3a60, and B-U2snRNP (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20797886\">Tripathi (2010)</a>).\n\nMalat1-depleted HeLa cells show increased cellular levels of dephosphorylated SRSF1 (SF2/ASF) (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20729808\">Bernard (2010)</a>), as well as a moderately increased cytoplasmic pool of poly(A)+ RNA (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20797886\">Tripathi (2010)</a>). It has recently been shown to regulate alternative splicing of endogenous target genes by modulating SR splicing factor phosphorylation, affecting their levels and the distribution and ratio of phosphorylated to dephosphorylated pools (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20797886\">Tripathi (2010)</a>). \n\nSuggested to interact with the PRC2 complex in the HCT-116 cancer cell line (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/22659877\">Guil (2012)</a>)."], ["Characteristics", "Intergenic ~7kb single exon transcript (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12970751\">Ji (2003)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17270048\">Hutchinson (2007)</a>).\n\nA conserved tRNA-like sequence at the 3' end is cleaved off and processed to generated a short tRNA-like ncRNA mascRNA (MALAT1-associated small cytoplasmic RNA) (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19041754\">Wilusz (2008)</a>).\n\nPost transcriptional processing of Malat1 therefore allows two ncRNAs to be created from the one original transcript (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19041754\">Wilusz (2008)</a>)."], ["Conservation", "Therian mammals (found in oppossum as well as placental mammals) (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17270048\">Hutchinson (2007)</a>).\n\nRecently described in zebrafish. Sequence homology to zebrafish was limited to the 3\u2019 end, but the ~7kb long, single exon structure as well as positional synteny was conserved, as was the high expression in brain found identified in mammals (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/22196729\">Ulitsky (2011)</a>)."], ["Expression", "Both Malat1 and the processed mascRNA transcript are expressed in a wide range of tissues (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12970751\">Ji (2003)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17270048\">Hutchinson (2007)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19041754\">Wilusz (2008)</a>), <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20729808\">Bernard (2010)</a>), (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/22196729\">Ulitsky (2011)</a>). \n\nMalat1 is highly expressed in the brain. RNA fluorescence in-situ hybridization (RNA-FISH) on adult mouse brain sections showed high expression of nuclear-localized Malat1 transcripts in pyramidal neurons of the hippocampus, Purkinje cells of the cerebellum and neurons of the substantia nigra and motoneurons, but very low levels in non-neuronal cells (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20729808\">Bernard (2010)</a>). In the hippocampus and in Purkinje cells, Malat1 was first detected between post-natal day 0 (P0) and P7 and its level increased until P28 (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20729808\">Bernard (2010)</a>). This high expression appears to come from up-regulation of Malat1 during differentiation, with in-vitro differentiation of neural stem cells showing significant up-regulation of expression in neuronal and glial differentiated progeny (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20137068\">Mercer (2010)</a>).\n\nExpressed in the nucleus accumbens of normal human brains and upregulated in this brain region in heroin abusers (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21128942\">Michelhaugh (2010)</a>). \n\nIn neuroblastoma cells Malat1 was up-regulated by the hormone oxytocin (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20149803\">Koshimizu (2010)</a>). \n\nMalat1 is up-regulated in a range of cancers (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12970751\">Ji (2003)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16441420\">Yamada (2006)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16878148\">Lin (2007)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19379481\">Guffanti (2009)</a>).\n\nHigh expression of Malat1 is associated with metastasis in certain histological subtypes of non-small cell lung cancer (NSCLC) and is predictive of poor prognosis (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12970751\">Ji (2003)</a>).\n\nMalat1 is up-regulated in placenta previa increta/percreta, a disease characterised by excessive invasion of fetal placental trophoblasts into the uterus  (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19690017\">Tseng (2009)</a>).\n\n\nMalat1 is stable in human B cells and Hela and wt MEFs (half-life >7 hrs) but has significantly lower stability in mouse 3T3 and N2A cells. Suggesting differences in Malat1 stability both within and between species (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19561200\">Friedel (2009)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20729808\">Bernard (2010)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/22406755\">Clark (2012)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/22369889\">Tani (2012)</a>).\n\n\nMalat1 localises to SC35 domain nuclear speckles in several cell lines (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17270048\">Hutchinson (2007)</a>) (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19217333\">Clemson (2009)</a>). Localisation to nuclear speckles is transcription-dependent, as RNA pol II inhibition promoted re-distribution of Malat1 ncRNA from nuclear speckles to a homogenous nuclear localisation (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20729808\">Bernard (2010)</a>). Malat1 co-localises with pre-mRNA-splicing factor SF2/ASF and CC3 antigen in the nuclear speckles (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20729808\">Bernard (2010)</a>).\n\nMALAT1 is enriched in nuclear speckles in interphase cells and concentrates in mitotic interchromatin granule clusters (IGCs, structural analogs of nuclear speckles present in mitotic cells), but unlike Neat1 it is not required for the structural integrity of the nuclear domain (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20797886\">Tripathi (2010)</a>).\n\nmascRNA derived from Malat1 is transported to the cytoplasm (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19041754\">Wilusz (2008)</a>)."], ["Name", "Malat1: Metastasis-associated lung adenocarcinoma transcript 1\nNeat2: Nuclear enriched abundant transcript 2\n"]]|
|20167|;|Characteristics|;|0|;|1|;|0|;|[["Function", "In cell culture, mutations in SOD1 cause cell death, MSUR1 protect cells in a dose dependent manner and acts to decrease levels of hydroxl radicals and the oxidation of cellular proteins.\n\nMSUR1 didn't affect the level of SOD1 protein, instead acting to reduce cellular oxidative stress. The mechanism of MSUR1 action is unknown."], ["Characteristics", "~1.7kb transcript consisting of the first 1700nuc of 18s rRNA followed by 31bp of non rRNA sequence. 3' sequence contains a polyA signal and the transcript is polyadenylated.\n\nLength and identity of transcript was confirmed by RT-PCR and northern blotting with a 3' probe."], ["Misc", "Mutations in superoxide dismutase (SOD1) are linked to amyotrophic lateral sclerosis (ALS) a fatal neurodegenerative condition. A mouse SOD1 mutant replicates this condition.\n\nGenomic position of MSUR1 transcript not known."], ["Expression", "Expressed in a broad range of tissues.\n\nUp-regulated in the spinal cord of SOD1 mutant mice prior to onset of amyotrophic lateral sclerosis (ALS) type symptoms."], ["Name", "MSUR1: mutant SOD1(G93A)-up-regulated RNA 1"]]|
|20095|;|Characteristics|;|0|;|1|;|0|;|[["Characteristics", "~2.8kb, spliced 2 exon transcript. Contains a 'human accelerated region' (HAR). Overlaps with an antisense noncoding RNA, <a href=\"http://www.lncrnadb.com/Default.aspx?TKeyid=232\">HAR1B</a> (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16915236\">Pollard (2006)</a>).\n\nConserved HAR1 sequence (common to both HAR1A and HAR1B) forms a secondary structure which is highly conserved (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16915236\">Pollard (2006)</a>) but has undergone changes from a hairpin structure in chimps to a cloverleaf structure in humans (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18511501\">Beniaminov (2008)</a>)."], ["Conservation", "Contains a 'human accelerated region', which is a sequence highly conserved in amniotes (negative selection) but which has evolved rapidly in the human lineage (positive selection) since the divergence of humans and chimpanzees from the last common ancestor (18 bases out of 118 are different between human and chimpanzee but only 2 differences between chimpanzee and chicken) (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16915236\">Pollard (2006)</a>).\n\nHAR1A has orthologues in a number of closely mammals but in mouse and more distantly related species only the HAR1 sequence is conserved (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16915236\">Pollard (2006)</a>)."], ["Expression", "Expressed in adult brain and during cortical development (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16915236\">Pollard (2006)</a>). \n\nExpressed in Cajal-Retzius neurons in the neocortex during early to mid-gestation (7-9 to 17-19 weeks) in humans and macaques (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16915236\">Pollard (2006)</a>).  \n\nDuring mid-gestation expressed in developing hippocampus, dentate gyrus and cerebellar cortex in human. Expression was found in adult brain, ovary and testis (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16915236\">Pollard (2006)</a>).\n\nRepressed transcriptionally by REST, which causes repression of HAR1A in the striatum of Huntington's disease patients (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20179156\">Johnson (2010)</a>). \n\nThe overlapping antisense RNA (<a href=\"http://www.lncrnadb.com/Default.aspx?TKeyid=232\">HAR1B</a>) is also expressed in adult brain (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16915236\">Pollard (2006)</a>).\n\nIn mouse, locus is expressed during embryonic development (peak at E15) and in adults it is specifically expressed in the brain (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16915236\">Pollard (2006)</a>)."]]|
|20094|;|Characteristics|;|0|;|1|;|0|;|[["Characteristics", "mascRNA is a conserved, 61 nucleotide, tRNA-like sequence at the 3' end of Malat1 that is cleaved off the full length transcript and processed to generate a short tRNA-like ncRNA.\n\nMature mascRNA undergoes a post-transcriptional CCA addition and folds into a tRNA like structure but could not be amino acylated."], ["Conservation", "Conserved in mammals and back to reptiles and amphibians. More highly conserved than most of Malat1."], ["Expression", "mascRNA was cleaved off Malat1 in a wide variety of human tissues. \n\nmascRNA is cleaved off Malat1 by RNaseP in the nucleus before further processing by RNaseZ and then exported to the cytoplasm."], ["Name", "mascRNA (MALAT1-associated small cytoplasmic RNA)"]]|
|20281|;|Characteristics|;|0|;|1|;|0|;|[["Function", "PTENP1 asRNA alpha:\nInhibits transcription of the PTEN coding gene (knockdown caused up-regulation of PTEN, while asRNA alpha overexpression inhibited PTEN mRNA levels). \n\nPTENP1 asRNA alpha acts in trans by localising to the PTEN coding gene promoter and inhibiting expression. Repression of PTEN by PTENP1 asRNA alpha also involves EZH2 and DNMT3A. PTENP1 asRNA alpha binds DNMT3A (DNA methylase) and is required for the deposition of repressive H3K27me3 chromatin marks at the PTEN promoter.\n\nPTENP1 asRNA alpha regulation of PTEN is functionally significant. Loss of asRNA alpha leads to increased PTEN and p21 protein levels, negatively regulating the cell cycle and also sensitizing cells to apoptosis.\n\nPTENP1 asRNA beta:\nPTENP1 asRNA beta isoform forms an RNA-RNA interaction with PTENP1 sense and stabilizes it. This interaction promotes the function of PTENP1 sense as a positive regulator of PTEN mRNA levels, potentially by allowing the export of PTENP1 sense to the cytoplasm.\n\nSummary:\nPTENP1 asRNA alpha and beta have different functions. Alpha negatively regulating PTEN transcription and beta positively regulating PTEN mRNA post-transcriptionally through PTENP1 sense. \nSense and antisense transcrips from PTEN pseduogene regulate both transcription and translation of PTEN."], ["Characteristics", "Several lncRNA transcripts, alpha, beta and unspliced, expressed antisense to <a href=\"http://www.lncrnadb.org/Detail.aspx?TKeyID=187\">PTENP1 pseudogene</a> (also known as PTENpg1)\n\nAlpha and beta isoforms are, at least, four exon transcripts that differ in the position of the transcription start site (TSS). Alpha isoform initiates 5' and so has a longer first exon.\n\nUnspliced isoform initiates transcription from alpha TSS.\n\nSpliced transcripts show evidence of alternative splicing of exon 3."], ["Misc", "Not clear if 3' ends of various isoforms are known. BX374997 EST, which appears to initiate at beta start site may not be full length. "], ["Expression", "Alpha and beta spliced isoforms found predominately in cytoplasm and polyA +. Unspliced alpha isoform was predominately in nucleus and polyA-.\n\nExpression of PTENP1 asRNAs negatively correlates with expression of PTEN coding gene and positively correlates with PTENP1 sense pseudogene expression. Combined, the PTENP1 asRNAs generally showed higher expression than the sense PTENP1 pseudogene.\n\nAsRNAs expressed in a number of cell lines including HEK293T, U2OS, A375 and DU145."]]|
|20163|;|Characteristics|;|0|;|1|;|0|;|[["Function", "\"p53 mRNA region that interacts with the Mdm2 RING domain also encodes the amino acids which bind the N-terminus of Mdm2 protein\""], ["Characteristics", "Messenger RNA that encodes the p53 protein, but also has a role as regulatory RNA that interacts with Mdm2 protein, controlling its function and p53 gene expression."], ["Conservation", "N/A"], ["Expression", "N/A"], ["Misc", "p53 is a key tumour suppressor gene which \"<a href=\"http://www.ncbi.nlm.nih.gov/gene/7157\">responds to diverse cellular stresses to regulate target genes that induce cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism</a>\". MDM2 is an important regulator of p53, with binding of MDM2 protein to p53 protein promoting p53 degradation."]]|
|20263|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Found to interact with a number of chromatin binding proteins/complexes in mESCs including PRC1, PRC2, JARID1B, SUV39H1, SETD8 and CBX1, with the general pattern being interaction with repressors of gene expression (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21874018\">Guttman (2011)</a>)."], ["Characteristics", "2-4 exon transcript terminates 4kb upstream from Myosin IG (Myo1G). No evidence the transcripts join.\n\nAlternative splicing and potentially alternative initiation sites.\n\nTranscripts contain repeat sequences.\n\nSnoRNA host gene, sequence homologous to human SNORA9 present in one intron.\n"], ["Conservation", "Poorly conserved except for intronic snoRNA.\n\nIn syntenic position is human C7orf40, though there is little sequence conservation. "], ["Expression", "Expressed in mouse embryonic stem cells (ESCs) (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20436462\">Guttman (2010)</a>)."]]|
|20262|;|Characteristics|;|0|;|1|;|0|;|[["Function", "First lncRNA identified as a miRNA target (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21964070\">Hansen (2011)</a>). Acts as a miRNA sponge for miR-7 and miR671 but with different functional outcomes (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21964070\">Hansen (2011)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/23446346\">Hansen (2013)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/23446348\">Memczak (2013)</a>).\n\nFunction in association with miR-7:\nCDR1 AS acts as a sponge for miR-7, which can bind to CDR1 AS but not degrade it (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/23446346\">Hansen (2013)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/23446348\">Memczak (2013)</a>). \nCDR1 AS shows high levels of miR-7 and Ago2 association, which causes co-localisation of CDR1 AS to P-bodies (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/23446346\">Hansen (2013)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/23446348\">Memczak (2013)</a>).\nCDR1 AS and miR-7 expression patterns are not identical. However co-expression in the same brain cells can be identified in the dentate hilus and different layers of the cingulate gyrus (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/23446346\">Hansen (2013)</a>). The lack of CDR1 AS expression outside the brain makes it possible this is a brain specific interaction and function.\nCDR1 AS inhibit miR-7 activity causing depression of some miR-7 targets (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/23446346\">Hansen (2013)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/23446348\">Memczak (2013)</a>).\nExpression of human or mouse circular CDR1 AS in developing zebrafish (which have miR-7 but not the CDR1 locus) caused a decrease in midbrain size. This closely mimicked the phenotype of miR-7 knockdown, further supporting CDR1 AS as a biologically relevant miR-7 sponge (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/23446348\">Memczak (2013)</a>).  \n\n\nFunction in association with miR-671: \nCDR1 AS functions to stabilize CDR1 mRNA, as a decrease in CDR1 AS levels leads to a decrease in the expression level of the sense CDR1 mRNA. Conversely, the sense transcript does not act to stabilize the antisense lncRNA and appears to destabilize it, perhaps through a feedback mechanism (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21964070\">Hansen (2011)</a>).\nCDR1 AS and hence CDR1 sense are regulated by miR-671. A conserved miR-671 binding site is present in the antisense transcript (a site which corresponds to near the transcriptional start site of the sense CDR1 mRNA). miR-671 localises to the nucleus and can repress CDR1 AS and CDR1 sense mRNA (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21964070\">Hansen (2011)</a>).\nmiR-671 causes Ago2 mediated cleavage and down-regulation of CDR1 AS, likely due to the near perfect complementarity between miR-671 and CDR1 AS (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21964070\">Hansen (2011)</a>).\nMechanism for how CDR1 AS stabilizes CDR1 is not certain but it does not appear to be due to the lncRNA acting as a miR-671 sponge (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21964070\">Hansen (2011)</a>).\nBy down-regulating CDR1 AS miR-671 could potentially indirectly regulate miR-7 and hence the levels of miR-7 target genes (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/23446346\">Hansen (2013)</a>)."], ["Characteristics", "Identified as ~1.5kb (no internal splicing) and ~1.3kb (with internal splicing) (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21964070\">Hansen (2011)</a>). \n\nCircular transcript in which 5\u2019 and 3\u2019 ends have splice donor and acceptor sequences and are spliced together (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21964070\">Hansen (2011)</a>).\n\nHuman CDR1 AS contains 1 target site with almost perfect complementarity to miR-671 and 73/74 miR-7 target sites, of which 63 are conserved. The miR-7 sites have seed and 3' base pair matches to miR-7 but also central mismatches, which would be expected to prevent miR-7 mediated cleavage (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/23446346\">Hansen (2013)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/23446348\">Memczak (2013)</a>).\n\nAlso contains 2 internal splice sites (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21964070\">Hansen (2011)</a>).\n"], ["Misc", "Note: Evidence of antisense transcription across locus from a number of tissues present in Illumnia Body Atlas (IBA2). These suggest antisense transcripts can extend in both 5\u2019 and 3\u2019 directions and can be longer than 1.5kb. Whether these represent longer or primary CDR1 AS transcript is unclear.\n\nAK054921 may represent an isoform although the sequence does not reach the miR-671 binding site."], ["Conservation", "CDR1 AS found in eutherian mammals (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21964070\">Hansen (2011)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/23446346\">Hansen (2013)</a>).\n\nmiR-7 targets sites are conserved in eutherian mammals (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/23446346\">Hansen (2013)</a>), with 63 present in a least one other species (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/23446348\">Memczak (2013)</a>)."], ["Name(s)", "CDR1 Antisense\nCDR1 Natural antisense transcript\nCircular RNA sponge for miR-7"], ["Expression", "Highly expressed in HEK293 cells where it could potentially bind up to 20 000 miR-7 molecules per cells (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/23446348\">Memczak (2013)</a>).\n\nHighly expressed in human adult and fetal brain and spinal cord. Expression in brain considerably higher than that of CDR1 mRNA. Modest expression in other human tissues including heart, lung, thymus and thyroid (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21964070\">Hansen (2011)</a>).\n\nExpressed in mouse brain (cerebellum, cerebrum/cerebral cortex, hippocampus, forebain and midbrain) (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21964070\">Hansen (2011 )</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/23446348\">Memczak (2013)</a>), with high expression in the neocortex, hippocampus (including the dentate gyrus), thalamus and E13.5 midbrain.  At a tissue level CDR1 AS highly overlaps miR-7 expression (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/23446346\">Hansen (2013)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/23446348\">Memczak (2013)</a>).\n\nLocalises to neuronal cell bodies and dendrites (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/23446346\">Hansen (2013)</a>)."]]|
|20261|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Involved in maintaining pluripotency in ESCs (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21874018\">Guttman (2011)</a>).\n\nKnockdown in mECSs lead to down-regulation of Nanog, Oct4, Sox2, Klf4 and Zfp42 expression (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21874018\">Guttman (2011)</a>).\n\nFound to interact with chromatin binding protein/complexes in mouse embryonic stem cells including SUV39H1 and CBX3 (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21874018\">Guttman (2011)</a>)."], ["Characteristics", "Intergenic ~40kb 3\u2019 from HoxA locus, transcribed back towards HoxA locus.\n\n3-4 exons, alternative splicing  (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20436462\">Guttman (2010)</a>).\n\nContains a number of repeat sequences."], ["Conservation", "No evidence for expressed orthologue in human."], ["Expression", "Expressed in mouse embryonic stem cells (ESCs) and neural progenitors (NPCs)  (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20436462\">Guttman (2010)</a>).\n"]]|
|20260|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Involved in maintaining pluripotency in ESCs (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21874018\">Guttman (2011)</a>).\n\nKnockdown in mECSs lead to down-regulation of Nanog, Oct4, Sox2, Klf4 and Zfp42 expression (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21874018\">Guttman (2011)</a>)."], ["Characteristics", "Bidirectional with Cbln1, two-five exons. LincRNA (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20436462\">Guttman (2010)</a>).\n\nAlternative splicing and multiple transcriptional start sites generate a number of isoforms.\n\nSome isoforms contain repeat elements."], ["Expression", "Expressed in mouse embryonic stem cells (ESCs) (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20436462\">Guttman (2010)</a>).\n\nExpressed in cerebellum."]]|
|20267|;|Characteristics|;|0|;|1|;|0|;|[["Function", "P53 effector gene, acts in response to DNA damage to limit apoptosis while CDKN1A induces cell cycle arrest.\n\nLoss of PANDA leads to the apoptosis of doxorubicin treated cells.\n\nLoss of PANDA affected the expression of many genes during the DNA damage response.  Upregulated genes were enriched for those involved in apoptosis, including the apoptotic activators APAF1, BIK, FAS and LRDD. Leading to apoptosis of doxorubicin treated cells.\n\nCell death genes downstream of p53 are known to have NF-YA binding sites. PANDA RNA interacts with the transcription factor NF-YA and attenuates its occupany of target gene promoters."], ["Characteristics", "Bidirectional transcript from the CDKN1A promoter.\n\n1.5kb single exon.\n\nSequence runs antisense through a processed LAP3 pseudogene and contains a SINE.\n"], ["Conservation", "Syntenic sequence appear to be present in apes and old world monkeys (the Catarrhini)."], ["Expression", "One of five lncRNAs surrounding the transcription start site of the cell cycle gene CDKN1A that, along with the CDKN1A protein coding gene, were induced in human fetal lung fibroblasts upon DNA damage by doxorubicin.\n\nInduced up to 40 fold upon DNA damage peaking 16 h after doxorubicin treatment, a much greater response than shown by CDKN1A.\n\nExpression of PANDA and CDKN1A were positively regulated by p53. CDKN1A did not induce PANDA."]]|
|20266|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Role in activation of gene expression and cell differentiation. Required for the epigenetic activation of Hoxa6 and Hoxa7 and hence their target genes during mESC differentiation.\n\nMira was required for the recruitment of MLL1 to the Mira gene locus and the activation of Hoxa6 and Hoxa7. Mira mediated a local rearrangement in chromatin structure to bring the Mira, Hox66 and Hoxa7 loci into a complex providing a mechanism for MLL1 to act on HoxA6/A7 after recruitment to the Mira locus.\n\nMira bound to the SET domain of MLL1 through a short hairpin (activator binding motif, ABM) near the 3\u2019 end of the RNA. In vitro binding studies suggested MLL1 recruitment was mediated by Mira forming a RNA/DNA hybrid with a protruding ssRNA 3\u2019 end containing the ABM. "], ["Characteristics", "Transcribed from region between Hoxa6 and Hoxa7.\n\n798 nt, single exon, polyA+."], ["Expression", "Expression in mouse embryonic stem cell (mESC) induced by retinoic acid treatment.\n\nActivation of Mira expression occurs before expression of Hoxa6 and Hoxa7."]]|
|20264|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Transcript disrupted by a balanced translocation, 46,XY,t(2;6)(p15;p22.3), in a patient with West Syndrome (a form of infant epilepsy). Lack of effect on other nearby genes or presence of mutations in known West Syndrome disease genes leads to possible implication of BX118339 in the clinical phenotype (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/22245136\">Vandeweyer (2012)</a>)."], ["Characteristics", "Longest identified isoform is 738bp with 4 exons. Deep sequencing has also identified two shorter isoforms (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21890647\">Cabili (2011)</a>).\n\nSome exons overlap multiple SINEs"], ["Expression", "Transcript isoform(s) expressed in testis (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21890647\">Cabili (2011)</a>) and also reported in fetal brain (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/22245136\">Vandeweyer (2012)</a>)."]]|
|20129|;|Characteristics|;|0|;|1|;|0|;|[["Characteristics", "LincRNA ~100kb from the Sox2 transcription factor in mouse (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19182780\">Guttman (2009)</a>)."], ["Misc", "The chromosomal position of the lincRNA given in Guttman et al., (2009) is quite broad, however it is probable that it corresponds to the sequence, Accession ID and Browser link provided. "], ["Expression", "Expressed in embryonic stem cells but not in other cells tested (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19182780\">Guttman (2009)</a>).\n\nPromoter bound by Oct4 and Nanog (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19182780\">Guttman (2009)</a>).\n\nPromoter cloning showed expression can be driven by Sox2 and Oct4 individually and synergistically (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19182780\">Guttman (2009)</a>)."]]|
|20091|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Regulation of lipid-induced oxidative and ER stress (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19150982\">Brookheart (2009)</a>).\n\nCauses growth arrest and cell death (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/8649973\">Hollander (1996)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19150982\">Brookheart (2009)</a>). \n\nFound in cytoplasm associated with active ribosomes (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/8561505\">Crawford (1996)</a>), however all attempts at in-vitro and in-vivo translation have failed to express any peptides from the short ORFs found in the sequence (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/8561505\">Crawford (1996)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/8649973\">Hollander (1996)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19150982\">Brookheart (2009)</a>). Suggests ribosomal association could be regulatory, though translation of gadd7 can't be completely ruled out. \n\nInduction by hydrogen peroxide required calcium (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/8638945\">Crawford (1996)</a>). "], ["Characteristics", "Gene involved in the cellular response to a number of stressors.\n\n754 nt (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/8649973\">Hollander (1996)</a>)."], ["Conservation", "Identified in hamster."], ["Expression", "Induced by DNA damage (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/8649973\">Hollander (1996)</a>), lipotoxic-stress (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19150982\">Brookheart (2009)</a>), non-lipid oxidative stress (ie hydrogen peroxide exposure) (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/8561505\">Crawford (1996)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/8638945\">Crawford (1996)</a>), serum starvation (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/8649973\">Hollander (1996)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/8638945\">Crawford (1996)</a>) and heat shock (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/8638945\">Crawford (1996)</a>)."]]|
|20146|;|Characteristics|;|0|;|1|;|0|;|[["Function", "*Transfection of Jurkat T cells with a 326 bp fragment of LUST (originally termed Je2) suppresses CD95-mediated apoptosis (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/10949932\">Sutherland (2000)</a>).\n\n*Ectopic over-expression of LUST affects splicing of RBM5: it correlates with elevated expression of the full-length RBM5+5+6 splice variant, and with reduced expression of the truncated RBM5+5+6t isoform, which is cytotoxic (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19559772\">Rintala-Maki (2009)</a>). "], ["Characteristics", "~1.4 - 2.4 kb. Intronic, unspliced and transcribed antisense to the putative tumour suppressor gene RBM5/LUCA-15/H37, spanning introns 6 to 4 (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19559772\">Rintala-Maki (2009)</a>).\n\nContains SINE elements."], ["Expression", "Originally cloned from an human bone marrow library (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/10949932\">Sutherland (2000)</a>), this transcript is abundant in skeletal and cardiac muscle (as detected by Northern blot) (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19559772\">Rintala-Maki (2009)</a>)."], ["Name", "LUST: LUCA-15-specific transcript."]]|
|20190|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Controls RNAP II activity by inhibiting P-TEFb elongation factor, which is a cdk-cyclin kinase that functions as both a general and an HIV-1 Tat-specific transcription factor (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11713533\">Nguyen (2001)</a>) (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11713532\">Yang (2001)</a>), with an impact on cell growth and differentiation.\n\n7SK snRNA is a central scaffold that coordinates protein-protein interactions and, by inhibiting P-TEFb kinase-mediated CTD phosphorylation, regulates RNAP II elongation (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11713533\">Nguyen (2001)</a>). 7SK snRNP (composed of 7SK snRNA, Hexim1, Larp7/Pip7S, and the P-TEFb subunits CycT1 and Cdk9) is not only critical for controlling transcription, but also for regulating alternative splicing coupled to transcription elongation (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19416841\">Barboric (2009)</a>). It is also essential for vertebrate development (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19416841\">Barboric (2009)</a>). The 3' end of HIC mRNA has full activity and contains a predicted structure resembling the 3'-terminal hairpin of 7SK that is critical for P-TEFb binding (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19416841\">Barboric (2009)</a>).\n\n7SK has been found highly enriched in isolated chromatin fractions, which may be related to its role in transcriptional regulation (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20404130\">Mondal (2010)</a>).\n\nAt an early stage of the HIV transcription cycle, elongation is prevented as P-TEFb is recruited to the HIV-1 promoter in a catalytically inactive state bound to the 7SK snRNP and also the Tat trans-activator of transcription protein. The inhibitory 7SK snRNP may be displaced by the nascent TAR HIV RNA that also binds Tat protein, activating P-TEFb kinase and transcriptional elongation (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20562857\">D'Orso (2010)</a>). Displacement of 7SK may also be performed by cellular RNAs, as indicated by the 3'-untranslated region (~300-nt) of HIC mRNA, which forms complexes with P-TEFb and is necessary and sufficient for stimulation of P-TEFb-dependent transcription of the HIV promoter (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17925858\">Young (2007)</a>).\n\n7SK RNA also inhibits APOBEC3C deaminase activity and sequesters it to the nucleolus, suggesting broader role for 7SK RNA in regulating key nuclear functions (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17381310\">He (2006)</a>)."], ["Name", "RN7SK: RNA, 7SK small nuclear"], ["Characteristics", "~330 nt in vertebrates*. Transcribed by RNAP III, GC-rich sequence forming conserved secondary structures  (especially 3' and 5' stem-loop motifs).\n\n7SK RNA is capped at its 5' end by BCDIN3, a specific methylase methylphosphate capping enzyme (MePCE) (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17643375\">Jeronimo (2007)</a>). \n\nRNAP II was recently found to bind near 7SK promoter, as well as many other known Pol III genes, suggesting that RNAP II may also play a role in regulating their transcription (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20139302\">Raha (2010)</a>).\n\n*In invertebrates, 7SK homologs may have different sizes (such as >400 nt and ~130 nt in drosophilids and nematodes, respectively). (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18566019\">Gruber (2008)</a>) (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19734296\">Marz (2009)</a>)"], ["Misc", "The 7SK family contains a number of pseudogenes and derived repeats.\n\nMay be implicated in the transformation-dependent activation of oncogenes SV40 T-antigen and c-myc gene promoters (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9018369\">Krause (1996)</a>)."], ["Conservation", "Highly conserved throughout jawed vertebrates (but in lamprey it differs in 32% of its sequence from the mammalian 7SK (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/10824089\">G\u00fcrsoy (2000)</a>)), and has a few conserved sequence and structure motifs over longer evolutionary distances. Homologs have been identified in deuterostome invertebrates and in two protostome phyla (mollusks and annelids) (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18193315\">Gruber (2008)</a>). More recently, it has also been detected in arthropods, showing that two highly structured conserved domains (5'- and 3'-stem regions) were present in the bilaterian ancestor (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18566019\">Gruber (2008)</a>), and even in nematode Caenorhabditis species (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19734296\">Marz (2009)</a>)."], ["Expression", "Nuclear, highly abundant (one of the most abundant small RNAs in vertebrate cells), first isolated from HeLa nuclear extracts, but ubiquitously expressed.\n\nRNA sequencing from 11 humans tissues confirmed ubiquitous high expression of 7SK with expression in some tissues being higher than any mRNA (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20668672\">Castle (2010)</a>). "]]|
|20192|;|Characteristics|;|0|;|1|;|0|;|[["Function", "The function of dutA remains unclear. Disruption of dutA showed no morphological phenotype under normal conditions of growth and development (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/8127653\">Yoshida (1994)</a>), which may be due to functional redundancy. \n\nHowever, over-expression of dutA segments suppresses mutations in the signaling component Dd-STATa (the functional homolog of metazoan STAT transcriptional factors), rescuing stalk formation that is impaired in the mutants and indicating an inhibitory role of dutA in culmination. It also restores expression of target genes and tyrosine phosphorylation, indicating that dutA acts upstream of Dd-STATa in the signal transduction pathway and has an important role in Dictyostelium multicellular development switch (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17435008\">Shimada (2007)</a>)."], ["Characteristics", "~1.3 kb, transcribed by RNAP II, and exported to the cytoplasm (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/8127653\">Yoshida (1994)</a>)."], ["Misc", "Contains some peculiar sequence motifs."], ["Expression", "\"Developmentally regulated\" during Dictyostelium discoideum multicellular organization: induced during aggregation and exhibits a distinct expression pattern during stalk formation, ceasing with the onset of culmination (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/8127653\">Yoshida (1994)</a>) (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/7488100\">Kumimoto (1995)</a>) (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12796308\">Maeda (2003)</a>). dutA expression is not affected by cAMP signaling but requires protein kinase A (PKA) signaling (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/8764472\">Kumimoto (1996)</a>).\n\nA Serial Analysis of Gene Expression (SAGE) study indicates that dutA is the most abundant polyadenylated RNA in the Dictyostelium transcriptome, expressed at a level almost twice that of the next highest gene (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20309825\">Whitney (2010)</a>).\n\nA microarray analysis of D. discoideum cells infected with Legionella pneumophila indicated down-regulation of dutA mRNA, suggesting a possible function of dutA in host\u2013pathogen interaction (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16469056\">Farbrother (2006)</a>)."], ["Name", "DutA: Development-specific but UnTranslatable RNA A"]]|
|20270|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Required for normal embronyic development in Zebrafish. Morpholinos to decrease transcript level or block conserved (miR-7 recognition) site had neural development defects and short tails.\n- Lack of functional cyrano caused small heads and eyes, \u201cdefect in neural tube opening, loss of NeuroD-positive cells in the retina and tectum and enlarged nasal placodes\u201d.\n\nDefects could be recused by mature zebrafish cyrano transcript as well as the human and mouse orthologues.\n\nConserved site was necessary but not sufficient to explain cyrano function in zebrafish."], ["Characteristics", "Has similar structural characteristics in different vertebrate species. Spliced transcript with long (4-8kb) terminal exon which contains a number of conserved sequences.\n\nZebrafish: ~4.5kb, 3 exons with long terminal exon. Terminal exon contain several DNA transposons. Convergent transcription with oip5.\n\nHuman: ~8.8kb transcript has positional synteny, generally 3 or 4 exons, full length transcript has a long terminal exon.\n\nMouse: ~8.2kb, transcript has positional synteny, 3 exons, full length transcript has a long terminal exon. "], ["Conservation", "Long terminal exon shows a number of conserved sequences within tetrapods. One ~300nt highly conserved sequence contains a 67 nt sequence conserved between tetrapods and zebrafish, a 26nt subregion of which is almost perfectly conserved in vertebrates and is hypothesised to be a miR-7 binding site. \n"], ["Expression", "Expressed in zebrafish nervous system. Brain and notochord at 24 hours post fertilization (hpf), expression at 72 hpf also includes zebrafish spinal cord.\n\nMouse and human homolgoues are widely expressed in adult and developing tissues and cell lines including the brain (ENCODE, Gascoigne et al).\n\nRNA stability half-life of mouse homologue was 3-4 hr in neuroblastoma cells, close to lncRNA median (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/22406755\">Clark (2012)</a>).\n"]]|
|20271|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Linc-birc6 was required for normal embronyic brain development in Zebrafish. Morpholinos to decrease transcript level or block conserved site had brain and eye development defects.\n- Lack of functional megamind at 48 hpf caused \u201csmaller heads and eyes, enlarged brain ventricles (a hydrocephalic phenotype), and loss of NeuroD-positive cells in the retina and tectum.\u201d\n\nDefects could be recused by mature zebrafish megamind transcript (linc-birc6) as well as the mouse (AK012713, upstream of BDKRB2) and human (BX093813, antisense BIRC6) orthologues. \n\nConserved site was necessary, but not sufficient, to explain megamind function in zebrafish."], ["Characteristics", "Zebrafish linc-birc6: 2.4kb, 3 exons, alternative splicing. Antisense to intron of birc6. 5\u2019 of last exon alignable and contains a highly conserved region.\n\nHuman (antisense birc6) - full length transcript has not been characterised, at least 2 exons, 5\u2019 of second exon contains the highly conserved region.\n\nHuman LOC100507043 (upstream of BDKRB2) - ~3.2 kb, 2 exons, 5\u2019 of second exon contains the highly conserved region.\n\nMouse 2810011L19Rik  (upstream of BDKRB2) - 3.3 kb, 3 exons, 5\u2019 of final exon contains the highly conserved region."], ["Conservation", "Has core highly conserved region in vertebrates of 93 nt. 15 of conserved nucleotides are T\u2019s with 3 nt periodicity."], ["Expression", "Linc-birc6 was most highly expressed of zebrafish megamind homolgoues. Expressed in zebrafish nervous system. Brain and eye at 24 hours post fertilization (hpf), brain only at 72 hpf.\n\nExpressed in brain in mammals."], ["Gene copies", "Several genomic locations for megamind homologues are possible in vertebrate genomes and many vertebrates have more than one homologous copy.\n\nThree possible positions for megamind homolgoues have been identified: \n(1) Antisense to birc6 intron, \u201c(2) gene desert upstream of bdkrb1/,2 and (3) near hhipl1 homologs (found only in fish genomes)\". All contain a conserved region near the 5\u2019 of the final exon. \n\nZebrafish has expressed transcripts at all 3 loci, humans have (1) and (2)."]]|
|20088|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Gomafu can bind the splicing factor 1 (SF1) protein through its UACUAAC repeat sequences. This sequence is a much stronger intron branch point sequence than found in most mammalian introns. In-vitro Gomafu binding to SF1 can inhibit splicing and spliceosomal complex formation suggesting Gomafu can function to regulate splicing efficiency (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21463453\">Tsuiji (2011)</a>).\n\nRegulates retinal cell fate specification (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20459797\">Rapicavoli (2010)</a>).\n\nVariants confer susceptibility to myocardial infarction, possibly through altering the RNA's protein binding properties (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17066261\">Ishii (2006)</a>).\n\nProbable target of transcription factor Oct4 in mESCs. Appears to maintain Oct4 expression in a feedback loop helping to maintain pluripotency (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20026622\">Sheik Mohamed (2010)</a>).  "], ["Characteristics ", "Intergenic, ~9-10kb alternatively spliced transcript in mammals (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17066261\">Ishii (2006)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17623775\">Sone (2007)</a>).\n\nContains tandem UACUAAC repeats, which match the conserved intron branch point sequence in Saccharomyces cerevisiae (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21463453\">Tsuiji (2011)</a>)."], ["Conservation", "Well conserved in placental mammals, present in chicken and appears to be conserved back to amphibians (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20459797\">Rapicavoli (2010)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21463453\">Tsuiji (2011)</a>).  \n\nOutside of mammals sequence conservation is low but the SF1 binding UACUAAC repeats are conserved (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20459797\">Rapicavoli (2010)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21463453\">Tsuiji (2011)</a>)."], ["Expression", "Expressed predominantly in the nervous system (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17066261\">Ishii (2006)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17623775\">Sone (2007)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18184812\">Mercer (2008)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21463453\">Tsuiji (2011)</a>).\n\nShows dynamic regulation during retinal development (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15226823\">Blackshaw (2004)</a>), differentiation of neural stem cells into oligodendrocytes (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20137068\">Mercer (2010)</a>) and in mouse embryonic stem cell (mESC) differentiation (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20026622\">Sheik Mohamed (2010)</a>)(<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18562676\">Dinger (2008)</a>). \n\nExpressed in the nucleus accumbens of normal human brains and one of a few genes up-regulated in this brain region in both cocaine and heroin abusers (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16710320\">Albertson (2006)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21128942\">Michelhaugh (2010)</a>).\n\nNuclear specific localisation to novel nuclear matrix subdomain (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17623775\">Sone (2007)</a>)."], ["Names", "MIAT: myocardial infarction associated transcript (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17066261\">Ishii (2006)</a>).\nRNCR2: retinal noncoding RNA 2 (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15226823\">Blackshaw (2004)</a>)."]]|
|20089|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Initial studies indicated that DHFR upstream transcripts could impair the formation of the preinitiation complex (PIC) on the major promoter in vitro, thereby repressing the transcriptional activity of the major DHFR promoter (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12461786\">Blume (2003)</a>). DHFR upstream transcripts were shown to inhibit transcription from the DHFR core promoter in-trans in a concentration-dependent manner in in-vitro runoff transcription assays. Transcription factor binding sites positioned between the minor and major promoters within the DHFR gene were indicated to be affected by the upstream regulatory transcripts, which selectively sequestered transcription factor Sp3, and to a lesser extent Sp1, preventing their binding to the DHRF core promoter. The sequestration of Sp3 and Sp1 by the DHFR upstream transcripts appears to involve an altered conformation of the RNA, and a structural domain of the protein distinct from that required for binding DNA (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12461786\">Blume (2003)</a>). However, in-vitro experiments confirmed that transcription from the major promoter could be suppressed in-trans in the absence of Sp1 or any other upstream activating sequence (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/7566158\">Akoulitchev (1995)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17237763\">Martianov (2007)</a>).\n\nA more recent study demonstrated that these promoter associated transcripts act as interfering transcripts, directly interacting with TFIIB and dissociate the PIC efficiently to repress DHFR expression (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17237763\">Martianov (2007)</a>). Transcription of the regulatory RNA in trans has a repressive effect on the major DHFR promoter only when the transcript contained the sequence of the core major DHFR promoter (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17237763\">Martianov (2007)</a>). In addition, the major DHFR promoter is GC-rich and contains several G-track sequences (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12461786\">Blume (2003)</a>), and specific and stable triplex structures have been shown to form between the DHFR upstream transcripts and the major promoter, which may contribute to promoter targeting and repression in vivo (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17237763\">Martianov (2007)</a>) (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12461786\">Blume (2003)</a>).\n\nA comparison of in-vitro transcription from templates containing DHFR minor, major or both promoters in their original sequential order indicated very low transcriptional activity when the minor promoter preceded the major one, but robust transcription from the major promoter, suggesting that transcriptional interference in-cis may also play a role in DHFR inhibition by DHFR upstream transcripts (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17237763\">Martianov (2007)</a>)."], ["Characteristics", "DHFR upstream transcripts initiate from an upstream minor promoter of the DHFR (dihydrofolate reductase) gene and extend from approximately 400 nucleotide upstream of the 5'-untranslated region of DHFR (which corresponds to DHFR major/core promoter), to the second intron of the DHFR gene where they terminate (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/2859520\">Masters (1985)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17237763\">Martianov (2007)</a>). Therefore, the region located between minor and major transcript initiation sites (~400 bp) corresponds to a noncoding transcript and is a promoter of DHFR.\n\nDiscrete DHRF upstream initiating transcripts of diverse sizes have been reported, including five major discrete species with sizes of 4.3, 3.8, 3.1, 2.1, and 1.0 kb and four minor ones with sizes of 7.3, 5.0, 1.4, and 0.8kb. Primarily in the poly(A)+ fraction (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/2859520\">Masters (1985)</a>).\n\nDHFR upstream transcripts adopt a series of structures in vitro that are dependent on the G-tract encompassed in its sequence (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12461786\">Blume (2003)</a>)."], ["Misc", "Unpublished analysis of the epigenetic effects of DHFR upstream transcripts indicated similarities to epigenetic markers associated with transcriptional gene silencing induced by the targeted application of synthetic antigene RNAs complementary to the promoter regions of mammalian genes (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17237763\">Martianov (2007)</a>).\n\nDHFR is the major target of methotrexate, a key component in childhood acute lymphoblastic leukemia (ALL) treatment. DNA variations of major promoter/noncoding transcript region and specifc haplotype subtypes involving this region have been associated with childhood ALL, including associations with high-risk patients and lower event-free survival. One particular haplotype (Haplotype *1b) is associated with higher DHFR expression (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19861437\">Al-Shakfa (2009)</a>)."], ["Expression", "Enriched in the nucleus (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/2859520\">Masters (1985)</a>).\n\nAt least six minor 5' ends mapping upstream of the DHFR gene correspond to approximately 1% of the DHFR-specific polysomal polyA RNA. Most of these species have been found in 6A3 cells, VA2-B cells (the parental line of 6A3), and in HeLa cells (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/2859520\">Masters (1985)</a>).\n\nDHFR upstream transcripts accumulate in a population of serum-starved, contact-inhibited (quiescent) U2OS cells, in which the levels of DHFR mRNA are markedly reduced (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17237763\">Martianov (2007)</a>)."]]|
|20274|;|Characteristics|;|0|;|1|;|0|;|[["Function", "KDM5B-AS1 expression appears to stimulate KLHL12 gene expression (in HeLa cells). A gene located ~80kb from KDM5B-AS1 on the opposite strand."], ["Characteristics", "Spliced two exon transcript.\n\nMultiple splice variants, ~550- ~750 nt in length, second exon varies.\n\nExpressed bidirectionally with KDM5B.\n\nIn-vitro translation showed no sign of protein product."], ["Expression", "Expressed in HeLa, K562 and GM12878 cells, plus a number of human tissues."]]|
|20110|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Over-expression leads to inhibition of apoptosis induced by doxorubicin."], ["Name", "Prostate-specific transcript 1 (PCGEM1)"], ["Characteristics", "1643 nt."], ["Misc", "N/A"], ["Conservation", "N/A"], ["Expression", "Prostate tissue-specific and prostate cancer-associated."]]|
|20276|;|Characteristics|;|0|;|1|;|0|;|[["Function", "PDZK1IP1-AS1 expression appears to stimulate CMPK1 gene expression (in Jurkat cells). A gene located over 150 kb 3\u2019 of PDZK1IP1-AS1 on the same strand. "], ["Characteristics", "Spliced, two exon 661nt transcript.\n\nTranscribed bidirectionally with <a href=\"http://www.lncrnadb.org/Detail.aspx?TKeyID=275\">CYP4A22-AS1</a>.\n\nLincRNA catalogue from deep RNA sequencing suggests variation in transcript length and also potential alternative splicing (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21890647\">Cabili (2011)</a>).\n\nExpressed downstream of TAL1 and PDZK1IP1 on the opposite strand.\n\nIn-vitro translation showed no sign of protein product.\n"], ["Expression", "Expressed in Jurkat cells, but not in MCF7 cells (unlike CYP4A22-AS1)."]]|
|20112|;|Characteristics|;|0|;|1|;|0|;|[["Function", "siRNA knock-down experiments indicate that PINC RNA performs dual roles in cell survival and regulation of cell-cycle progression (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16574773\">Ginger (2006)</a>)."], ["Characteristics", "~1 and 1.6 kb isoforms identified."], ["Conservation", "PINC identified in rodents. Other mammals contains several conserved sequence blocks (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16574773\">Ginger (2006)</a>). However, it is unclear if a PINC homologue exists in these species, for example the syntenic human locus is antisense to the 3' of DIRC3 and no sense RNAs have been identified which contain the conserved sequence blocks."], ["Expression", "Developmentally regulated (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16574773\">Ginger (2006)</a>). Expressed in alveolar structures of the mammary gland and induced by pregnancy and hormonal stimulation (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11682629\">Ginger (2001)</a>). Also present in testis, liver and heart. Different isoforms show a tissue-specific distribution.\n\nIsoforms localise in distinct foci predominantly in the cytoplasm or nucleus depending on stage of cell cycle (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16574773\">Ginger (2006)</a>)."]]|
|20082|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Summary: Functions to regulate localised translation at dendrites, controlling neuron excitability and place learning. Lack of BC1 causes a susceptibility to epileptic seizures. \n\n\nBinds eIF4A, eIF4B and PABP to repress translation initiation by blocking assembly of the 48S initiation complex (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12451124\">Wang (2002)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12162957\">Muddashetty (2002)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16330711\">Wang (2005)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16154588\">Kondrashov (2005)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18316401\">Lin (2008)</a>).\n\nTranslational repression is mediated by its 3' domain and A rich region (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12162957\">Muddashetty (2002)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16330711\">Wang (2005)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16154588\">Kondrashov (2005)</a>).\n\nInhibits eukaryotic initiation factor 4A helicase by uncoupling ATPase activity from helicase/ duplex unwinding activity (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18316401\">Lin (2008)</a>).\n\nBy regulating localised translation BC1 can control neuron excitability; \nie: by regulating dopamine receptor levels and dopamine signalling in the striatum (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17699670\">Centonze (2007)</a>) \nie: inhibiting translation activation from metabotropic glutamate receptor (mGluR) signalling (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19675232\">Zhong (2009)</a>). \n\n\nKnock-out of BC1 in mouse affected exploratory behaviour and anxiety, leading to higher mortality in field experiments  (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12944471\">Skryabin (2003)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15302134\">Lewejohann (2004)</a>).\n\nBrain phenotypes of BC1 knockout mice include neuronal hyperexcitability triggered by mGluR signaling or GABAa receptor stimulation which stimulates protein translation BC1 would act to repress (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19675232\">Zhong (2009)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21124905\">Zhong (2010)</a>). Epileptogenic susceptibility (epileptic activity and convulsive seizures) upon auditory stimulation (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19675232\">Zhong (2009)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21124905\">Zhong (2010)</a>) and defects in place learning (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21124905\">Zhong (2010)</a>). \n\nThe combination of BC1 and fragile X mental retardation protein (FMRP) knockouts causes neuronal excitability, epileptogenesis, and place learning deficits of increased severity than individual knockouts suggesting BC1 and FMRP act independently to repress translation (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21124905\">Zhong (2010)</a>)."], ["Characteristics", "152 nt; evolved from a tRNA Ala (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/2437583\">DeChiara (1987)</a>)."], ["Conservation", "Evolved from a tRNA Ala (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/2437583\">DeChiara (1987)</a>).\n\nRodent specific (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/7692450\">Martignetti (1993)</a>).\n\nBC1, BC200 and G22 likely form a family of independently exapted repetitive elements which have evolved to carry out similar functions in different mammalian species (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12162957\">Muddashetty (2002)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17175535\">Khanam (2007)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18316401\">Lin (2008)</a>). "], ["Expression", "Expressed by a specific subset of neurons in the central and peripheral nervous system; localises to dendrites (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/1706516\">Tiedge (1991)</a>), or both axons and dendrites (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12040034\">Muslimov (2002)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17699670\">Centonze (2007)</a>) in different subsets of neurons and in a developmentally regulated manner. \n\nDecreased expression in brains of mice that suffer chronic epileptic seizures (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20974111\">Gita\u00ed (2011)</a>).\n\nAlso expressed in germ cells (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12040034\">Muslimov (2002)</a>).\n\nDendritic localisation mediated by an extended stem loop element (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11350036\">Rozhdestvensky (2001)</a>) in 5' 62 nucleotides (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9169532\">Muslimov (1997)</a>), containing two targeting codes a stem bulge motif that specifies nuclear export and a GA kink-turn (KT) motif that binds heterogeneous nuclear ribonucleoprotein A2 and mediates transport to the distal ends of dendrites (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17074884\">Muslimov (2006)</a>)."], ["Name", "Brain Cytoplasmic RNA 1"]]|
|20083|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Knockdown of BORG via transfection of antisense oligonucleotides partially inhibits BMP-induced differentiation of C2C12 cells into osteoblastic cells. Proposed involvement in bone morphogenesis."], ["Name", "BMP/OP-responsive gene (BORG) RNA"], ["Characteristics", "~2.8kb. Spliced and polyadenylated RNA with three exons.\n\nBORG RNA contains a number of repeat sequences."], ["Misc", "BMP: bone morphogenic protein\nOP: osteogenic protein"], ["Conservation", "Likely to be rodent specific as much of locus (and transcript) consists of rodent specific repeats. Unknown if a transcript is expressed in rat."], ["Expression", "Identified in a myoblast cell line (C2C12) trans-differentiating into osteoblastic cells. \n\nImmediate early response gene to bone morphogenic proteins (BMPs), expressed within 2 hrs, peaked between 12-24 hours before declining back to basal levels.\n\nExpression induced by BMPs and osteogenic proteins in multiple cell types that respond to BMP signaling."]]|
|20081|;|Characteristics|;|0|;|1|;|0|;|[["Function", "BACE1AS expression is elevated in Alzheimers disease (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18587408\">Faghihi (2008)</a>). It was shown to regulate BACE1 mRNA and protein expression in vitro and in vivo ie: over-expression, shRNA and siRNA knockdown of BACE1AS affected BACE1 expression, influencing amyloid-beta 1-42 levels (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18587408\">Faghihi (2008)</a>).\n\nIt was proposed that BACE1-AS and BACE1 form an RNA duplex and this increases the stability of BACE1 (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18587408\">Faghihi (2008)</a>). More recently, it was suggested that BACE1AS may prevent translational repression of BACE1 mRNA by miR-485-5p via masking the binding site for the microRNA. Supporting this hypothesis, BACE1AS over-expression prevented miRNA-induced suppression (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20507594\">Faghihi (2010)</a>). Expression of BACE1-AS as well as miR-485-5p are dysregulated in RNA samples from Alzheimer's disease subjects compared to control individuals (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20507594\">Faghihi (2010)</a>). \n\nBACE1-AS may also be involved in sporadic inclusion-body myositis (s-IBM), whose muscle-fiber phenotype shares molecular similarities with Alzheimer-disease brain (including increased BACE1 protein). BACE1-AS and BACE1 transcripts are significantly increased in s-IBM, and experimental induction of endoplasmic reticulum (ER) stress increased both BACE1-AS and BACE1 transcripts. These results suggest that ER stress and increased BACE1-AS expression may be involved in s-IBM (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20236612\">Nogalska (2010)</a>)."], ["Name", "BACE1 antisense RNA"], ["Characteristics", "~2 kb; two splice variants were identified for human and mouse BACE1-AS. Transcribed  from an intron of the beta-secretase-1 (BACE1) gene in antisense direction it also completely overlapps exon 6 of BACE-1 (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18587408\">Faghihi (2008)</a>)."], ["Misc", "Mouse AK078885 and human CB960709 full-length clones are unspliced and are ~1.2kb- and 798b-long, but two spliced variants were extended by RACE by Faghini et al., 2008."], ["Conservation", "BACE1-AS transcript has been identified in mouse and humans, with a conserved association with BACE1 across species (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18587408\">Faghihi (2008)</a>)."], ["Expression", "BACE1 and BACE1AS are co-expressed in a wide range of tissues and cell lines in mice and humans. BACE1 mRNA expression levels are higher than BACE1-AS levels across all tissues examined, except in Alzheimer's disease (AD) where, in contrast, BACE1-AS is expressed at a higher level in brain. Bace1 and Bace1-AS transcripts are also observed in various regions of the mouse brain (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18587408\">Faghihi (2008)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20507594\">Faghihi (2010)</a>).\n\nSeveral cell stressors, such as high temperature, serum starvation, amyloid-beta 1-42, H2O2 and high glucose, specifically increase BACE1-AS RNA and BACE1 protein levels (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18587408\">Faghihi (2008)</a>).\n\nShowed increased expression in sporadic inclusion-body myositis (s-IBM) muscle fibers (possibly caused by endoplasmic reticulum stress). Nevertheless, unlike in AD and AD-transgenic mouse brain samples in which BACE1-AS transcript was increased more than the sense BACE1 transcript , in s-IBM muscle biopsies the reversed was found (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20236612\">Nogalska (2010)</a>).\n\nMouse RNA stability was very close to median for lncRNAs, with a half-life 3.6 hr in N2A (neuroblastoma) cells (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/22406755\">Clark (2012)</a>). "]]|
|20087|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Proposed to affect myeloid development by regulating eosinophil gene expression, as knockdown of EGO in vitro in CD34+ cells decreases eosinophil granule protein MBP (major basic protein) and EDN (eosinophil derived neurotoxin) mRNA levels."], ["Characteristics", "Two isoforms:\n~1.0kb unspliced EGO-A and ~1.5 kb spliced (two exons) EGO-B.\n\nTranscribed antisense from a conserved intron of ITPR1 gene."], ["Conservation", "EGO and some of surrounding sequence is conserved. However the presence of EGO has not been investigated outside of humans. "], ["Expression", "Highly expressed in human bone marrow CD34+ cells and BMMC (bone marrow mononuclear cells).\n\nHighly upregulated during eosinophil development from CD34+ human hematopoietic stem cells before returning to basal levels within 72 hours. Despite a return to basal levels, EGO transcripts were present and inducible in mature eosinophils."], ["Name", "Eosinophil granule ontogeny (EGO) RNA"]]|
|20173|;|Characteristics|;|0|;|1|;|0|;|[["Function", "All function characterisation was on the AT2 isoforms.\n\nPR antisense transcripts act as a scaffold for other RNAs and proteins to bind, allowing them to regulate transcription of the progesterone receptor.\n\nDifferent small RNAs targeted at PR antisense transcripts can activate or repress PR transcription. A PR antisense transcript was necessary for activating PR transcription via a small RNA.\n\nPR antisense transcripts could associate with small RNAs, Argonaute proteins and hnRNP-k to bring about regulation of the PR protein coding gene. "], ["Characteristics", "Found several antisense transcripts which initiate in the progesterone receptor (PR) promoter region. \n\nAT1 and AT3 were unspliced.\n\nAT2-T47D and AT2-MCF7 were spliced with seven exons and transcribed over a 70kb region. AT2 isoforms initiated between the PR A and B start sites, had different (cell line specific) start sites but were otherwise identical. \n\nAT2-T47D ~1.35kb. AT2-MCF7 ~1.5kb."], ["Misc", "Accessions:\nAT-1: FJ515871\nAT-2-MCF7: FJ515872\nAT-2-T47D: FJ515873\n "], ["Expression", "Expression identified in human breast cancer cell lines (MCF7 and T47D).\n\nAT2 isoforms were the most highly expressed antisense transcripts.\n\nAT2 isoforms could be detected in the nucleus."], ["Name", "Progesterone receptor promoter antisense transcripts"]]|
|20257|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Involved in maintaining pluripotency in ESCs (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21874018\">Guttman (2011)</a>).\n\nKnockdown in mECSs lead to down-regulation of Nanog, Oct4, Sox2, Klf4 and Zfp42 expression as well as changes to ESC morphology (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21874018\">Guttman (2011)</a>)."], ["Characteristics", "Intergenic, 3-5 exon transcript. LincRNA (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20436462\">Guttman (2010)</a>).\n\nAlternative splicing and three transcription start sites generate a number of isoforms (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20436462\">Guttman (2010)</a>).\n\nContains multiple repeat sequences.\n\n~25kb downstream of Magi1 coding gene on same strand."], ["Conservation", "No evidence for expressed orthologue in human"], ["Expression", "Expressed in mouse embryonic stem cells (ESCs) (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20436462\">Guttman (2010)</a>)."]]|
|20171|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Due to the inverse or complementary expression pattern between Hoxa11 and HOXA11as mRNA expression levels, in the developing limbs (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/7789268\">Hsieh-Li (1995)</a>) and adult endometrium (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12050232\">Chau (2002)</a>), HOXA11as has been proposed to negatively regulate Hoxa11 mRNA levels (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12050232\">Chau (2002)</a>)."], ["Characteristics", "Bidirectional promoter with HOXA11. Multiple splice isoforms are present which share a common 3' exon (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/7789268\">Hsieh-Li (1995)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9745033\">Potter (1998)</a>), only some overlap HOXA11 (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9745033\">Potter (1998)</a>).\n\nAnnotated human isoform is ~1.6kb. A number of isoforms including ~1.4, ~1.9, ~2.9 and ~3.2kb transcripts have been identified in mouse (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/7789268\">Hsieh-Li (1995)</a>)."], ["Conservation", "Sequence highly conserved (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9745033\">Potter (1998)</a>), found throughout mammals."], ["Expression", "More highly expressed than HOXA11 in mouse development (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/7789268\">Hsieh-Li (1995)</a>).\n\nExpressed in developing limbs where it showed a complementary expression pattern to HOXA11 (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/7789268\">Hsieh-Li (1995)</a>). Also expressed in fetal kidney (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9745033\">Potter (1998)</a>),  placenta, adult colon, muscle and prostate (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17185360\">Sessa (2007)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17445766\">Sasaki (2007)</a>). Shows collinear regulation of expression like HOX PTC genes (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17445766\">Sasaki (2007)</a>).\n\nExpressed in same cell types as HOXA11 in the uterus. HOXA11as was dynamically expressed in the uterus during the menstrual cycle, with a peak in the endometrial late-proliferative phase, showing a pattern inverse to HOXA11 (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12050232\">Chau (2002)</a>). \n\nHOXA11as levels were down-regulated by progesterone in primary uterine stromal cells, which correlated with HOXA11 up-regulation in the same cells (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12050232\">Chau (2002)</a>). "], ["Misc", "Some HOXA11as isoforms have long ORFs, however these ORFs are not conserved between human and mouse (despite high nucleotide sequence conservation) (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/7789268\">Hsieh-Li (1995)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9745033\">Potter (1998)</a>). So while HOXA11as is thought to be noncoding, a possible role for HOXA11as encoding a protein cannot be completely discounted."]]|
|20108|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Identified in a shRNA knock down screening for conserved long noncoding RNAs that modulate the activity of nuclear factor of activated T cells (NFAT).\n\nKnockdown of human or mouse NRON sequences in human embryonic kidney (HEK) 293 cells or mouse 3T3 and Jurkat cell lines resulted in significantly increased NFAT activity.\n\nKnockdown of NRON increases NFAT transcription factor activity by specifically affecting NFAT nuclear trafficking. This effect is observed on the activity of multiple NFAT family members (NFATc1, NFATc2, NFATc3, and NFATc4).\n\nUsing an RNA-protein affinity purification strategy with part of NRON sequence, 11 proteins were reported to putatively bind NRON. These included: calmodulin-binding protein (IQGAP1), a nuclear transport factor (KPNB1), the structural subunit of a phosphatase (PPP2R1A), a component of the proteasome (PSMD11) and an RNA helicase (DDX3X); as well as three members of the importin-beta superfamily, factors which mediate the nucleocytoplasmic transport of cargoes such as NFAT. Direct interaction was demonstrated with importin-beta 1 (KPNB1).\n\nIn summary, having a repressive effect on NFAT signaling, NRON is proposed to regulate NFAT's subcellular localization as an RNA component of a protein complex that acts to represses NFAT activity.\nIt has presumed implications in immune response and developmental processes regulated by NFAT."], ["Characteristics", "noncoding repressor of NFAT (NRON)\n\n~2.7 kb. Composed of three exons, which can be alternatively spliced to yield transcripts ranging in size from 0.8 to 3.7 kb."], ["Conservation", "NRON contains blocks of sequence which are highly conserved back to chicken. In particular, it contains two large regions of 300 to 400 bases regions of near-perfect sequence conservation between rodents and primates."], ["Expression", "Expressed in relatively low levels. Present in mouse embryos and enriched in cells derived from human and mouse placenta, muscle, and lymphoid tissues such as the spleen, thymus and lymph nodes, with differential expression of isoforms."]]|
|20241|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Involved in the regulation of X chromosome inactivation in mammals via activation of the Xist RNA, possibly by interfering with Tsix expression (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21029862\">Tian (2010)</a>).\n\nJpx seems to act in trans, as its deletion prevents Xist up-regulation also from the Xist allele on the wild type chromosome (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21029862\">Tian (2010)</a>)."], ["Characteristics", "Spliced (5 exons), with multiple isoforms. Located at the X-inactivation center (XIC), transcribed from an unmethylated CpG island 10 kb upstream of Xist. Transcribed in antisense orientation to Xist. (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12160738\">Johnston (2002)</a>)"], ["Conservation", "First exon is highly conserved in mouse, human and cow (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12045143\">Chureau (2002)</a>)."], ["Expression", "Ubiquitously expressed.\n\nUp-regulated during both male and female embryonic stem cell differentiation (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21029862\">Tian (2010)</a>)."], ["Names", "Jpx; Enox (expressed neighbor of Xist)"]]|
|20243|;|Characteristics|;|0|;|1|;|0|;|[["Characteristics", "Antisense and head to head with Dio3 from the Dlk1-Dio3 imprtinted locus (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/14962667\">Hernandez (2004)</a>). A large number of isoforms are transcribed through alternative splicing and start sites some of which overlap Dio3 (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/14962667\">Hernandez (2004)</a>).\n\nAlso overlaps a provisional microRNA miR1247."], ["Conservation", "Aside from the short exon 1, there is poor sequence conservation and no conserved ORFs between mouse and human Dio3os (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/14962667\">Hernandez (2004)</a>)."], ["Expression", "Various DIO3OS isoforms are expressed in a wide range of human tissues including adult testis, adrenal cortex, heart, bladder, uterus, placenta and fetal lung (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/14962667\">Hernandez (2004)</a>).  \n\nExpressed in embryonic and extra-embryonic tissue in mouse. Weakly expressed in several neonatal and adult tissues: brain and liver (adult only), intestine and tougue (neonate only),  kidney and lung (expressed in both) (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16309881\">Tierling (2006)</a>).  \n\nAnalysis in different cell culture lines showed co-expression of DIO3OS transcripts and DIO3 (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16935842\">Kester (2006)</a>). Conversely differentiation of mature brown adipose tissue (BAT) adipocytes from precursor cells showed that Dio3 was only expressed in the proliferating precursors while a specific Dio3os isoform was expressed only in differentiated adipocytes (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17510246\">Hernandez (2007)</a>).\n\nNot imprinted in mouse (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16309881\">Tierling (2006)</a>).\n"]]|
|20242|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Functions to promote reprogramming of differentiated cells to iPSCs.\n- Knockdown decreased the number of iPSC colonies formed without affecting cell number. While over-expression increased the number of iPSC colonies formed.\n\nFunctions in maintenance of ESCs and iPSCs.\n- Knockdown lead to modest increase in apoptosis and activation of p53 pathways.\n"], ["Characteristics", "2.6kb, four exons.\n\nMost of the sequence is composed of LINE, SINE and LTR elements.\n"], ["Conservation", "No syntenic correlate expressed in mouse ESCs. Some exons appear to be transcribed from human specific repeat sequences. While others appear limited to certain primates."], ["Expression", "LincRNA enriched in ESC (embryonic stem cells) and iPSCS (induced pluripotent stem cells) compared to the fibroblast and CD34 cells the iPSCs were derived from. \n\nAlso more highly expressed in iPSCs than ESCs.\n\nLocus is a binding site for pluripotency transcription factors Oct4, Sox2 and Nanog. Knockdown of Oct4 or differentiation of stem cells caused down-regulation of lincRNA-RoR expression. Suggesting expression is controlled by these transcription factors."]]|
|20102|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Regulates DNA methylation in the T-DMR of Sphk1 promoter (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15325271\">Imamura (2004)</a>; <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19056938\">Preker (2008)</a>). In vitro over-expression of two fragments of Khps1 in NRK cells cause demethylation of CG sites of the T-DMR, but which is accompanied of DNA methylation at three CC(A/T)GG sites (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15325271\">Imamura (2004)</a>)."], ["Name", "Khps1a : Sphk1a antisense transcript"], ["Characteristics", "1290 nt*; originates from the CpG island and overlaps a \"tissue-dependent differentially methylated region\" (T-DMR) of Sphk1. Single-exon, 5'-capped and 3'-polyadenylated, it spans the region -2095 to -3384 in relation to the commonly used +1 translation start site for Sphk1 subtypes, which covers the entire region of the T-DMR (-3233 to -3023) and the alternative first exons of both Sphk1a and -c (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15325271\">Imamura (2004)</a>).\n\n*Northern blot with probes for Khps1 also indicates the presence of transcripts with different sizes (600-20,000nt)."], ["Misc", "There are possible open reading frames in Khps1a, in which the maximal size is 306 bp, but no recognizable amino acid motifs or domains in the possible proteins were found, and three possible start codons in the rat  Khps1a aligned with different codons in the corresponding human genomic DNA sequences (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15325271\">Imamura (2004)</a>)."], ["Conservation", "Rat Khps1a exhibits 88.7% and 56.2% nucleotide sequence identity with corresponding DNA sequences in the genome databases at NCBI for human and mouse  (Accession Nos. NT_1010641 and NT_039521), respectively (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15325271\">Imamura (2004)</a>).\n\nESTs overlapping Sphk1 T-DMR CpG island in mouse, homologous to the CpG island of rat Sphk1, are described (mouse EST AA796730 shows 87% similarity with the CpG island of rat  Sphk1). Human transcripts in the region were also detected by RT-PCR in HEK293 and HeLa cells (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15325271\">Imamura (2004)</a>)."], ["Expression", "Expression of Khps1 is detected in many tissues, with high levels in the kidney and only weakly expressed in the liver and brain. Expression was detected in the cytoplasm of primary cell culture from rat  fetuses, as well as nuclei in some cells, indicating that Khps1 is exported to the cytoplasm (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15325271\">Imamura (2004)</a>).\n\nSimilar to Sphk1, the expression of Khps1 is also detected from only one allele (demonstrating that it is also imprinted), and Khps1 and Sphk1 show mutually exclusive expression in individual cells (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15325271\">Imamura (2004)</a>).\n\nIdentified as a PROMPT (promoter upstream transcript) which are degraded by the exosome and generally highly unstable (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19056938\">Preker (2008)</a>)."]]|
|20103|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Regulates cell cycle or viability in embryonic stem cells but not self-renewal (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16767105\">Ivanova (2006)</a>)."], ["Characteristics", "Spliced transcript localized ~181kb from the Enc1 gene (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19182780\">Guttman (2009)</a>).\n\nmRNAs and ESTs suggest several transcripts or isoforms are present at this locus, which is currently not well defined."], ["Misc", "NRED accession ID is for another putative isoform and covers a splice junction not contained in the identified lincENC1 sequence. While the browser link is for Mm.219358/Gm2373."], ["Expression", "Expressed in embryonic stem cells and down-regulated upon retinoic acid induced differentiation (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16767105\">Ivanova (2006)</a>). "]]|
|20101|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Summary: Kcnq1ot1 has a role in the organization of a tissue/lineage-specific nuclear domain involved in epigenetic silencing of the Kcnq1 imprinting control region.\n\n\nGenes imprinted by kcnq1ot1 include Kcnq1, Cdkn1c, Slc22a18 and Phlda2, which are ubiquitously imprinted and Cd81, Osbpl5, Tssc4, Tspan32 and Ascl2, which are only imprinted in placenta (reviewed in <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21345374\">Kanduri (2011)</a>. An expansion of the Kncq1ot1 imprinted domain to include splice variants of Th and Ins2 was recently described (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21576366\">Jones (2011)</a>). \n\nKcnq1ot1 silences genes by coating chromatin and recruiting repressive chromatin remodeling complexes such as G9a, PRC1 and PRC2 (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18848501\">Terranova (2008)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18951091\">Pandey (2008)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15516932\">Umlauf (2004)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21172659\">Zhao (2010)</a>) .\n\nKcnq1ot1 transcript has a modular structure, the silencing element (that mediates the epigenetic silencing and directs the imprinted locus to a heterochromatin environment in the perinucleolar region) appears to be a short <1kb conserved sequence near the 5' of the transcript (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18299392\">Mohammad (2008)</a>).\n\nKcnq1ot1 forms a silenced subdomain (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18848501\">Terranova (2008)</a>)(<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19144718\">Redrup (2009)</a>) commonly localised to the perinucleolar region during S phase (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18299392\">Mohammad (2008)</a>). The silenced subdomain may be important to the maintenance of transcriptional repression.\n\nKcnq1ot1 interacts with Dnmt1 and recruits it to somatically acquired differentially methylated regions (DMRs) of imprinted genes (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20573698\">Mohammad (2010)</a>).\n\nIn vivo knockout study shows that paternal inheritance of a deletion encompassing an 890-bp (Delta890) silencing domain downstream of the Kcnq1ot1 promoter leads reduced interaction with DNMT1 and to selective incomplete relaxation of the imprinting of imprinted genes in a tissue-specific manner (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20573698\">Mohammad (2010)</a>).\n\nDelta890 showed altered DNA methylation at somatically acquired DMRs but not in histone modifications of the ubiquitously imprinted genes. Thus, it has been proposed that the ubiquitous and placental-specific imprinting of genes within the Kcnq1 domain might be mediated by distinct mechanisms, and Kcnq1ot1 RNA might mediate the silencing of ubiquitously imprinted genes by maintaining allele-specific methylation through its interactions with Dnmt1 (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20573698\">Mohammad (2010)</a>)."], ["Name", "Kcnq1ot1: Kcnq1 opposite transcript 1\nLIT1: long QT intronic transcript 1"], ["Characteristics", "91 kb, unspliced; imprinted (paternally expressed), it is transcribed from intron 10 of the maternally expressed Kncq1 (KvLQT1) gene from a CpG island that is the imprinting control region (IC2) (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/10393948\">Smilinich (1999)</a>). This imprinted region contains at least eight genes that are expressed exclusively or preferentially from the maternal allele (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21345374\">Kanduri (2011)</a>)."], ["Misc", "(Syndromes and diseases associated, eg Beckwith-Wiedemann syndrom, and cancers (see references list):\nAssociated with multiple balanced chromosomal rearrangements in Beckwith-Wiedemann syndrome (BWS) and an additional break-point in embryonal rhabdoid tumours; in particular, aberrant methylation of the CpG island associated with Kcnq1ot1 promoter is strongly associated with cancer risk and specific birth defects in BWS (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/10393948\">Smilinich (1999)</a>)). \n\nFor review on Kcnq1ot1 mechanism of action see (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21345374\">Kanduri (2011)</a>)."], ["Conservation", "Patches of highly conserved repeats in 5' side of transcript, which contains the silencing domain (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18299392\">Mohammad (2008)</a>). Promoter control elements are highly conserved between mouse and humans, including CCAAT elements that are targets of NF-Y regulation (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15459184\">Pandey (2004)</a>), as well as the position of CpG islands in the imprinting control region (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15590939\">Paulsen (2005)</a>)."], ["Expression", "Nuclear localised. \n\nExpressed in most human tissues.\n\nMouse RNA found to be highly unstable with a half-life <2 hr in N2A (neuroblastoma) cells (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/22406755\">Clark (2012)</a>)"]]|
|20106|;|Characteristics|;|0|;|1|;|0|;|[["Function", "ncR-uPAR can act in-trans to stimulate PAR-1 expression.\n\nncR-uPAR binds nuclear proteins in-vivo, which could provide a mechanism for it to positively regulate the PAR-1 promoter during embryogenesis."], ["Characteristics", "~400 bp. RNA polymerase II transcript. Found several kb upstream of the human protease-activated receptor-1 (PAR-1) gene.\n\nMostly made up of repeat sequences including an Alu element."], ["Misc", "Refseq ncR-uPAR appears to be the ncR-uPAR promoter and the lncRNA sequence. UCSC genomic co-ordinates are to this Refseq annotation, while the sequence provided is from the identified transcriptional start site to the end of the polyadenylation sites (exact 3' terminus is unknown)."], ["Expression", "Expressed during embryonic development.\n\nPresence of the ncR-uPAR promoter sequence drives expression of a transgene during embryonic vascular development at E9, which recapitulates PAR-1 expression at E9 quite well. At E16 expression was seen in brain and in arteries but not veins."], ["Name", "ncR-uPAR: non-protein coding RNA, upstream of F2R/PAR1"]]|
|20107|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Over-expression of the ncRNA enhances oligodendrocytic differentiation."], ["Characteristics", "4.3 kb. Spliced, antisense to Nkx2.2 (upstream sense of Pax1)."], ["Conservation", "N/A"], ["Expression", "Preferentially expressed in the nervous system."], ["Misc", "N/A"]]|
|20104|;|Characteristics|;|0|;|1|;|0|;|[["Function", "<b>Summary:</b> Meg3 is important for proper growth and development and is a putative tumour suppressor which functions to activate p53 and inhibit cell proliferation. Meg3 can also control gene expression at imprinted loci through recruitment of the PRC2 complex. \n\n<b>Function in Cancer:</b>\nExpression of the Meg3a splicing isoform was silenced in pituitary tumours and ectopic expression was found to inhibit growth in human cancer cells, leading to the proposition that Meg3 RNA acts as a growth suppressor (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/14602737\">Zhang (2003)</a>).\n\nSilencing of Meg3 is associated with meningioma pathogenesis and progression while ectopic expression inhibited growth and stimulated p53 (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20179190\">Zhang (2010)</a>).\n\nMeg3 knock-out increased expression of VEGF (Vascular Endothelial Growth Factor) signaling pathway genes in the brain, suggesting the RNA has a role in the control of vascularization, and therefore may function as a tumor suppressor in part by inhibiting angiogenesis (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20392836\">Gordon (2010)</a>).\n\n\n<b>Mechanism of action:</b>\nMeg3 stimulates p53 expression and can also inhibit cell proliferation/ DNA synthesis in the absence of p53 suggesting these functions are independent of each other (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17569660\">Zhou (2007)</a>), <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20032057\">Zhang (2010)</a>. Meg3 contains several predicted secondary structural elements common to all isoforms. Replacement of the motif most important in p53 activation with a different sequence that formed the same structure maintained Meg3 function showing the RNA structural motifs are critical to Meg3 function (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20032057\">Zhang (2010)</a>). \n\nMeg3 binds the PRC2 chromatin modification complex in mouse embryonic stem cells.  Binding appears to be mediated by the 5\u2019 1kb of the RNA (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21172659\">Zhao (2010)</a>).\n\nControls expression of Dlk1 at the Dlk1-Meg3 imprinted locus, likely by recruiting PRC2 to the Dlk1 locus in cis. Knockdown lead to increased expression of Dlk1 and Gtl2-as along with a decrease in Ezh2/PRC2 recruitment to and H3K27me3 marks at the Dlk1 promoter (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21172659\">Zhao (2010)</a>).\n\n\n<b>Developmental phenotypes:</b>\nKnockout of Meg3 and the Meg3 differentially methylated region (DMR) on the maternal allele lead to post-birth lethality, while paternal knockout lead to increased pre and post-birth lethality and growth retardation. However other lncRNAs (Rian, Meg9) were also down-regulated, perhaps due to the loss of the DMR, making attribution of the phenotype to specific lncRNAs difficult (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19264764\">Takahashi (2009)</a>). A potentially more specific lacZ gene trap insertion gave a parent of origin dwarfism phenotype (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9626496\">Schuster-Gossler (1998)</a>).\n\nAberrant repression of Meg3 and other maternally expressed lncRNAs from the DLK1-Dio3 imprinting cluster is present in most induced pluripotent stem cell (iPSC) lines and is responsible for the failure of iPSCs to form viable mice (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20418860\">Stadtfeld (2010)</a>). \nNB: iPSC embryos died mid-gestation, which was more severe than a maternal Meg3 KO (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19264764\">Takahashi (2009)</a>) indicating the phenotypic impact of other lncRNAs from this locus (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20418860\">Stadtfeld (2010)</a>)."], ["Characteristics", "~1.6 kb in humans with a number of splice isoforms and evidence of retained introns creating longer transcripts (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/10759892\">Miyoshi (2000)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20032057\">Zhang (2010)</a>). \n\nSimilar situation in mouse and sheep with ~2kb - ~10kb transcripts due to alternative splicing, alternative 5' and 3' ends and retained introns.  (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9626496\">Schuster-Gossler (1998)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11683710\">Bidwell (2001)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19194500\">Hagan (2009)</a>).\n \nImprinted: Maternally expressed from the Dlk1-Gtl2 imprinted locus (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9626496\">Schuster-Gossler (1998)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/10759892\">Miyoshi (2000)</a>). "], ["Misc", "Contains a microRNA: miRNA 770 in the last intron, (although it appears that this intron is sometimes retained) (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19194500\">Hagan (2009)</a>).\n\nA number of probes for Meg3 exist in NRED due to the large number of isoforms, accession IDs given are for probes that are common to most isoforms."], ["Localisation", "Localisation was generally nuclear, but some cells showed localisation to the cytoplasm or to both compartments (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9626496\">Schuster-Gossler (1998)</a>). In the nucleus Meg3 has been found associated with chromatin (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20404130\">Mondal (2010)</a>)."], ["Regulation", "Expression of Meg3 is stimulated by cyclic-AMP (cAMP). cAMP stimulates CREB transcription factor(s) to bind a cyclic-AMP-response element (CRE) in the proximal promoter which is important for Meg3 expression. Methylation of this promoter region blocks cAMP action (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16793321\">Zhao (2006)</a>).\n"], ["Conservation", "Mammals.\n\nBoth the human and mouse gene have ten exons with the middle exons being those which are alternatively spliced in both species (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20032057\">Zhang (2010)</a>)."], ["Expression", "Expressed in a temporal and spatially regulated manner: expressed early in mouse embryos in visceral yolk sac and embryonic ectoderm. Later in paraxial mesoderm, epithelial ducts, and also in skeletal muscle, cochlea, brain and eye (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9626496\">Schuster-Gossler (1998)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16342203\">Manji (2006)</a>). \n\nDynamically expressed during mouse CNS development. This includes expression during retinal development (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15226823\">Blackshaw (2004)</a>) and in many developing forebrain areas including the \"diencephalon, ventral telencephalon, post mitotic cell layers of the neocortex and pyramidal cell layer of the hippocampus\" (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16356785\">McLaughlin (2006)</a>). Also found to be up-regulated during differentiation of neuronal progenitors to GABAergic neurons in vitro (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20137068\">Mercer (2010)</a>).\n\nExpressed in adult brain (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/10759892\">Miyoshi (2000)</a>) but in a more restricted manner (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16356785\">McLaughlin (2006)</a>).  \n\nIsoform Meg3a is detected in human normal pituitary gland, but is absent in nonfunctioning pituitary adenomas (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/14602737\">Zhang (2003)</a>).\n\nExpressed in the nucleus accumbens of normal human brains and upregulated in this brain region in heroin abusers (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21128942\">Michelhaugh (2010)</a>). Conversely, levels are decreased in the caudate nucleus of patients suffering from the neurodegenerative condition, Huntington's disease (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/22202438\">Johnson (2012)</a>). \n\nSee cited papers for a more detailed analysis of developmental and tissue specific expression."]]|
|20105|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Transcription of Neat1 is essential for the assembly, maintenance and structural integrity of paraspeckles (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19217333\">Clemson (2009)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19188602\">Sasaki (2009)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19106332\">Sunwoo (2009)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21170033\">Mao (2011)</a>).\n\nNewly transcribed Neat1 RNA nucleates the formation of paraspeckles at its transcription site, recruiting paraspeckle proteins. Continued expression is required to maintain paraspeckles, identifying the dynamic nature of this nuclear body (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21170033\">Mao (2011)</a>).\nLiterature currently provides conflicting evidence about whether Neat1 v1 is sufficient for the formation of paraspeckles, or if this requires full length Neat1 v2 (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19188602\">Sasaki (2009)</a>, (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21240286\">Shevtsov (2011)</a>). In vivo however, significant expression of Neat1 v2 appears to be required for cells to form more than 1 or 2 paraspeckles (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21444682\">Nakagawa (2011)</a>).\n\nNeat1 appears to constrain the size and mediate the cylindrical geometry of paraspeckles. Neat1 short and the identical 5' end of Neat1 long plus the 3' of Neat1 long all localise to the periphery of paraspeckles, while the central region of Neat1 long is found in the interior of the nuclear body (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20881053\">Souquere (2010)</a>).\n\nInteracts with paraspeckles proteins PSPC1, PSF/SFPQ and NONO/P54NRB either directly or in a complex (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19217333\">Clemson (2009)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19188602\">Sasaki (2009)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19106332\">Sunwoo (2009)</a>).\n\nInteraction of short isoform with p54 requires protein interaction regions near the 5' and 3' of the transcript (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20211624\">Murthy (2010)</a>).\n\nNeat1 knockout lead to loss of paraspeckles, however mice were viable and fertile with normal morphology and populations of differentiated cells in one Neat1 v1 and v2 expressing tissue tested (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21444682\">Nakagawa (2011)</a>).\n\nNeat1 has also been reported to interact with a number of chromatin binding protein/complexes in mouse embryonic stem cells including PRC1, PRC2,\tJARID1B, ESET\tand SUV39H1, with the general pattern being interaction with repressors of gene expression (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21874018\">Guttman (2011)</a>)"], ["Name", "Neat1: Nuclear enriched abundant transcript 1. Short isoform - Neat1 v1. Long isoform - Neat1 v2\n\nMultiple endocrine neoplasia 1 (MEN1). Short isoform - MEN epsilon. Long isoform - MEN beta. \n\nVINC:  Virus-inducible ncRNA"], ["Characteristics", "Two isoforms: ~3.7 (NEAT1 v1/ MEN epsilon) and ~23 kb (NEAT1 v2/ MEN beta) transcribed from the MEN1 locus (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9253601\">Guru (1997)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16760401\">Saha (2006)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17270048\">Hutchinson (2007)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19106332\">Sunwoo (2009)</a>).\n\nIntergenic, single exon transcript. One transcriptional start site, long isoform is a continuation of the short isoform (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17270048\">Hutchinson (2007)</a>)."], ["Misc", "A conserved tRNA like sequence at the 3' end is cleaved off and processed to generate a short tRNA-like ncRNA from the long (Men beta) transcript, similar to Malat1 (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19106332\">Sunwoo (2009)</a>).\n\nThe last ~500bp of the short (Men epsilon) isoform has been shown to be expressed in trophoblast cells with a function potentially independent from the Neat1 transcript. This transcript, TncRNA has its own entry."], ["Conservation", "Placental mammals. Dog Neat1 is found in several genomic locations, version that is found near single dog Malat1 gene is given below (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17270048\">Hutchinson (2007)</a>). "], ["Expression", "Expressed in a wide range of human and mouse tissues (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9858482\">Peyman (1999)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16760401\">Saha (2006)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17270048\">Hutchinson (2007)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19106332\">Sunwoo (2009)</a>). Although expression of the long isoform (Neat1 v2/ Men beta) is much lower than Neat1 v1/ Men epsilon in many tissues (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21444682\">Nakagawa (2011)</a>).\n\nUp-regulation of Neat1 (and subsequent formation of/increase in paraspeckles) may be a general feature of differentiation. Neat1 is up-regulated upon human ESC differentiation (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19716791\">Chen (2009)</a>), muscle differentiation (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19106332\">Sunwoo (2009)</a>) and in-vitro neuronal differentiation (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20137068\">Mercer (2010)</a>).\n\nUp-regulated upon infection of mice with Japanese encephalitis virus or Rabies virus (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16760401\">Saha (2006)</a>).\n\nExpressed in the nucleus accumbens of normal human brains and upregulated in this brain region in heroin abusers (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21128942\">Michelhaugh (2010)</a>). In addition, expression levels are elevated in the caudate nucleus of patients suffering from the neurodegenerative condition, Huntington's disease (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/22202438\">Johnson (2012)</a>).\n\nLocalised to paraspeckles within the nucleus (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17270048\">Hutchinson (2007)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19106332\">Sunwoo (2009)</a>).\n\nMouse Neat1 found to be highly unstable (half-life <2 hr) in N2A (neuroblastoma) and 3T3 cells, although low stability did not prevent paraspeckle formation (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19561200\">Friedel (2009)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/22406755\">Clark (2012)</a>), while human NEAT1 appears to be more stable (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19561200\">Friedel (2009)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19188602\">Sasaki (2009)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19106332\">Sunwoo (2009)</a>). The two Neat1 isoforms also have differing stability, with the long (v2/Men beta) isoform more stable than than the shorter (v1/Men epsilon) isoform in N2A and 3T3 cells (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/22406755\">Clark (2012)</a>)."]]|
|20224|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Bind to La autoantigen protein (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9279391\">Rosa (1981)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/6262773\">Lerner (1981)</a>) and PKR in vitro, and have been suggested to block PKR activity and confer resistance to Fas-mediated apoptosis of host cells (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/1673026\">Clarke (1991)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/7901835\">Sharp (1993)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16160154\">Nanbo (2005)</a>), although inhibition of PKR has not been observed in vivo (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16282456\">Ruf (2005)</a>).\n\nEBER-1 interacts with RPL22 (ribosomal protein L22), which is known to interact with components of different viruses (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/7494316\">Dobbelstein (1995)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16556938\">Fok (2006)</a>). EBER-1 mediates stable relocalisation of L22 from nucleoli to nucleoplasm in EBV-infected cells, which is critical for EBER-dependent functions (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19640998\">Houmani (2009)</a>). Burkitt's lymphoma (BL) cells expressing mutated EBER-1 RNAs incapable of binding L22 have reduced capacity to enhance BL cell growth (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19640998\">Houmani (2009)</a>).\n\nRole in the growth and maintenance of BL cell malignant phenotype (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/8057484\">Shimizu (1994)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11024153\">Ruf (2000)</a>). Also contribute to the growth of other B-cell lymphoma-, gastric carcinoma-, and nasopharyngeal carcinoma-derived cell lines (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/14612496\">Iwakiri (2003)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15608666\">Iwakiri (2005)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11068051\">Yamamoto (2000)</a>).\n\nInhibit alpha interferon-induced apoptosis in latently infected B-cell lines. EBER RNAs induce the expression of interleukin (IL)-10 in BL cells (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11118209\">Kitagawa (2000)</a>), as well as insulin-like growth factor (IGF)-1 in gastric carcinoma and nasopharyngeal carcinoma cells, and IL-9 in T cells, which acts as an autocrine growth factor.\n\nEBERs can be secreted from EBV-infected cells and can be detected in the sera of infected patients. RNAs are recognized by toll-like receptor (TLR)3, leading to induction of type-I IFNs and inflammatory cytokines (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19720839\">Iwakiri (2009)</a>), suggesting that activation of TLR3 signaling could lead to the pathogenesis of active EBV infectious diseases (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19720839\">Iwakiri (2009)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20399962\">Iwakiri (2010)</a>).\n\nFunctionality of EBER1 and 2 does not appear to be redundant, as transforming capacity of EBER2-deleted virus is comparable to that of EBV lacking both EBERs, but that of EBER-1-deleted virus is as high as wild-type EBV, indicating that EBER1 does not play a critical role in EBV-induced B-cell growth transformation. (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17686859\">Wu (2007)</a>)"], ["Characteristics", "Encoded by Epstein-Barr virus. EBER genes are separated by 161 base pairs (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9279391\">Rosa (1981)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/6262773\">Lerner (1981)</a>).\n\nEBER1: 167nt, EBER2: 172nt. Show significant sequence similarity with each other. Heterogeneity resides at the 3' termini (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9279391\">Rosa (1981)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/6262773\">Lerner (1981)</a>). Highly structured, resulting in the formation of several stable stem-loops (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/2828685\">Glickman (1988)</a>).\n\nTranscribed by RNA polymerase III. Possess 5' pppA termini. Non-polyadenylated (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9279391\">Rosa (1981)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/6262773\">Lerner (1981)</a>)."], ["Misc", "Many similarities with adenovirus VAI and VAII RNAs (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9279391\">Rosa (1981)</a>), as well as other virus-encoded ncRNAs (eg. <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/2839701\">Howe (1988)</a>)."], ["Conservation", "The primary sequences of EBERs are strongly conserved among EBV strains (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/2536122\">Arrand (1989)</a>)."], ["NULL", "EBER: Epstein-Barr virus (EBV)-encoded small RNA"], ["Expression", "Highly expressed during EBV latency in infection of many cell types and all associated human malignancies (EBERs are the most abundantly expressed RNAs during latency).\n\nNuclear localisation."]]|
|20258|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Involved in maintaining pluripotency in ESCs (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21874018\">Guttman (2011)</a>).\n\nKnockdown in mECSs lead to down-regulation of Nanog, Oct4, Sox2, Klf4 and Zfp42 expression (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21874018\">Guttman (2011)</a>).\n\nFound to interact with chromatin binding protein/complexes in mouse embryonic stem cells including JARID1C and ESET (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21874018\">Guttman (2011)</a>)."], ["Characteristics", "Bidirectional transcript with Zfp148.\n\nSeveral splice isoforms. LincRNA (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20436462\">Guttman (2010)</a>).\n\nSequence can contain a number of repeat elements."], ["Conservation", "No evidence for expressed orthologue in human"], ["Expression", "Expressed in mouse embryonic stem cells (ESCs) (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20436462\">Guttman (2010)</a>)."]]|
|20259|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Involved in maintaining pluripotency in ESCs (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21874018\">Guttman (2011)</a>).\n\nKnockdown in mECSs lead to down-regulation of Nanog, Oct4, Sox2, Klf4 and Zfp42 expression (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21874018\">Guttman (2011)</a>).\n\nFound to interact with a number of chromatin binding proteins/complexes in mESCs including PRC1, PRC2 and JARID1C (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21874018\">Guttman (2011)</a>)."], ["Characteristics", "Intergenic, four-six exon transcript. LincRNA (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20436462\">Guttman (2010)</a>).\n\nAlternative splicing and two transcriptional initiation sites (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20436462\">Guttman (2010)</a>).\n\nContains multiple repeat sequences."], ["Expression", "Expressed in mouse embryonic stem cells (ESCs) (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20436462\">Guttman (2010)</a>).\n\nRNA found to be highly unstable with a half-life <2 hr in N2A (neuroblastoma) cells (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/22406755\">Clark (2012)</a>)."]]|
|20178|;|Characteristics|;|0|;|1|;|0|;|[["Characteristics", "Alternatively spliced transcripts found in a head to head arrangement with Otx2.\n\nMouse ~750nuc.  Humans ~2.4kb.\n\nContains a number of repeat sequences (human). Mostly free of repeats (mouse)."], ["Conservation", "Low conservation between mouse and human transcripts."], ["Expression", "Expression restricted to retina in panel of adult tissues (retina also shows the highest expression of Otx2).\n\nOtx2 and Otx2os1 had a partially complementary expression pattern in adult retinal layers. Otx2 was predominately expressed in the outer nuclear layer (ONL) and into the inner nuclear layer (INL), while Otx2os was predominately expressed in the ganglion cell layer (GCL) and into the INL."], ["Name", "Otx2os1: OTX2 opposite strand transcript 1"], ["Misc", "Otx2 is a transcription factor involved in brain and eye development.\n\nOtx2os1 Mouse: GeneID: 606497.  Human GeneID: 100309464"]]|
|20177|;|Characteristics|;|0|;|1|;|0|;|[["Characteristics", "Multiple spliced transcripts between HoxA6 and HOXA7 on the antisense strand, share some splice junctions but have different 5' and 3' ends (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17185360\">Sessa (2007)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17445766\">Sasaki (2007)</a>).  \n \nSome HOX6as transcripts overlap to one or both HOX protein coding genes (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17185360\">Sessa (2007)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17445766\">Sasaki (2007)</a>)."], ["Misc", "Example accessions: AK091933, AK092154."], ["Expression", "Expressed in adult lung, kidney, testis, placenta, colon, muscle. Fetal ovary and kidney, similar to HOXA6 and HOXA7 (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17185360\">Sessa (2007)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17445766\">Sasaki (2007)</a>).\n\nExpression can be induced by retinoic acid (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17185360\">Sessa (2007)</a>).\n\nShows collinear regulation of expression like HOX PTC genes (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17185360\">Sessa (2007)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17445766\">Sasaki (2007)</a>)."], ["Conservation", "HOXA6as transcripts contain sequences conserved in mammals and even sequences ultra conserved in vertebrates.\n\nSimilar mouse transcripts are not known, however, transcripts which run antisense to both HOXA5 and HOXA6, that share an splice junction with HOXA6as and transcribe through the vertebrate conserved element, are present in both species. "]]|
|20176|;|Characteristics|;|0|;|1|;|0|;|[["Characteristics", "Antisense to the long isoform of HOXA3 and to the 3' end of HOXA4 (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17185360\">Sessa (2007)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17445766\">Sasaki (2007)</a>).\n\nSeveral spliced, overlapping, transcripts are present at this locus (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17185360\">Sessa (2007)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17445766\">Sasaki (2007)</a>)."], ["Conservation", "Antisense transcripts to HoxA3 and HoxA4 also exist in mouse but unclear if they are homologous."], ["Expression", "Various antisense transcripts show similar expression profiles to each other and to HOXA3 and HOXA4. Expressed in the lung, kidney and testis (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17185360\">Sessa (2007)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17445766\">Sasaki (2007)</a>).\n\nExpression can be induced by retinoic acid (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17185360\">Sessa (2007)</a>).\n\nShows collinear regulation of expression like HOX PTC genes (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17185360\">Sessa (2007)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17445766\">Sasaki (2007)</a>).\n"], ["Misc", "Example accession is: BC035889"]]|
|20175|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Summary:\nControls activation of 5\u2019 HOXA genes. Chromosomal lopping bring it into close association with 5\u2019 gene loci. HOTTIP binds WDR5 and recruits a MLL chromatin modifiying complex to maintain a domain of active chromatin over the 5\u2019 of HOXA cluster (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21423168\">Wang (2011)</a>). \n\n- HOTTIP controls activation of 5\u2019 HOXA genes in mammals and chicken. \n- Impact on HOXA genes decreases with increased genomic distance from HOTTIP.\n- Phenotypic impact in chicken forelimb of HOTTIP knockdown was shorter than normal distal bones. \n\n- HOTTIP doesn\u2019t affect chromosomal structure and looping but it was necessary for maintenance of H3 K4me3 chromatin marks over the distally expressed 5\u2019 half of the HOXA locus. HOTTIP RNA binds WDR5 a component of MLL/Trithorax complexes recruiting a MLL complex to lay down H3 K4me3 marks.\n- WDR5 binding mediated by sequence(s) in 5\u2019 1kb of HOTTIP. \n\nHOTTIP appears to act in cis, its function is facilitated by the chromosomal looping that brings it into close proximity with 5\u2019 HOXA genes. "], ["Name", "HOTTIP - HOXA transcript at the distal tip"], ["Characteristics", "Gene located at 5\u2019 end of HoxA cluster, bidirectional transcript with HOXA13 (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17445766\">Sasaki (2007)</a>).\n\n~3.8kb, transcript in human, spliced and polyadenylated (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21423168\">Wang (2011)</a>).\n\n~2.3kb transcript in mouse, different splice isoforms, currently known transcripts initiate downstream from the syntenic site in human. "], ["Misc", "Background: Hox genes are found in 4 clusters. Genes in each cluster are expressed in certain tissues along body axes dependent on their position in the cluster. In the HoxA cluster genes near the 5\u2019 are expressed in more distal tissues while genes near the 3\u2019 are expressed in more proximal tissues.\n\nExpressed genes have active chromatin marks and show close physical association (likely due to chromosomal looping). Inactive genes do not associate and have repressive chromatin marks (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21423168\">Wang (2011)</a>).\n\n\nHuman clone accession: GU724873\nMouse clone accession: BC046496"], ["Conservation", "Present in human and mouse. Portions of HOXA13as sequence are well conserved throughout mammals (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21423168\">Wang (2011)</a>). \n\nAppears to be present in chicken although there is little homology (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21423168\">Wang (2011)</a>).\n\nRNA contains some highly conserved sequences which are predicted to form a conserved structure (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17445766\">Sasaki (2007)</a>)."], ["Expression", "Shows collinear regulation of expression like HOX protein coding genes (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17445766\">Sasaki (2007)</a>).\n\nHas bivalent chromatin marks (both H3 K4me3 and H3 K27me3) whether expression off or on, but only expressed in more distal cells (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21423168\">Wang (2011)</a>).\n\nHas a similar expression profile to HOXA13, expressed in colon, prostate, placenta and uterus, as well as hand, foreskin and foot fibroblasts (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17451645\">Sasaki (2007)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17445766\">Sasaki (2007)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21423168\">Wang (2011)</a>). Mouse E13.5 in-situs gave similar results (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21423168\">Wang (2011)</a>).\n\nNuclear localised, generally to a single small nuclear spot (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21423168\">Wang (2011)</a>).\n\nLowly expressed, estimated at ~0.3 copies/cell in expressing tissues (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21423168\">Wang (2011)</a>)."]]|
|20256|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Involved in maintaining pluripotency in ESCs (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21874018\">Guttman (2011)</a>).\n\nKnockdown in mECSs lead to down-regulation of Nanog and Oct4 expression as well as changes to ESC morphology (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21874018\">Guttman (2011)</a>)."], ["Characteristics", "Intergenic, two exon transcript. LincRNA (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20436462\">Guttman (2010)</a>).\n\nTwo transcription start sites generating unique first exons (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20436462\">Guttman (2010)</a>).\n\n~7kb upstream of Enah coding gene on same stand"], ["Conservation", "No evidence for expressed orthologue in human"], ["Expression", "Expressed in mouse embryonic stem cells (ESCs) (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20436462\">Guttman (2010)</a>)."]]|
|20172|;|Characteristics|;|0|;|1|;|0|;|[["Function", "EMX2OS is suggested to regulate EMX2 expression (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12573261\">Noonan (2003)</a>), which may involve distinct regulatory mechanisms in different cell types (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20066053\">Spigoni (2010)</a>).\n\nIn vitro knock-down experiments indicate that Emx2os contributes to post-transcriptional down-regulation of its sense partner in cortical precursors and their neuronal progenies, possibly by a Dicer1-dependent process  (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20066053\">Spigoni (2010)</a>).\n\nHowever, ectopic expression of a 5' fragment (OS1-179+) of Emx2os in neural precursors of the rhombo-spinal tract stimulates expression of Emx2, indicating a complex regulatory mechanism, perhaps at transcriptional level. In addition, Emx2 knock-out results in a strong reduction of Emx2os transcript levels, indicating a possible reciprocal regulatory loop (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20066053\">Spigoni (2010)</a>)."], ["Name", "Emx2os: Emx2 opposite strand transcript."], ["Characteristics", "5 kb. Spliced, bi-directional to Emx2, with a 271 nucleotide head-to-head antisense overlap. Riboprobe Northern blot indicates the existence of three additional Emx2os splicing isoforms differentially detected in the murine urogenital system, with sizes of 6.0, 2,3 and 1,8 kb, which are supported by cDNA evidence (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12573261\">Noonan (2003)</a>)."], ["Misc", "EMX2OS lies in the minimal interval with allelic loss in endometrial tumors and is a candidate endometrial cancer tumor suppressor (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12573261\">Noonan (2003)</a>)."], ["Conservation", "Association of Emx2os and Emx2 is conserved between mouse and humans, but no sequence conservation was found (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12573261\">Noonan (2003)</a>)."], ["Expression", "EMX2 and EMX2OS and their murine orthologs have similar profiles and extensively coincident cellular expression patterns in the endometrium. Expressed in the uterus, abundant in normal postmenopausal endometrium, reduced in premenopausal endometrium (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12573261\">Noonan (2003)</a>).\n\nEmx2os is expressed in the developing mouse CNS. Examination of expression at E10.5, E12.5, E14.5 and E18.5 showed, similar to Emx2, that its levels reduce progressively from E10.5 to E18.5. At E12.5, it is detected in a number of CNS structures also expressing Emx2 mRNA, such as the pallium and basal ganglia, mammillary recess of the hypothalamus, optic tectum, olfactory placode and otic vesicle. Emx2os is found in the developing telencephalon in periventricular proliferative layers and the cortical plate (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20066053\">Spigoni (2010)</a>).\n\nHowever, the sense/antisense pair may also show mutually exclusive patterns, such as within the cortex. Emx2os is detected in periventricular precursors that also express Emx2, but peaks in newly born post-mitotic neurons, which do not express Emx2, whereas Emx2 is expressed Cajal-Retzius neurons lying in the marginal zone, which do not express the antisense RNA (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20066053\">Spigoni (2010)</a>).\n\nIn human brain, expression has been detected in normal nucleus accumbens (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21128942\">Michelhaugh (2010)</a>)."]]|
|20254|;|Characteristics|;|0|;|1|;|0|;|[["Characteristics", "Intergenic, 2 exon transcript in mouse, with HeK4me3 chromtain mark at 5' (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20624288\">Chodroff (2010)</a>).\n\nHuman ortholog is linc-POLR3G-8 (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21890647\">Cabili (2011)</a>). Human ortholog has a number of splice isoforms with 3 or more exons."], ["Conservation", "Highly conserved for a lincRNA 36.7% mouse transcript overlaps phastCons elements (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20624288\">Chodroff (2010)</a>).\n\nConserved in mammals and back to frog, although mouse exon 2 is not conserved in all orthologs (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20624288\">Chodroff (2010)</a>).\n\nOpossum ortholog [GenBank:GU951678]. Frog and chicken ([GenBank: CX847574.1 and CR35248.1] respectively (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20624288\">Chodroff (2010)</a>).\n"], ["Expression", "Expressed in specific regions of embryonic and post-natal mouse brain (see Chodroff for details) including the rostal migratory stream at P3 with a \u201cpotential association with inhibitory GABAergic neurons\u201d (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20624288\">Chodroff (2010)</a>).\n\nExpressed in opossum and chicken embryonic brains showing spatio-temporal conservation of expression (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20624288\">Chodroff (2010)</a>).\n"], ["Misc", "Mouse transcript contains Evofold-predicted RNA secondary structure (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20624288\">Chodroff (2010)</a>).\n\nLncRNA transcripts in human from bidirectional promoter with TMEM161B (over 50kb upstream from linc-POLR3G-8 start site) can also share exons 2 and/or 3. See <a href=\"http://www.ncbi.nlm.nih.gov/nuccore/BC047059\">BC047059</a>."]]|
|20255|;|Characteristics|;|0|;|1|;|0|;|[["Characteristics", "Several isoforms of ~1.4, ~2 and ~3kb identified (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20062813\">Uhde (2010)</a>). Has splice variants, multiple alternative promoters (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20624288\">Chodroff (2010)</a>).\n\nIntergenic, transcription start site contains a HeK4me3 locus (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20624288\">Chodroff (2010)</a>)."], ["Expression", "Expressed in specific regions of embryonic and post-natal mouse brain (see <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20624288\">Chodroff (2010)</a> and <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20062813\">Uhde (2010)</a> for details).  \n\nExpression in embryonic brain includes in \u201c ventral midbrain where dopaminergic neurons are formed\u201d (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20062813\">Uhde (2010)</a>). So Rmst may be a marker for developing dopaminergic neurons (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20062813\">Uhde (2010)</a>).\n\n2kb transcript also expressed in adult brain, eye and lowly expressed in muscle and ovary (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20062813\">Uhde (2010)</a>).\n\nTranscript found to be highly unstable with a half-life <2 hr in N2A (neuroblastoma) cells (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/22406755\">Clark (2012)</a>)."]]|
|20183|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Competing endogenous RNA (ceRNA). Functions as a sponge/ target mimic for miR-372 through a conserved target site, reducing the expression and activity of miR-372 (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20423907\">Wang (2010)</a>).\n\nOne of targets of miR-372 is Prkacb (catalytic subunit of PKA) which is able to phophorylate CREB. Hence expression of HULC stimulates further HULC expression by inhibiting miR-372, and allowing PRKACB to create active CREB (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20423907\">Wang (2010)</a>).\n\nHULC knockdown affects expression of other genes including some described in liver cancer (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17241883\">Panzitt (2007)</a>).\n"], ["Characteristics", "~500nuc, spliced, polyadenylated, two exon transcript (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17241883\">Panzitt (2007)</a>).\n\nExon 1 mainly consists of an LTR (MLT1A) (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17241883\">Panzitt (2007)</a>)."], ["Conservation", "HLUC also present in other primates, gene shows good conservation above that of surrounding sequence. Not detected in rodents so may be primate specific (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17241883\">Panzitt (2007)</a>).\n"], ["Expression", "Binding of phospho-CREB to the HULC promoter activates HULC expression. Phosphorylation of CREB was stimulated by PKA signaling (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20423907\">Wang (2010)</a>). \n\nHighly up-regulated in hepatocellular carcinoma (HCC) and to a lesser extent in liver focal nodular hyperplasia (FNH). Up-regulation was specific to HCC with high expression not detected in normal liver, other tissues and their associated neoplasms (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17241883\">Panzitt (2007)</a>).\n\nHULC expression was also up-regulated in colorectal carcinomas that metastasised to the liver but not in primary colorectal carcinomas or carcinomas that metastasised to lymph nodes (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19445043\">Matouk (2009)</a>).\n\nHULC RNA could be detected in the blood of HCC patients (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17241883\">Panzitt (2007)</a>).\n\nLocalised to the cytoplasm, may associate with ribosomes, but no sign of translated products could be found (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17241883\">Panzitt (2007)</a>).\n\nHULC expression was also identified in 3 old world monkeys (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17241883\">Panzitt (2007)</a>)."], ["Name", "HULC: Highly upregulated in liver cancer RNA"]]|
|20187|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Competing endogenous RNA (ceRNA). PTENP1, through its 3'UTR, acts as a decoy for miRNAs that target PTEN.\n\nPTNEP1 functions as a tumour suppressor gene.\n\nOverexpression of the PTENP1 3'UTR lead to an increased level of PTEN and cellular growth inhibition, an effect dependent on the presence of mature miRNAs, supporting PTENP1's role as a miRNA decoy. While knockdown of PTENP1 lead to a decrease in PTEN levels and faster cell growth.\n\n<a href=\"http://www.lncrnadb.org/Detail.aspx?TKeyID=281\">PTENP1 asRNA beta</a> isoform forms an RNA-RNA interaction with PTENP1 sense and stabilizes it. This interaction promotes the function of PTENP1 sense as a positive regulator of PTEN mRNA levels, potentially by allowing the export of PTENP1 sense to the cytoplasm (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/23435381\">Johnsson (2013)</a>).\n\nThe PTENP1 locus was lost in a subset of colon cancers and a relationship was reported between PTENP1 copy number and PTEN expression level."], ["Characteristics", "Processed pseudogene of PTEN tumour suppressor gene at 9p13.3.\n\n~3.9kb.\n\nPredominately polyA- (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/23435381\">Johnsson (2013)</a>).\n\nPTENP1 \"coding sequence\" quite similar to PTEN but has lost start codon, while 3'UTR is ~1kb shorter than PTEN. Part of the PTENP1 3'UTR sequence is highly conserved compared to PTEN (~95%) with seed matches to the same miRNAs."], ["Misc", "Cells are very sensitive to levels of PTEN, with even subtle changes influencing cancer susceptibility (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20400965\">Alimonti (2010)</a>).\n\nA wider role for pseudogenes as miRNA decoys/ sponges has been proposed."], ["Expression", "Expressed in a very wide variety of human tissues and in prostate cancer. Good correlation between PTENP1 and PTEN levels.\n\nInhibition of endogenous miRNAs with seed matches to PTEN and PTENP1 leads to an increase in PTENP1 expression, validating it is targeted by miRNAs known to repress PTEN. "], ["Name", "PTENP1: PTEN Pseudogene 1"]]|
|20185|;|Characteristics|;|0|;|1|;|0|;|[["Function", "COOLAIR suggested to function in early cold induced silencing of FLC transcription (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20010688\">Swiezewski (2009)</a>).\n\nCOOLAIR promoter could silence some reporter genes. Suggests COOLAIR may function through transcriptional interference, although a function for the transcripts has not been tested (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20010688\">Swiezewski (2009)</a>)."], ["Characteristics", "Multiple spliced, polyadenylated isoforms. Short version ~400bp, long version ~750 bp (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20010688\">Swiezewski (2009)</a>).\n\nTranscription initiates just 3' of the FLC polyA site. Some isoforms terminate just beyond the start of the FLC gene (antisense transcription covers the entire FLC gene) (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20010688\">Swiezewski (2009)</a>)."], ["Misc", "COOLAIR short accession: GQ342259.1\nCOOLAIR long accession: GQ352646.1 \n\nCOOLAIR is distinct from <a href=\"http://www.lncrnadb.org/Detail.aspx?TKeyID=272\">COLDAIR</a>, which has been functionally characterized.\n"], ["Expression", "Antisense transcription over much of FLC locus. Generally shows a positive correlation with FLC transcripts, except upon cold treatment (vernalization) (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20010688\">Swiezewski (2009)</a>).\n\nAntisense transcripts show a transient accumulation upon cold treatment with a peak after 10-14 days (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20010688\">Swiezewski (2009)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21127216\">Heo (2011)</a>), before declining with further prolonged cold or when plants returned to warmth. Transcription of FLC decreases during cold treatment (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20010688\">Swiezewski (2009)</a>)."], ["Name", "COOLAIR: cold induced long antisense intragenic RNA (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20010688\">Swiezewski (2009)</a>)."]]|
|20098|;|Characteristics|;|0|;|1|;|0|;|[["Function", "HOTAIRM plays a role in the regulation of gene expression during RA-induced myeloid differentiation (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19144990\">Zhang (2009)</a>). Knock-down of HOTAIRM prevented induction of HOXA1 and HOXA4 expression during myeloid differentiation as well as the induction of myeloid differentiation genes CD11b and CD18 (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19144990\">Zhang (2009)</a>).\n\nFound to interact with a number of of chromatin binding proteins/complexes in mouse embryonic stem cells including PRC1, PRC2 and CBX1 (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21874018\">Guttman (2011)</a>)."], ["Characteristics", "Bidirectional transcript with HoxA1. Located between HOXA1 and HOXA2 genes (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17185360\">Sessa (2007)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17445766\">Sasaki (2007)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19144990\">Zhang (2009)</a>).\n\nIdentified transcript is 483 nt (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19144990\">Zhang (2009)</a>) but other splice isoforms are also likely to be expressed."], ["Conservation", "Sequence quite highly conserved in mammals, with transcripts also detected in mouse and rat (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19144990\">Zhang (2009)</a>). "], ["Expression", "Expressed in the myeloid lineage (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19144990\">Zhang (2009)</a>). Has also been identified as showing a similar expression pattern to HoxA1 and A2 with expression in thymus, muscle, colon, lung, kidney, spleen etc (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17185360\">Sessa (2007)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17445766\">Sasaki (2007)</a>).\n\nInduced by retinoic acid (RA) (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17185360\">Sessa (2007)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19144990\">Zhang (2009)</a>).\n\nShows collinear regulation of expression like HOX PTC genes (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17185360\">Sessa (2007)</a>).\n\nExpressed in mouse embryonic stem cells (ESCs) (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21874018\">Guttman (2011)</a>)"], ["Name", "HOTAIRM1: HOX antisense intergenic RNA myeloid 1"]]|
|20229|;|Characteristics|;|0|;|1|;|0|;|[["Function", "21AS is one of a number of RNAP III-transcribed short ncRNAs that have sequence complementarity to protein-coding genes, possibly acting as as a natural trans-chromosomal antisense RNA. Aligned to the human genome, it shows several homology hits, among which the most highly significant were associated to multiple intronic regions of centromeric protein F gene (CENP-F). In vitro over-expression of 21AS transcripts inhibits CENP-F protein accumulation and decreased levels of CENP-F mRNA, indicating that 21AS regulates CENP-F expression in trans.\n\n21A RNAs has a role in the control of the proliferation of human tumor cell lines, possibly via regulation of CENP-F expression. This effect was not observed in a mouse cell line."], ["Characteristics", "~300 nucleotide, nonpolyadenylated, RNAP III transcript. \n\nSINE (short interspersed nucleotide element - AluJb). 21A lacks the Alu-specific intragenic consensus elements needed to promote its pol III transcription such as the blocks A and B, which points to transcription driven by an extragenic type 3 pol III promoter.\n\nVery low free energy (deltaG) value (deltaG < -100) indicating strong secondary structure."], ["Conservation", "Similarly to all of the 7SL/Alu-derived elements, 21A is primate-specific."], ["Expression", "Nuclear localisation. Detected in tested cultured cells such as HeLa and skin fibroblast cells.\n\nThe level of 21A transcription was very low in three immortalized, fully proliferating cell lines (HeLa, 293T, and LAN5) compared to unproliferating/resting PBL (peripheral blood lymphocyte) cells. Similarly, the 21A RNA level in primary skin fibroblasts was higher than in 293T cells, reinforcing an inverse correlation between endogenous 21A expression and cell proliferation. "]]|
|20228|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Positively regulates gene expression of FANK1 and ADAM12 neighboring genes through modulating the chromatin structure in cis, as siRNA knock-down of the Intergenic10 ncRNA results in reduced expression of both FANK1 and ADAM12 mRNAs, with a significant decrease in the level of active chromatin mark H3K4me2 on FANK1 and ADAM12 promoters.\n\nKnock-down of the ncRNA had no effect on the expression of two tested distal genes, UROS and DOCK1.\n\nNote: Despite its overlap with the 3' end of ADAM12, Intergenic 10 is not simply an Adam12 3'UTR, as siRNA knockdown of Adam12 failed to decrease FANK1 expression unlike knockdown of CAR Intergenic 10. "], ["Characteristics", "Positioned between 3' ends of of FANK1 (fibronectin) and ADAM12 (ADAM metallopeptidase domain 12) genes, with an overlap of a few hundred base pairs with ADAM12."], ["Expression", "CAR Intergenic 10, ADAM12 and FANK1 are co-expressed in different tissues, including placenta, brain and a human skin fibroblast (HF) cell line. \n\nCAR Intergenic 10 was most highly expressed in HF cells and very lowly expressed in brain, with placenta in-between."], ["Name", "CAR10: Chromatin Associated RNA 10"]]|
|20164|;|Characteristics|;|0|;|1|;|0|;|[["Characteristics", "17kb, polyadenylated, but not spliced. \n\nSense intronic to Phosphodiesterase 7B, also covers one exon.\n\nContains a number of repeats, mostly near the 3 end."], ["Conservation", "Has short regions of conserved sequence."], ["Expression", "Expressed in activated, but not resting, CD4+ T cells. Also found in stimulated peripheral blood mononuclear cells (PBMC) and CD8+ T cells.\n\nLocalisation is predominately nuclear.\n\nShows a similar expression pattern to the interferon-gamma receptor gene, found ~1Mb away, which may suggest a co-regulation of the two transcripts in immune cell activation/development."], ["Name", "NTT: noncoding transcript in T cells."], ["Misc", "Phosphodiesterase 7B is a cAMP-specific phosphodiesterase, a member of the cyclic nucleotide phosphodiesterase family. Involved in cAMP and cGMP signaling.\n\nSequence given is from genomic DNA, which corresponded to results from RT-PCR and RACE."]]|
|20090|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Evf-2 ncRNA and Dlx-2 proten display an intranuclear colocalization (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16705037\">Feng (2006)</a>).\n\nThe ultraconserved region* of Evf-2 binds and co-operates with Dlx-2 in vivo to increase the transcriptional activity of the Dlx-5/6 enhancer in a target and homeodomain-specific manner (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16705037\">Feng (2006)</a>). *The Evf-2 5' region is both necessary and sufficient for activity.\n\nEvf2 recruitment of DLX2 and MECP2 controls the expression of targets Dlx5, Dlx6 and Gad1 through trans and cis-acting mechanisms in developing ventral forebrain. Evf2 function is also required for proper gene regulation and formation of hippocampal GABA-dependent neuronal circuitry in mouse adult brain (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19620975\">Bond (2009)</a>)."], ["Characteristics", "~3.8 kb. Antisense to Dlx6 genes in the Dlx5/6 cluster. Evf1 and 2 are isoforms with alternative promoters expressed from ultraconserved enhancers. Different Evf-1 and Evf-2 transcripts result from alternative transcription initiation, alternative splicing of exon 3, and alternative polyadenylation. Therefore, Evf-1 and Evf-2 cDNA sequences have unique 5' and 3' ends, and share a 2561bp region of identity (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16705037\">Feng (2006)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15183307\">Kohtz (2004)</a>).\n\nA large (7.5-kb) non-polyadenylated form recognized by both Evf-1 and Evf-2 Northern blot probes is present in the total RNA fraction and absent from the poly(A) containing fraction. The Evf-2-specific probe also identifies a smaller (500-bp) transcript (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16705037\">Feng (2006)</a>)."], ["Conservation", "Evf-2 is transcribed from (and contains in its first exon) a vertebrate ultraconserved element. Analysis of transcripts by isolation from a cDNA library (rat), RT\u2013PCR (zebrafish and chicken), or expressed sequence tag (EST) databases (human and mouse) showed that transcription of the ultraconserved element associated with Evf-2 (enhancer ei) is conserved in vertebrates (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16705037\">Feng (2006)</a>).\n\nEvf-1 and Evf-2 exhibit a high degree (86%\u201393%) of conservation between rat and mouse sequences in their 5' and 3' regions, and a compilation of transcripts found in human, rat, mouse, zebrafish, and chicken shows that only transcription from exon 2 is conserved (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16705037\">Feng (2006)</a>)."], ["Expression", "Nuclear localisation (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16705037\">Feng (2006)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17623775\">Sone (2007)</a>).\n\nSimilar expression pattern to Dlx6 and Dlx5 mRNAs. Developmentally regulated, expressed in the ventral forebrain. Detected in immature neurons as they exit the ventricular zone (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16705037\">Feng (2006)</a>).\n\nEctopic expression of Sonic hedgehog (Shh) induces the expression of Evf-2, Evf-1, Dlx-2, Dlx-5, and Dlx-6 in the dorsal telencephalon in vivo (mouse embryos)  (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16705037\">Feng (2006)</a>).\n\nUp-regulated in vitro during differentiation of neuronal progenitors to GABAergic neurons and during mouse embryonic stem cells differentiation (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18562676\">Dinger (2008)</a>) (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20137068\">Mercer (2010)</a>). Also found co-expressed in the first and second branchial arches of E10.5 mouse embryos (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18697905\">Jeong (2008)</a>).\n\nBrain expression of Evf2 and Evf1 is dependent on Dlx1/2 function. Expression of Evf2 and Evf1 is also greatly reduced in Dlx5/6, and Dlx5 or Dlx6, knock-out mutants, indicating that they may be their direct or indirect regulatory targets (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15183307\">Kohtz (2004)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18697905\">Jeong (2008)</a>). Evf1 and Evf2 were more down-regulated in Dlx5-/- than in Dlx6-/- mutants (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18697905\">Jeong (2008)</a>)."], ["Misc", "Evf-2 is proposed to belong to a class of transcription regulating, ultraconserved ncRNAs (trucRNAs), and may be part of a broader Dlx gene/antisense RNA regulatory network (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16705037\">Feng (2006)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18562676\">Dinger (2008)</a>)."]]|
|20166|;|Characteristics|;|0|;|1|;|0|;|[["Characteristics", "7 known dUHGs (dUHG 1-5, 7-8), spliced noncoding RNAs that contain intronic snoRNAs (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11302516\">Tycowski (2001)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15987805\">Huang (2005)</a>). Nb: UHG6 identified as protein coding.\n\nThese 7 genes contain around half the known box C/D snoRNAs in Drosophila with snoRNAs in almost every intron (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15987805\">Huang (2005)</a>).\n\ndUHG1 & 2 transcriptional start sites have characteristics of the 5' TOP gene family (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11302516\">Tycowski (2001)</a>)."], ["Conservation", "dUHG 1 and 2 contain snoRNAs that appear homologous to some of those found in UHG/SNHG1 and Gas5/SNHG2. Calling these genes homologous is not straightforward however, ie: both dUHG1 and 2 contain snoRNAs found in UHG, dUHG2 also contain snoRNAs found within introns of mammalian protein coding genes."], ["Expression", "dUHG1 and 2 can be stabilised by inhibition of protein synthesis suggesting they are normally degraded by nonsense mediated decay (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11302516\">Tycowski (2001)</a>)."], ["Name", "dUHG: Drosophila U snoRNA Host Gene."], ["Misc", "GeneID NCBI Entrez Gene\ndUHG1: 3772106. dUHG2: 3772246. dUHG3: 3772557. dUHG4: 8673973. dUHG5: 8673975. dUHG7: 8674061. dUHG8: 8674065.  "]]|
|20092|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Necessary and sufficient for growth arrest in human peripheral blood T-cells. Functions by  controlling apoptosis and the cell cycle in lymphocytes (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18354083\">Mourtada-Maarabouni (2008)</a>).\n\nIn some cell lines certain Gas5 isoforms act to sensitise the cells to apoptosis but can't induce apoptosis on their own. In other cells types Gas5 can both induce apoptosis and growth arrest and sensitise the cells to further apoptosis (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18836484\">Mourtada-Maarabouni (2009)</a>).\n\nGas5 can be regulated by mTOR, with mTOR (which promotes cellular proliferation) acting to inhibit the function of Gas5 (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20421347\">Mourtada-Maarabouni (2010)</a>).\n\nGas5 carries out its function by binding the DNA binding domain of the glucocorticoid receptor (GR) with a sequence that mimmics the glucocorticoid response element (GRE). Gas5 is translocated into the nucleus bound to the GR where it prevents GR from binding GREs and regulating transcription of target genes including apoptosis inhibitors (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20124551\">Kino (2010)</a>).\n\nGas5 also appears to repress the action of many steroid hormone receptors, showing some similarities to another lncRNA SRA (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20124551\">Kino (2010)</a>).\n\nGas5 is a snoRNA host and a functional RNA. Function does not require putative but nonconserved ORF, or the intronic snoRNAs (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18354083\">Mourtada-Maarabouni (2008)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18836484\">Mourtada-Maarabouni (2009)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20124551\">Kino (2010)</a>)."], ["Characteristics", "Growth arrest-specific transcript (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/3409319\">Schneider (1988)</a>), multiple splice isoforms (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/1630459\">Coccia (1992)</a>) of ~250, ~450, ~600nuc and longer (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18354083\">Mourtada-Maarabouni (2008)</a>), encodes 9 (10 in humans) snoRNAs in its introns (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9819378\">Smith (1998)</a>)."], ["Conservation", "Gas5 in mouse and human do not show high sequence identity (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17468437\">Tanaka-Fujita (2007)</a>) although the GRE mimmic region is conserved (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20124551\">Kino (2010)</a>).\n\nMost of the snoRNAs found in human Gas5 also cluster in the same order in a putatively noncoding RNA host gene in chicken. 42% homology was found between human Gas5 and the chicken gene which was named Gas5-like (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19232134\">Shao (2009)</a>)."], ["Expression", "Widely expressed in adult tissues and over embryonic development (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/1630459\">Coccia (1992)</a>).\n\nTranscript undergoes post-transcriptional regulation, highly unstable but stabilised by growth arrest, serum starvation and inhibition of protein synthesis (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/1630459\">Coccia (1992)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9819378\">Smith (1998)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20124551\">Kino (2010)</a>). Associates with ribosomes in the cytoplasm (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9819378\">Smith (1998)</a>).\n\nLocalises to both the nucleus and the cytoplasm (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20124551\">Kino (2010)</a>).\n\nDown-regulated in breast cancer (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18836484\">Mourtada-Maarabouni (2009)</a>).\n\nTranscript was classified as unstable with a half-life >4 hr in human Hela cells (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/22369889\">Tani (2012)</a>). Similar half-lives were identified in human B cells and mouse 3T3 fibroblasts (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19561200\">Friedel (2009)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/22406755\">Clark (2012)</a>)."], ["Misc", "Mourtada-Maarabouni., et al (2010) provide an interesting hypothesis for how Gas5 levels and therefore function is regulated.\n- Gas5 is stabilised by inhibition of protein synthesis suggesting it may normally be a target for nonsense mediated decay (NMD). mTOR regulates 5' TOP genes (which includes Gas5) promoting translation, whereas mTOR inhibition inhibits translation. This could allow mTOR to inhibit Gas5 by promoting Gas5 NMD. \n\nThis suggests that since Gas5 is known to be functional at the RNA level, any Gas5 translation may be a regulatory to control Gas5 levels and not necessarily to produce a functional protein.  "]]|
|20223|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Beta2.7 RNA has a fundamental role in preventing stress response and apoptosis of the host cell, by binding to components of the mitochondrial respiratory chain complex I (reduced nicotinamide adenine dinucleotide\u2013ubiquinone oxido-reductase). Beta2.7 specifically binds and prevents re-localization of essential complex I subunit genes associated with retinoid/interferon-induced mortality-19 (GRIM\u201319), in response to apoptotic stimuli. This interaction is also important for stabilizing the mitochondrial membrane potential and the mitochondrial ATP production, preventing metabolic dysfunction, which is essential for completion of the virus' life cycle (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17540903\">Reeves (2007)</a>).\n\nBeta2.7 transcripts have also been shown to protect endothelial cells from rat aorta against apoptosis during ischemia/reperfusion injury, which also involves complex I of the mitochondrial respiratory chain. Overexpression of beta2.7 RNA reduced reactive oxygen species production and inhibited apoptosis (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20036157\">Zhao (2010)</a>)."], ["Characteristics", "2.7kb transcript, encoded in the herpesvirus HCMV genome. Unspliced and polyadenylated (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/2436392\">Greenaway (1987)</a>)."], ["Misc", "A potential open reading frame of 170 amino acids was identified close to the 5'-terminus of the gene (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/2436392\">Greenaway (1987)</a>), but no protein product of this RNA has ever been detected in infected cells."], ["Expression", "Beta2.7 kb transcript is found predominantly in the cytoplasm and does associate with polysomes (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/2436392\">Greenaway (1987)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/2436392\">Greenaway (1987)</a>)(<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12917473\">McSharry (2003)</a>). It is an early transcript expressed upon infection (12 to 24 hours), and rapidly accumulated in infected cells, accounting to ~20% of viral RNA transcription (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/2436392\">Greenaway (1987)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/2436392\">Greenaway (1987)</a>)."], ["Conservation", "Beta2.7 sequence is highly conserved not only in HCMV clinical isolates but also in the common laboratory strains, demonstrating that the gene sequence was not substantially modified during prolonged in vitro passage (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12917473\">McSharry (2003)</a>)."]]|
|20222|;|Characteristics|;|0|;|1|;|0|;|[["Characteristics", "Sense intronic to the Phkb gene, close by to a putative recombination hotspot in mouse.\n\n2.4kb unspliced transcript, has a TATA box and polyA signal so appears to be an independent polymerase II transcript transcribed from an intron."], ["Conservation", "Some small blocks of sequence is conserved throughout mammals."], ["Expression", "Expressed in mouse testis, liver, kidney and spleen (by northern)."], ["Misc", "Transcription start and termination sites were not precisely mapped, but since primer extension did give a small region for initiation and a polyA signal was found near the 3' end the coordinates and sequence provided are close to correct. "]]|
|20097|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Originally identified as silencing the HoxD locus but has since been found to epigenetic silence gene expression at many sites across the genome by recruitment of PRC2 and LSD1/CoREST/REST repressive chromatin modifying complexes (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17604720\">Rinn (2007)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20616235\">Tsai (2010)</a>).\n\nHOTAIR acts as a scaffold for protein complexes. A 5' domain binds PRC2 while a 3' domain binds LSD1 (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20616235\">Tsai (2010)</a>).\n\nOncogene - regulates metastatic progression (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20393566\">Gupta (2010)</a>)(<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21637793\">Schorderet (2011)</a>).\n\nHOTAIR dysregulated in breast cancer with frequent overexpression in metastases. \nOverexpression of HOTAIR leads to PRC2 re-targeting across the genome to a state similar to that in embryonic fibroblasts, promoting tumour invasion and metatasis.  Oncogenic effects of HOTAIR upregulation were dependent on PRC2 (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20393566\">Gupta (2010)</a>).\n\nDeletion of the HoxC cluster containing the cognate Hotair transcript in mouse showed little phenotypic effect, with little change in the expression on levels of H3K27me3 coverage in corresponding human HOTAIR Hoxd target genes (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21637793\">Schorderet (2011)</a>)."], ["Characteristics", "2.2 kb; spliced, polyadenylated and comprised of 6 exons in humans (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17604720\">Rinn (2007)</a>). \n\nTranscribed from the HOXC locus from a position intergenic and antisense to the flanking HOXC11 and HOXC12 genes (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17604720\">Rinn (2007)</a>)."], ["Conservation", "HOTAIR exists in mammals but with poor sequence conservation (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17604720\">Rinn (2007)</a>)(<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21496275\">He (2011)</a>). A 239 bp domain in HOTAIR exon 6 is especially conserved in mammals (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21496275\">He (2011)</a>).\n\nThe mouse EST (AK035706) homologous to human HOTAIR is comprised of two exons only, with the second half of the first exon showing similarity to exon 4 of HOTAIR, whereas the second exon is homologous to exon 6 of HOTAIR (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21637793\">Schorderet (2011)</a>). This may underlie differences in function since the first three exons of HOTAIR (absent from mHotair) contain binding sites for EZH2, while the 3' extremity of human HOTAIR that interact with LSD1 is part of the least conserved DNA sequence within mHotair exon 2 (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21637793\">Schorderet (2011)</a>)."], ["Expression", "Expressed in posterior and distal fibroblasts (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17604720\">Rinn (2007)</a>).\n\nExpression level in cancer is an efficient predictor of metastasis and survival with high expression levels predictive of poor outcomes (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20393566\">Gupta (2010)</a>). Also in patients with stage IV colorectal cancer (CRC), HOTAIR expression levels were higher in cancerous tissues than in noncancerous tissues, with high HOTAIR expression tightly correlated with the presence of liver metastasis and associated with poor prognosis (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21862635\">Kogo (2011)</a>) .\n\nSome HOTAIR transcripts localise to the nucleus (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19571010\">Khalil (2009)</a>).\n\nIn situ hybridization analysis of the mouse cognate RNA (mHotair) showed expression similar to Hoxc11, with distinct levels in parts of the proximal hindlimbs, genital bud and tail in embryos at E11.5, as well as in in posterior part of the hindlimb and genital bud at E12.5 (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21637793\">Schorderet (2011)</a>). \n\nTranscript found to be quite unstable with a half-life >4 hr in human Hela cells (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/22369889\">Tani (2012)</a>). "], ["Name", "Hox antisense intergenic RNA"]]|
|20096|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Complex functions: \n\nInfluences growth via control of Igf2 expression, with a H19 knockout showing an overgrowth phenotype due in part to bi-allelic expression of Igf2 (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9203585\">Ripoche (1997)</a>).\n\nCan also function in trans to downregulate the expression of a number of imprinted genes in the hypothesised Imprinted Gene Network (IGN) including Igf2r, Dlk1 etc. Allowing H19 to regulate growth during development (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19762426\">Gabory (2009)</a>).\n\nImplicated as both a tumor suppressor (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/7692308\">Hao (1993)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18719115\">Yoshimizu (2008)</a>) and an oncogene upregulated by c-myc and hypoxia (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17786216\">Matouk (2007)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16707459\">Barsyte-Lovejoy (2006)</a> and references therein). A number of reports have also shown upregulation / reactivation of H19 in various cancers although the functional significance (if any) is unclear in many cases (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20486133\">Gabory (2010)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9811352\">Adriaenssens (1998)</a>).\n\n\nThe mode of action by which H19 functions is still unclear: \n\nFocusing on its regulation of Igf2, H19 has been hypothesised to act at the level of transcription since an H19 knockout lead to methylation changes and loss of imprinting of Igf2 (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9203585\">Ripoche (1997)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9294195\">Forn\u00e9 (1997)</a>). However, H19 can bind Igf2 mRNA binding-protein (IMP) family members (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/10875929\">Runge (2000)</a>), which appear to act to promote translation of Igf2 (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15121863\">Hansen (2004)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15753088\">Liao (2005)</a>), therefore competition between Igf2 and H19 for IMP1 binding may allow H19 to regulate Igf2 post-transcriptionally.\n\nBoth sense and antisense transcripts from the H19 locus were identified as binding to the PRC2 chromatin modification complex in mouse embryonic stem cells, suggesting a potential function for H19 RNA (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21172659\">Zhao (2010)</a>).\n\nmiR-675 may be responsible for the oncogenic activity of H19 as it was found to down-regulate the tumour suppressor retinoblastoma (RB) in human colorectal cancer, causing increased tumour cell growth (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19926638\">Tsang (2010)</a>). Also, in adult human chondrocytes, expression of H19 (and subsequently miR-675) is driven by SOX9 with miR-675 acting to positively regulate COL2A1 which encodes a collagen protein important to the cartilage matrix (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20529846\">Dudek (2010)</a>).\n\n\nH19 appears to be a bi-functional RNA acting as both a miRNA and a lncRNA. Such properties may help to explain the conflicting reports that it is both a tumour suppressor and an oncogene (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18587395\">Smits (2008)</a>). Additionally its effect on tumour development may be heavily context dependent (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20486133\">Gabory (2010)</a>). "], ["Characteristics", "2.3 kb. Imprinted at the Igf2 locus (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/1709450\">Bartolomei (1991)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/1303252\">Zemel (1992)</a>).\n\nAlso contains a microRNA (miR-675) in exon one (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17237358\">Cai (2007)</a>)."], ["Conservation", "Conserved and imprinted in therians (eutherians and marsupials). Both the miRNA and the  H19 lncRNA exon structure are conserved (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18587395\">Smits (2008)</a>)."], ["Expression", "Expressed from the maternal allele, while the neighbouring Igf2 gene is transcribed from the paternal allele (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/1709450\">Bartolomei (1991)</a>). \n\nIn mice, H19 is activated in extra-embryonic cell types at the time of implantation. Strongly expressed during embryogenesis, down-regulated after birth with strong expression only retained in skeletal muscle and cartilage (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/6206499\">Pachnis (1984)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/3396539\">Pachnis (1988)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/1811930\">Poirier (1991)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20668672\">Castle (2010)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20529846\">Dudek (2010)</a>); upregulated in various tumors (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17786216\">Matouk (2007)</a>).\n\nCan be found in both the nucleus and the cytoplasm (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/10875929\">Runge (2000)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17948025\">Schoenfelder (2007)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/1688465\">Brannan (1990)</a>). "], ["Misc", "First long noncoding RNA described in mammalian cells (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/1688465\">Brannan (1990)</a>). Gabory 2010 provides a useful review of some of the extensive literature on H19 (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20486133\">Gabory (2010)</a>)."]]|
|20220|;|Characteristics|;|0|;|1|;|0|;|[["Features", "AK023948 is embedded in the TG-SLA (thyroglobulin and Src-like adaptor) locus on chromosome 8q24, a susceptibility locus for papillary thyroid carcinoma (PTC). An unspliced cDNA, AK023948 is located in an intron of both the TG (sense orientation) and SLA (antisense) genes.\n\nA 12 Kb haplotype containing 8 SNP markers for PTC is harboured in the TG-SLA locus, which also includes two additional putative noncoding RNA genes.\n\nAK023948 (cDNA FLJ13886 fis, clone THYRO1001559) was cloned from thyroid gland and is 2,807b long (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/14702039\">Ota (2004)</a>). The transcript is significantly down-regulated in most PTC tumors, thus representing a candidate susceptibility gene for PTC."]]|
|20272|;|Characteristics|;|0|;|1|;|0|;|[["Function", "COLDAIR is required for stable repression of FLC after vernalization and a lack of COLDAIR lead to late flowering after vernalization.\n\nCOLDAIR binds PRC2 complex protein CURLY LEAF (CLF), with maximal interaction after 20 days of vernalization / cold exposure. \n\nCOLDAIR is required to recruit PRC2 to the FLC locus allowing deposition of the repressive H3K27me3 chromatin mark.\n\nCOLDAIR did not impact the expression of other genes that repress flowering. "], ["Characteristics", "~1.1kb sense transcript from first intron of FLC\n\n5\u2019 capped, but not generally polyadenylated\n\nRNA polymerase II transcript\n\nTranscriptional start site within vernalization response element (VRE), which is required for proper vernalization dependant repression of FLC and appears to act as the promoter for COLDAIR."], ["Expression", "Transcriptional start site within vernalization response element (VRE), which is required for proper vernalization dependant repression of FLC and appears to act as the promoter for COLDAIR.\n\nExpression specifically and transiently induced during vernalization / cold exposure with a peak at around day 20 and return to baseline levels by day 30. \nNb: this expression pattern is similar to COOLAIR, but up to 10 days delayed.\n\nCOLDAIR transcription may be shut off in negative feedback loop, where it shuts off transcription within the FLC gene including its own.  "], ["Background", "Epigenetic represssion of FLOWERING LOCUS C (FLC) is required for Arabodopsis flowering in spring.\n\nPolycomb repressive complex 2 is required for FLC repression.\n\nCOLDAIR is distinct from <a href=\"http://www.lncrnadb.org/Detail.aspx?TKeyID=185\">COOLAIR</a>, which does not appear to interact with PRC2."]]|
|20273|;|Characteristics|;|0|;|1|;|0|;|[["Function", "LncRNA stimulates ECM1 gene expression (in HEK293 cells) (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20887892\">\u00d8rom (2010)</a>)."], ["Characteristics", "Spliced two exon transcript of ~550 nt in length (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20887892\">\u00d8rom (2010)</a>).\n\n~2kb downstream from 3\u2019 of Extracellular Matrix Protein 1  (ECM1), however a H3K4me3 peak at the TSS provides good evidence it is an independent transcript (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20887892\">\u00d8rom (2010)</a>).\n\nIn-vitro translation showed no sign of a protein product (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20887892\">\u00d8rom (2010)</a>)."], ["Expression", "ECM1 and LINC00568 are both upregulated during differentiation of primary human keratinocytes with TPA (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20887892\">\u00d8rom (2010)</a>).\n\nLINC00568 identified as enriched in K562 and HepG2 nuclear fractions (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/22955988\">Derrien (2012)</a>).\n"]]|
|20111|;|Characteristics|;|0|;|1|;|0|;|[["Function", "siRNA knock-down shows that PRINS is required for cell viability after serum starvation (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15855153\">Sonkoly (2005)</a>), and also alters cell morphology and gene expression (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20377629\">Szegedi (2010)</a>).\n\nElevated PRINS expression in the epidermis is suggested to contribute to psoriasis susceptibility (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15855153\">Sonkoly (2005)</a>).\n\nIn keratinocytes PRINS regulates the expression of the G1P3 gene, an anti-apoptotic protein that is overexpressed in psoriasis (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20377629\">Szegedi (2010)</a>), although the mechanism is unknown. "], ["Characteristics", "~3.6 kb, transcribed by RNA Polymerase II; spliced (2 exons) and polyadenylated (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15855153\">Sonkoly (2005)</a>)."], ["Misc", "PRINS RNA contains contains two Alu elements, as well as a short sequence stretch with ~70% similarity to an element in a small cytoplasmic noncoding RNA, named G8, from Tetrahymena thermophila, whose expression responds to heat shock and is involved in thermotolerance (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15855153\">Sonkoly (2005)</a>)."], ["Expression", "Elevated expression in psoriatic epidermis. Regulated by the proliferation and differentiation state of keratinocytes (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15855153\">Sonkoly (2005)</a>).\n\nExpressed at different levels in various human tissues, with highest levels detected in veins (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15855153\">Sonkoly (2005)</a>).\n\nSeveral stress signals such as ultraviolet-B (UV-B) irradiation, viral infection (herpes simplex virus), and translational inhibition increased the RNA level of PRINS (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15855153\">Sonkoly (2005)</a>), as well as HaCaT keratinocyte cell treatment with microbial agents such as bacteria peptidoglycan, lipopolysaccharide (LPS) and wall extract (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21750967\">Bari (2011)</a>). "], ["Name", "Psoriasis susceptibility-related RNA Gene Induced by Stress (PRINS)"]]|
|20151|;|Characteristics|;|0|;|1|;|0|;|[["Function", "In humans, NDM29 maps in a genomic region whose deletion has been shown to be involved in neuroblastoma development (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16000168\">De Preter (2005)</a>).\n\nIn-vitro over-expression of NDM29 promoted differentiation of neuroblastoma (NB) cells into cells with neuron-like features (including marker expression, morphology,  anchorage-dependent growth and excitatory properties), and a reduction in the tumor initiating ('stem-like') cell fraction in the NB cell population. In-vitro and in-vivo experiments indicated that increased expression of NDM29 restricts NB development and malignancy. It also lead to reduced expression of multidrug resistance 1 (MDR1) mRNA in malignant NB cells, and so increased their susceptibility to doxorubicin and cis-platinum antiblastic drugs used in NB therapy (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20581224\">Castelnuovo (2010)</a>)."], ["Name", "NDM29: neuroblastoma differentiation marker 29 (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20581224\">Castelnuovo (2010)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17274687\">Pagano (2007)</a>)."], ["Characteristics", "~130 nt. 'Alu-like RNA', it has a canonical Alu/7SL-derived sequence structure. Transcribed by RNA Polymerase III from the first intron of the ASCL3 (Achaete Scute-Like homologue 3) gene (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20581224\">Castelnuovo (2010)</a>)."], ["Misc", "NDM29 transcript comprises Alu sequences and unique sequences and might have been inserted into the genomic locus by retrotransposition (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20581224\">Castelnuovo (2010)</a>).\n\nSimilar to 21A RNA, it is also a short interspersed nucleotide element, marked as AluJb elements. (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17274687\">Pagano (2007)</a>)\n"], ["Conservation", "RNA was detected in humans - Alu-derived elements are restricted to primate lineage  (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20581224\">Castelnuovo (2010)</a>)."], ["Expression", "NDM29 expression was analyzed in 6 different cell types and found in abundant levels in neural cells (neuroblastoma cell lines SHSY5Y and SKNBE2, and primary culture of human glioma cells), but  at a very low levels in epithelial-derived cells (HeLa, HEK293, and primary cultures of skin fibrobroblast). NDM29 expression was increased in differentiating cells (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20581224\">Castelnuovo (2010)</a>).\n\nNDM29 RNA was detected in both the nucleus and cytoplasm of SKNBE2 and HeLa cells, but enriched (~70%) in the latter (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20581224\">Castelnuovo (2010)</a>)."]]|
|20150|;|Characteristics|;|0|;|1|;|0|;|[["Function", "antiPeg11 binds the PRC2 chromatin modification complex (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21172659\">Zhao (2010)</a>).\n\nantiPeg11 miRNAs target Rtl1 (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15854907\">Davis (2005)</a>)."], ["Characteristics", "Antisense transcript to Peg11/Rtl1. Peg11 is a retrotransposon-like protein coding gene (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11337479\">Charlier (2001)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20072617\">Byrne (2010)</a>).\n\nReciprocal imprinting: antiPeg11 maternally expressed whereas Rtl1/Peg11 is paternally expressed. (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11337479\">Charlier (2001)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12796779\">Seitz (2003)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19194500\">Hagan (2009)</a>).\n\nantiPeg11 contains 5 maternally expressed miRNAs (4 found in mammals, 1 specific to rodents, 1 specific to non-rodents) (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12796779\">Seitz (2003)</a>,\t<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15854907\">Davis (2005)</a>).\n\nIn humans these are mir-431, mir-433, mir-127, mir-432 and mir-136. "], ["Conservation", "Eutherian mammals (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15854907\">Davis (2005)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18532878\">Edwards (2008)</a>).\n\nSuggested that anti-rtl1 has evolved as part of the parental conflict hypothesis where the maternally expressed antisense gene inhibits the paternally expressed (fetal growth promoting) gene (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15854907\">Davis (2005)</a>)."], ["Expression", "Peg11 is expressed in a number of tissues in mouse, while antiPeg11 expression is restricted mostly to embryos and adult brain. In brain it was expressed at a higher level than Peg11 (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19194500\">Hagan (2009)</a>).\n\nantiPeg11 miRNAs have a similar expression profile to the full length transcript (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15854907\">Davis (2005)</a>).\n\nHigh expression of antiRtl1 in sheep skeletal muscle (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11337479\">Charlier (2001)</a>).\n\nFull length, unspliced, unprocessed, transcript was around ~5kb, with smaller (likely processed) species also present (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19194500\">Hagan (2009)</a>).\n"], ["Misc", "No full length antiPeg11 cDNAs have been cloned but there is a partial clone from mouse EU434921.1 which is given in the UCSC browser link below. This sequence \"Begins at the end of miR-431 precursor and ends at the beginning of miR-127 precursor\" (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19194500\">Hagan (2009)</a>).\n\nLike in mouse the exact nature of the transcript in other mammals is not known, human browser link below is to sequence defined by the microRNAs contained within antiPeg11, others are to Peg11."]]|
|20152|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Proposed to negatively regulate beta-MHC expression to coordinate the cardiac transition marked by the switch from beta- to alpha-MHC, during early neonatal development, and in adult heart in response to diabetes and to hypothyroid state (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9632112\">Luther (1998)</a>) (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17982008\">Haddad (2008)</a>)."], ["Characteristics", "Originally described as a ~6-kb transcript that initiates in the intergenic region between the alpha and beta myosin heavy chain (MHC) genes, ~2 kb downstream of the beta-MHC gene and transcribed across the entire gene in the antisense orientation (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12851393\">Haddad (2003)</a>).\n\nNatural antisense transcripts in the MHC cluster have been described forming three major products in rats, antisense to MHC IIa, IIx, and IIb genes. These antisense RNAs are named aII, xII, and bII NATs, respectively (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17030512\">Pandorf (2006)</a>). The aII NAT begins in the IIa-IIx intergenic region in close proximity to the IIx promoter, extends across the 27-kb IIa MHC gene, and continues to the IIa MHC gene promoter (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17030512\">Pandorf (2006)</a>)."], ["Conservation", "Comparative analyses of the MHC intergenic DNA sequence across five mammalian species (human, rat, mouse, hamster, and rabbit) indicates a conserved region that is proposed to be a common regulatory region for the alpha and antisense beta promoter (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12851393\">Haddad (2003)</a>)."], ["Expression", "Expressed in cardiac muscle development (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17982008\">Haddad (2008)</a>). Increasingly expressed following birth or in response to increases in T3 (3,5,3'-triiodothyronine) thyroid hormone.\n\nExpression is inversely correlated with beta-MHC levels: for example, expression of the antisense beta MHC RNA under altered thyroid state and in diabetes directly correlates with that of the alpha MHC mRNA, but negatively correlates with beta mRNA expression (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12851393\">Haddad (2003)</a>). \n\nNegative correlation has also been observed between the beta MHC mRNA expression and the antisense beta-RNA in response to aortic constriction-induced pressure overload, in which the beta-MHC gene is up-regulated while the alpha-MHC gene is down-regulated (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16415074\">Haddad (2006)</a>).\n\nExpression of MHC \"aII\" antisense is also up-regulated in muscles after spinal cord isolation (SI) in rats, and was negatively correlated with MHC IIa expression and positively correlated with MHC IIx gene expression (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17030512\">Pandorf (2006)</a>)."]]|
|20113|;|Characteristics|;|0|;|1|;|0|;|[["Function", "RepA repeats are required for X-chromosome silencing but not for localisation of Xist to the X-chromosome (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11780141\">Wutz (2002)</a>).  \n\nThe repA transcript recruits polycomb repressor complex 2 (PRC2) to the inactive X chromosome, with Ezh2 serving as the RNA binding subunit (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18974356\">Zhao (2008)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21172659\">Zhao (2010)</a>).\n\nRecruitment of PRC2 by the RepA transcript allows deposition of HE-K27me3 marks at the Xist locus which is needed for up-regulation of full length Xist. Suggests the RepA transcript is necessary for the initiation of X-chromosome inactivation (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18974356\">Zhao (2008)</a>)."], ["Characteristics", "~1.6 kb transcript containing the RepA repeats (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18974356\">Zhao (2008)</a>). Repeats are internal to Xist, near the 5' end (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11780141\">Wutz (2002)</a>). \n\nThe RepA repeat sequence is expressed as part of full length Xist and as part of the shorter RepA transcript.\n\nRepA repeats: 7.5 repeat units separated by spacers. Each repeat forms 2 stem loops (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11780141\">Wutz (2002)</a>)."], ["Conservation", "Sequence at 5' of Xist containing the A repeats and from where the separate RepA transcript is expressed show conservation throughout placental mammals."], ["Expression", "RepA transcript is expressed prior to the onset of X-inactivation (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18974356\">Zhao (2008)</a>)."]]|
|20157|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Required for bristle morphogenesis in external sensory organs.\n\nAppears to act downstream of cut and tramtrack"], ["Characteristics", "Two alternatively spliced ~3.5kb and ~6.5kb isoforms (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12019237\">Hardiman (2002)</a>).\n\nAnother longer extended isoform that is a precursor transcript for miR-263a has also been identified (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21179090\">Graveley (2011)</a>)."], ["Misc", "NCBI seq accession for two bft transcripts are: NR_001644.1 and NR_001643.1"], ["Expression", "Expressed in external sensory organs of the embryonic peripheral nervous system. Bristles in Drosophila are sensory organs and bereft is expressed in structural support cells during bristle formation.\n\nShows a punctate and possibly peri-nuclear localization"], ["Name", "bft: bereft"]]|
|20156|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Knockout showed reduced sperm motility and reduced testis weight."], ["Characteristics", "~850nuc, alternatively spliced 2 or 3 exon transcript.\n\nEvolution of a lncRNA gene from an intergenic region.\n\nHas an overlapping antisense transcript."], ["Conservation", "Gene is specific to certain Mus species. Intergenic region is present in other mammals (rat, human) and other more basal Mus species but no transcripts are expressed showing evolution of this gene in the past 2.5-3.5 million years.\n\nSplice and polyA sites utilised by Pldi were present as crytpic sites in other mouse species, mutations in the 5' regulatory region of Pldi appear to have allowed its expression, which has subsequently been selected for. "], ["Expression", "Expressed in postmeiotic cells in the testis.\n\nMay regulate the expression levels of other genes in testis. "], ["Name", "Pldi: Polymorphic derived intron containing ncRNA"]]|
|20158|;|Characteristics|;|0|;|1|;|0|;|[["Function", "IPS1 has complementarity to miR-399, but contains a mismatch loop that renders it uncleavable when miR-399 binds. Since target cleavage is the usual plant miRNA pathway the non-cleavable nature of IPS1 acts to sequester the miRNA (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17643101\">Franco-Zorrilla (2007)</a>).\n\nCompeting endogenous RNA (ceRNA). IPS1 carries out target mimicry to sequester miR-399 and attenuate its effects allowing increased expression of miR-399 targets including PHO2 (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17643101\">Franco-Zorrilla (2007)</a>)."], ["Name", "IPS1: Induced by phosphate starvation 1"], ["Characteristics", "IPS1 is a member of a family of RNAs induced by phosphate starvation in plants that have short non-conserved ORFs (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9106510\">Liu (1997)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9207836\">Burleigh (1997)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9880366\">Burleigh (1999)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11123795\">Mart\u00edn (2000)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16460506\">Shin (2006)</a>) and a region of complementarity to miR-399  (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17643101\">Franco-Zorrilla (2007)</a>).\n\nRNA of ~540 nuc (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11123795\">Mart\u00edn (2000)</a>)."], ["Misc", "Other family members include <a href=\"http://www.lncrnadb.com/detail.aspx?TKeyid=215\">At4</a>, <a href=\"http://www.ncbi.nlm.nih.gov/nuccore/42741749\">At4-1</a>, <a href=\"http://www.ncbi.nlm.nih.gov/nuccore/41396887\">At4-2</a> and <a href=\"http://www.ncbi.nlm.nih.gov/nucest/5842364?report=genbank\">At4-3</a> in Arabidopsis thaliana (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9880366\">Burleigh (1999)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16460506\">Shin (2006)</a> <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17643101\">Franco-Zorrilla (2007)</a>), <a href=\"http://www.ncbi.nlm.nih.gov/nuccore/1009717?report=genbank\">TPS11</a>  in tomato (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9106510\">Liu (1997)</a>), <a href=\"http://www.ncbi.nlm.nih.gov/nuccore/2231317\">Mt4</a> in Barrel Clover and Alfalfa (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9207836\">Burleigh (1997)</a>), Mt4-like in Soybean (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9880366\">Burleigh (1999)</a>). \n"], ["Conservation", "IPS1 family members have been identified in a number of plant species (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9106510\">Liu (1997)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9207836\">Burleigh (1997)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9880366\">Burleigh (1999)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11123795\">Mart\u00edn (2000)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16460506\">Shin (2006)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17643101\">Franco-Zorrilla (2007)</a>). \n\nHowever apart from At4 and IPS1 homology between family members is generally limited to the miR-399 binding site (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9880366\">Burleigh (1999)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16460506\">Shin (2006)</a>)."], ["Expression", "Expression induced upon phosphate starvation and accumulates into the roots and shoots (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11123795\">Mart\u00edn (2000)</a>).\n\nHormonal signaling by cytokinins repressed IPS1 expression in the roots (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11123795\">Mart\u00edn (2000)</a>)."]]|
|20277|;|Characteristics|;|0|;|1|;|0|;|[["Function", "LINC00570 expression appears to stimulate ROCK2 gene expression (in HeLa cells)."], ["Characteristics", "Multiple 2-4 exon isoforms with variation in splicing and TSSs.\n\nIsoforms between 380 nt and 1.3kb\n\nIntergenic between ROCK2 and E2F6\n\nIn-vitro translation showed no sign of protein product."], ["Expression", "Expressed in HeLa cells."]]|
|20278|;|Characteristics|;|0|;|1|;|0|;|[["Function", "LncRNA regulates gene expression through SNAI1 dependant and independent mechanisms. \n\nStimulates SNAI1 gene expression (in A549 cells) and like SNAI1 is required for cell migration.\n\nStimulates Aurora-kinase A (AURKA) expression, a gene found ~6 megabases from LOC100887755 on chr20. SNAI1 does not appear to regulate AURKA and so LOC100887755 appears to regulate AURKA by a SNAI1 independent mechanism."], ["Characteristics", "Two exon, 600 nt transcript\n\nAround 50 kb 3\u2019 from SNAI1 on the opposite strand.\n\nIn-vitro translation showed no sign of protein product."], ["Expression", "Expressed in A549 cells."]]|
|20238|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Transformed plants over-expressing npc536 showed heightened root growth under salt stress conditions, with increased primary root growth and secondary root length.\n\nNo phenotype could be observed in mutants that carry T-DNA insertions within npc536.\n\nIn response to certain abiotic stresses such as drought or cold treatment, the root expression of these two genes (AT1G67930 and npc536) tends to be anti-correlated (Pearson correlation coefficient of -0.636 and -0.983, respectively). However, accumulation of the AT1G67930 transcript was not significantly modified in plants over-expressing npc536 or in npc536 mutants (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18997003\">Ben Amor (2009)</a>)."], ["Characteristics", "597 nucleotides, unspliced. Sequence from full-length cDNA clone GSLTSIL78ZH02 is 645 bp-long.\n\nNpc536 transcript is antisense to the AT1G67930 mRNA (encoding a Golgi-transport complex related protein) (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18997003\">Ben Amor (2009)</a>)."], ["Misc", "Annotated as AT1G67920 hypothetical protein, Gene ID: 843120, in Genbank, and contains a small ORF conserved in rice (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18997003\">Ben Amor (2009)</a>). The 'hypothetical protein' is 67 aa."], ["Expression", "npc536 has a large dynamic range of expression across a wide range of tissues and hormonal, biotic, or abiotic treatments.\n\nUp-regulated in roots and leaves of Arabidopsis thaliana plants submitted to stress by phosphate starvation and salt (NaCl) stress (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18997003\">Ben Amor (2009)</a>)."]]|
|20239|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Overexpression of npc48 in Arabidopsis thaliana led to strong leaf serration (a symptom of defects in cell proliferation along the margins of leaf primordia). Plants overexpressing npc48 showed other drastic developmental anomalies, including an increase in the rosette diameter and a delay in flowering time compared with wild-type plants.\n\nThe phenotype of npc48-over-expressing plants resembles that of plants over-expressing MIR168, which have reduced levels of the miR168 AGO1 target, and of AGO1-sensitive miRNAs such as miR166. They also show decreased miR166 accumulation, but presence of AGO1 mRNA and miR168 at wild-type levels.\n\nIn addition, npc48 plants exhibited reduced accumulation of miR164, suggesting that npc48 could regulate a subset of miRNAs. Interestingly, mir164a mutants also display abnormal serrations of the leaf margins, which are milder than the serrations induced by overexpression of npc48, suggesting that the reduction in miR164 alone cannot account for the phenotype.\n\nOver-expression of npc48 did not have a general effect on miRNAs or AGO1 accumulation (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18997003\">Ben Amor (2009)</a>)."], ["Characteristics", "983 nucleotides, unspliced. Contain regions that display significant Z-score values for potential secondary structures, which span > 8% of its total length (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16500993\">Hirsch (2006)</a>)."], ["Expression", "Broadly expressed in all tissues analyzed (roots, rosettes, stems, inflorescences, etc) (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16500993\">Hirsch (2006)</a>)."]]|
|20279|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Competing endogenous RNA (ceRNA). Binds miR-135 and miR-133 and inhibits their repressive action, including on MEF2C and MAML1, two transcription factors required for proper muscle differentiation.\n\nlinc-MD1 required for normal up-regulation of MYOG, MHC and MCK genes during myoblast differentiation. \n\nNb: These linc-MD1 effects were also observed when linc-MD1 was mutated so miR-133b could not be released from the sequence, showing this effect was due to the lincRNA transcript. "], ["Characteristics", "Three exon transcript. Contains miR-206 in second intron and miR-133b in third and final exon. Has binding sites for miR-135 in exon2 and miR-133 in exon 3. This structure is conserved in mouse and humans.\n\nShows evidence of alternative splicing of exon 2 in mouse. This alternative isoform no longer contains the miR-135 binding sites. Functional characterization was on the standard isoform containing the miRNA recognition sequences.\n\nPolyA+"], ["Conservation", "Exon 1 and the region of exon 3 containing miR-133b is conserved in mammals and also back to chicken. Exon 2 conserved in mammals."], ["Expression", "Expression induced during myoblast differentiation but absent in proliferating myoblasts in mouse and humans.\n\nIn mouse tissues expression was restricted to certain skeletal muscles where it was found only in \"newly regenerating fibres\". Expression is found more widely found amongst skeletal muscle of mutant mice which do not express dystrophin. \n\nConversely in myoblasts from humans with Duchenne Muscular Dystrophy (DMD), there was little linc-MD1 expression and MYOG and MHC expression was also reduced.  \n\nPredominately cytoplasmic.\n\nPromoter regions near the linc-MD1 and miR-206 TSSs contain conserved CANNTG (E-box) sequences, and are bound by the muscle transcription factor MyoD. During myoblast differentiation and in muscles where linc-MD1 is expressed these promoter regions (plus others) form long distance chromatin interactions."], ["Misc", "Expression of miR-206 and miR-133b is specific to muscle tissue. miR-133b expression profile closely corresponds to that of linc-MD1.\n\nSequence provided is only partial length, it was reported that the transcript 3' ends are 1060 and 1450 nt further downstream."]]|
|20234|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Mouse RNA was found to interact with a number of chromatin binding protein/complexes in mouse embryonic stem cells including PRC1, PRC2, JARID1B, ESET, SUV39H1, SETD8 and\tCBX1 with the general pattern being interaction with repressors of gene expression (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21874018\">Guttman (2011)</a>)."], ["Name", "\"adaptive response 33\""], ["Characteristics", "1.46 and 0.99kb bands detected by Northern blot (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/8806733\">Wang (1996)</a>).\n\nMouse 5430416N02Rik has 0.6 and 3.5 kb isoforms."], ["Misc", "Adapt33 promoter constructs have strong activity in both hamster and human cells. (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12837039\">Wang (2003)</a>)"], ["Conservation", "Adapt33 sequence has homology to mouse AK017316."], ["Expression", "Isolated from Chinese hamster ovary cell-derived HA-1 fibroblasts (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/8806733\">Wang (1996)</a>).\n\nMultiple stress-responsive gene. Hydrogen peroxide-inducible. Induction appears to be dependent on calcium, occurred as early as 90 min, and was maximal at 5h. Adapt33 induction by hydrogen peroxide is suggested to occur at the mRNA stability level, and stability analysis indicated a short half-life. (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12837039\">Wang (2003)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/8806733\">Wang (1996)</a>)\n\nCell fractionation revealed that a significant proportion of adapt33 RNA is associated with active translation in the polysomes. (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/8806733\">Wang (1996)</a>)\n\nAnalysis of expression following the stimulation of apoptosis with hydrogen peroxide and staurosporine indicated a strong correlation with the apoptosis response. (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12837039\">Wang (2003)</a>)\n\nIn mouse probable homologue expressed in mouse embryonic stem cells (ESCs) (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21874018\">Guttman (2011)</a>).\n\nMouse RNA found to be highly unstable with a half-life <2 hr in N2A (neuroblastoma) cells (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/22406755\">Clark (2012)</a>). "]]|
|20236|;|Characteristics|;|0|;|1|;|0|;|[["Function", "PWR1 regulates expression of the FLO11/MUC1 gene in cis, in conjunction with a second lncRNA <a href=\"http://www.lncrnadb.com/Default.aspx?TKeyid=235\">ICR1</a>.\n\nExpression of ICR1 represses expression of FLO11, probably by promoter occlusion. \n\nExpression of ICR1 is repressed by PWR1 (again probably by promoter occlusion in cis), allowing expression of FLO11, so the regulatory circuit depends on whether PWR1 is expressed or repressed.\n\nICR1 is lowly expressed constitutively and competition between Flo8 and Sfl1 transcription factors determines which ncRNA is expressed and therefore if FLO11 is on or off."], ["Characteristics", "~1.2kb capped, polyadenylated, single exon transcript.\n\nPWR1 expressed in FLO11 regulatory region.\n\nExpressed on opposite strand to FLO11. Starts within a region covered by a second lncRNA <a href=\"http://www.lncrnadb.com/Default.aspx?TKeyid=235\">ICR1</a>, transcribed in antisense direction to ICR1 and terminates around the area of ICR1 initiation."], ["Misc", "FLO11/ MUC1 - cell surface glycoprotein that controls cell-cell adhesion and shows variegated expression in a clonal population of yeast cells (ie: expressed at high levels in some cells, silenced in others).\n\nSequence of PWR1 is found on chromosome IX from coordinates 395996 to 396936. See\nhttp://www.yeastgenome.org/cgi-bin/locus.fpl?sgdid=S000132614"], ["Expression", "Expression of ICR1 and PWR1 is inversely correlated. \n\nICR1 expression requires the Sfl1 transcription factor known to repress FLO11 and is repressed by the Flo8 transcription factor and the Rpd3L histone deacetylase (HDAC).\n\nPWR1 expression requires Rpd3L HDAC and Flo8 and is repressed by Sfl1."], ["Name", "PWR1: promoting Watson RNA1 \n"]]|
|20237|;|Characteristics|;|0|;|1|;|0|;|[["Characteristics", "Spliced, polyadenylated ~2.8kb transcript (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/8812481\">McGuinness (1996)</a>).\n \nExpressed from a highly conserved enhancer element downstream of Dlx1. Second exon overlaps exons and introns of Dlx1 in the antisense direction (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18562676\">Dinger (2008)</a>)."], ["Conservation", "Exon one initiates from an enhancer highly conserved in therian mammals (found in oppossum as well as placental mammals). Second exon also overlaps highly conserved sequences but this is mostly Dlx1 exon regions."], ["Expression", "Dlx1as and Dlx1 were progressively more highly expressed during differentiation of embryonic stem cells (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18562676\">Dinger (2008)</a>).\n\nDlx1as and Dlx1 were both up-regulated during differentiation of neuronal progenitors to GABAergic neurons in vitro, but down-regulated during oligodendrocyte differentiation from the same progenitors (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20137068\">Mercer (2010)</a>).\n\nExpressed in developing forebrain with highest expressive in the subventricular zone (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9415433\">Liu (1997)</a>).\n\nExpressed in adult mouse brain, including in regions associated with neurogenesis (anterior subventricular zone, rostral migratory stream, and olfactory bulb) similar to the expression of Dlx1 and Dlx2 (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18562676\">Dinger (2008)</a>).\n"], ["Misc", "Dlx1: distal-less homeobox 1. Transcription factor with an important role in brain development that is important role in specifying neuronal cell fate."]]|
|20232|;|Characteristics|;|0|;|1|;|0|;|[["Characteristics", "~900bp in humans. Contains a 'human accelerated region' (HAR). Overlaps with an antisense noncoding RNA, <a href=\"http://www.lncrnadb.com/Default.aspx?TKeyid=95\">HAR1A</a> (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16915236\">Pollard (2006)</a>).\n\nTwo splice isoforms, one with 2 exons, one with 3 exons (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16915236\">Pollard (2006)</a>).\n\nConserved HAR1 sequence (common to both HAR1A and HAR1B) forms a secondary structure which is highly conserved (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16915236\">Pollard (2006)</a>) but has undergone changes from a hairpin structure in chimps to a cloverleaf structure in humans (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18511501\">Beniaminov (2008)</a>)."], ["Conservation", "Contains a 'human accelerated region', which is a sequence highly conserved in amniotes (negative selection) but which has evolved rapidly in the human lineage (positive selection) since the divergence of humans and chimpanzees from the last common ancestor (18 bases out of 118 are different between human and chimpanzee but only 2 differences between chimpanzee and chicken) (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16915236\">Pollard (2006)</a>).\n\nRest of HAR1B sequence has little conservation outside of chimp and macaque (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16915236\">Pollard (2006)</a>)."], ["Expression", "Expression was found in adult brain, ovary and testis in human. Expression level was much lower than <a href=\"http://www.lncrnadb.com/Default.aspx?TKeyid=95\">HAR1A</a> (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16915236\">Pollard (2006)</a>).\n\nRepressed transcriptionally by REST, which causes repression of HAR1B in striatum of Huntington's disease patients (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20179156\">Johnson (2010)</a>).   \n\nThe mouse locus is expressed during embryonic development (peak at E15) and in adults it is specifically expressed in the brain. Unlike in human, \"HAR1B\" was expressed at similar levels to \"HAR1A\" in mouse (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16915236\">Pollard (2006)</a>)."]]|
|20201|;|Characteristics|;|0|;|1|;|0|;|[["Characteristics", "Along with DISC1 identified as a gene disrupted by translocation in a family with schizophrenia (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/10814723\">Millar (2000)</a>).\n\nAntisense to DISC1, and covers one DISC1 exon (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/10814723\">Millar (2000)</a>).\n\nContains a number of repeat sequences. SINEs, LINES and a DNA transposon (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/10814723\">Millar (2000)</a>).\n\nExact length and structure not certain. Described as unspliced and may be more than 15kb long. Polyadenylated. (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/10814723\">Millar (2000)</a>)."], ["Conservation", "Identified in humans, not found in mouse (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12573262\">Taylor (2003)</a>)."], ["Expression", "Expressed in adult heart, saw transcripts of >9.5, ~6, ~3 and ~2.5kb (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/10814723\">Millar (2000)</a>).\n\nDetected in several fetal tissues including heart and brain (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/10814723\">Millar (2000)</a>). "], ["Name", "DISC2: Disrupted-In-Schizophrenia 2 "], ["Misc", "Genebank accession for 15kb genomic sequence corresponding to DISC2: AF222981.1\n\nRefseq lists DISC2 as a 3.9kb unspliced RNA. Accession: NR_002227.2"]]|
|20200|;|Characteristics|;|0|;|1|;|0|;|[["Function", "B2 SINE RNA is a specific inhibitor of RNA polymerase II (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15300240\">Allen (2004)</a>).\n\nDuring heat shock B2 RNA associated with RNA polymerase II and repressed its action. Nb: Only saw association of B2 RNA with RNA polymerase II after heat shock. (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15300240\">Allen (2004)</a>).\n\nRepresses transcription by stably binding an RNA docking site on the core polymerase II complex and blocking activity of the RNA polymerase preinitiation complex (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15300239\">Espinoza (2004)</a>). To achieve this B2 RNA disrupts polymerase DNA binding at the promoter, preventing the formation of an active closed complex around the DNA (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19307572\">Yakovchuk (2009)</a>).\n\n51 nucleotide sequence from 3' half is sufficient for binding to and repressing RNA polymerase II (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17307818\">Espinoza (2007)</a>)."], ["Characteristics", "Short interspersed element (SINE) repeat present in more than 10^5 copies in the mouse genome (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/370792\">Kramerov (1979)</a>)\n\nRepeat is ~180nuc long (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/6296779\">Krayev (1982)</a>) but expressed B2 RNAs vary from ~0.2-0.6kb (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/6130513\">Kramerov (1982)</a>,<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/2426659\">Fornace (1986)</a>). \n\nThe 5' of B2 SINE is derived from a tRNA (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/3839306\">Lawrence (1985)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/3851163\">Daniels (1985)</a>) while the 3' contains an A rich sequence (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/6296779\">Krayev (1982)</a>).\n\nTranscribed by RNA polymerase III (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/6296779\">Krayev (1982)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/2581137\">Singh (1985)</a>)."], ["Conservation", "Rodents: mouse, rat, chinese hamster (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/6296779\">Krayev (1982)</a>)"], ["Expression", "Expression highly induced upon viral infection (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/2581137\">Singh (1985)</a>), heat shock (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/2426659\">Fornace (1986)</a>) and differentially regulated during development (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/2461884\">Bachvarova (1988)</a>).\n\nAlso shows higher expression in some tumour cells (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/6130513\">Kramerov (1982)</a>).\n\nFound in the nucleus (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15300239\">Espinoza (2004)</a>) and the cytoplasm (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/6130513\">Kramerov (1982)</a>)."], ["Misc", "Known that upon heat shock RNA polymerase II is transiently repressed.\n\nIn humans Alu repeat RNAs appear to play the role B2 RNA does in rodents upon heat shock. Alu and B2 elements have different origins but show convergent evolution functionally.\n\nB2 sequence provided is 177nt sequence specified by Espinoza et al. 2004 as mouse B2 RNA gene (region 121488-121665 of Mus musculus chromosome 18, clone RP23-6p18, GenBank accession number AC020972)."]]|
|20144|;|Characteristics|;|0|;|1|;|0|;|[["Function", "LXRBSV acts as a specific transcriptional co-activator for LXR-beta to enhance its receptor-mediated transactivation. LXRBSV synergistically augmented ligand-dependent activation of the SREBP-1c promoter (Sterol Response Element Binding Protein-1c promoter), but not of thyroid hormone receptor (TR) and peroxidase proliferator and activating receptors (PPARs).\n\nThe intronic sequence inserted into LXRBSV is required for its transactivation activity.\n\nLXRBSV protein was deduced to be 64 amino acids in length, but different evidence demonstrated that the alternative splicing transcript acts as a RNA co-activator: 1) a GAL4-LXRBSV fusion protein was not able to induce transactivation; 2) an ATG mutant of LXRBSV was able to induce transactivation as wild type, and 3) LXRBSV functions in the presence of cycloheximide (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19878653\">Hashimoto (2009)</a>)."], ["Characteristics", "In mouse, LXRBSV is an alternative splicing isoform of LXR-beta that has a 270bp intronic sequence retained between exons 4 and 5 (or exons 2 and 3 depending on LXR-beta isoform). Quantitative expression and promoter reporter assays indicated that LXRBSV is preferentially transcribed and expressed in the pituitary (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20211147\">Hashimoto (2010)</a>).\n\n5'-rapid amplification of cDNA ends (5'-RACE) produced a 677 bp PCR product and indicated that the transcriptional start site (TSS) of LXRBSV is located 40 bp downstream of LXR-beta's TSS (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20211147\">Hashimoto (2010)</a>).\n\nA LXRBSV construct was translated as an approximately 22 kDa protein by in-vitro translation."], ["Misc", "Because the LXRB locus produces both functional protein-coding and regulatory RNA transcripts, it may be considered a 'bi-functional' locus."], ["Expression", "LXRBSV was detected in various tissues, such as liver and different regions of the brain (pituitary, hypothalamus, cerebrum, cerebellum). It was expressed at lower levels than LXR-beta (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19878653\">Hashimoto (2009)</a>).\n\nQuantitative expression and promoter reporter assays indicated that LXRBSV is preferentially transcribed and expressed in the pituitary. LXRBSV expression in the whole brain and especially in the pituitary was significantly higher compared to that in the liver. This is in contrast to LXR-beta mRNA that showed similar expression in the liver and brain and significantly reduced expression in the pituitary and hypothalamus compared to liver (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20211147\">Hashimoto (2010)</a>)."], ["Name", "LXRBSV: Liver X receptor (LXR)-beta alternative splicing variant (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19878653\">Hashimoto (2009)</a>)."]]|
|20145|;|Characteristics|;|0|;|1|;|0|;|[["Function", "A 4.2 kb microdeletion in humans that ablates two GNAS antisense exons is associated with pseudohypoparathyroidism type Ib.  When maternally transmitted, this mutation causes loss of maternal GNAS imprints, partial gain of NESP55 methylation, and resistance to parathyroid hormone (PTH) in affected and obligate carrier individuals. Paternal transmission leads to epigenetic alterations in cis, including a partial loss of NESP55 methylation and a partial gain of A/B methylation. (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20444925\">Chillambhi (2010)</a>)\n\nNespas RNA was identified as binding to the repressive PRC2 chromatin modification complex in mouse embryonic stem cells, suggesting that like noncoding RNAs from other imprinted region, nespas could act to regulate the imprinting cluster it is transcribed from (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21172659\">Zhao (2010)</a>).  "], ["Characteristics", "Northern blot with a probe for Nespas detects a smear and discrete band of 4.4kb and larger (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/10716699\">Wroe (2000)</a>). In addition to an unspliced form, five alternatively spliced forms of up to 1.4 kb in length have also been detected (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11889554\">Williamson (2002)</a>).\n\nImprinted (transcribed from the paternal allele). Transcribed from intron 2 of Nesp (Gnas), encompassing exons 2 through 1. The imprinted GNAS locus encodes the alpha-subunit of the stimulatory G protein as well as additional imprinted transcripts including the maternally expressed NESP55 and other paternally expressed transcripts (XLalphas and A/B transcripts)."], ["Misc", "**Annotation in progress**"], ["Conservation", "N/A"], ["Names", "Nespas: neuroendocrine secretory protein (Nesp) antisense."], ["Expression", "Tissue-specific expression with signal in heart, in cerebral cortex, adrenal, and spleen, where Nesp is also expressed. Nesp and Nespas transcripts show expression from opposite parental alleles in most (but not all) tissues (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11056047\">Li (2000)</a>), and Nespas may be abundant in some tissues where Nesp is not detected (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11889554\">Williamson (2002)</a>). Furthermore, the Nesp transcripts can also remain imprinted in tissues that lack Nespas."]]|
|20142|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Intergenic transcripts (or their transcription) are believed to participate in the developmental switch of beta-globin cluster genes, with proposed roles in chromatin remodeling and long-range cis-activation. RNAs may be processed by RNAi machinery."], ["Characteristics", ">1 kb, intergenic RNAs transcribed from the beta-globin locus."], ["Conservation", "N/A"], ["Expression", "Dynamically expressed during erythroid cell development.\n\nNuclear localised."], ["Misc", "N/A"]]|
|20140|;|Characteristics|;|0|;|1|;|0|;|[["Function", "7SL RNA is required for structural and functional properties of SRP (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/6181418\">Walter (1982)</a>), being a scaffold component upon which the six proteins of the SRP bind in higher eukaryotes. In mammals SRP consists of the SRP RNA the six proteins named SRP9, SRP14, SRP19, SRP54, SRP68, and SRP72 (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/6196367\">Walter (1983)</a>).\n\nBacterial SRP has a much reduced complexity, consisting of a small SRP RNA (4.5S RNA) and a homolog of protein SRP54, also called Ffh or P48 (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/8389475\">Bernstein (1993)</a>). In archaea only two SRP proteins, SRP19 and SRP54, are thought to be part of the SRP, although SRP RNA closely resembles the mammalian homolog (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/10684931\">Bhuiyan (2000)</a>).\n\nThere is evidence that a highly conserved region of 7SL RNA catalyses the binding of SRP to its receptor SR, and that this RNA stimulates the GTPase activities of the SRP-SR complex (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18617187\">Zhang (2008)</a>) (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17164479\">Siu (2007)</a>) (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/10834842\">Peluso (2000)</a>)."], ["Name", "RN7SL1: RNA, 7SL, cytoplasmic 1"], ["Characteristics", "~300 nt, transcribed by RNAPIII. \n\nThe eukaryotic small cytoplasmic 7SL is an RNA component of the SRP (signal recognition particle), which associates with the ribosome and targets nascent proteins to the endoplasmic reticulum for secretion or membrane insertion (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/6181418\">Walter (1982)</a>) (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15611297\">Zwieb (2005)</a>)."], ["Misc", "7SL is the RNA ancestor of Alu transposon sequences, which emerged ~ 55 million years ago, are present specifically in primates and comprise ~10% of the human genome. Rodent B1 elements, as well as  4.5S and primate BC200 RNAs are also related to the terminal portions of 7SL RNA sequence (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/7528809\">Labuda (1994)</a>) (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/7529207\">Quentin (1994)</a>)."], ["Conservation", "May have originated from the bacterial SRP (GTP-regulated ribonucleoprotein that targets secretory or membrane proteins during translation), it is ubiquitously present in eukaryotic cells and several viruses (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/6802847\">Li (1982)</a>). The secondary structure of 7SL RNA is conserved from prokaryotes to distant eukaryotic species (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/7528809\">Labuda (1994)</a>)."], ["Expression", "Ubiquitously expressed at high levels. Localises to the cytoplasm. An expression profile from 11 human tissues using RNA sequencing showed 7SL was most highly expressed ncRNA and could be an order of magnitude more highly expressed than any mRNA (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20668672\">Castle (2010)</a>). "]]|
|20206|;|Characteristics|;|0|;|1|;|0|;|[["Function", "SNP polymorphisms in Igf2as associate with increased muscle damage (strength loss and soreness) after eccentric exercise, as do SNPs found in IGF2 (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17289909\">Devaney (2007)</a>)."], ["Characteristics", "Spliced transcript from bidirectional promoter with Igf2. Overlaps some Igf2 isoforms in antisense direction (mouse and human).\n\n~4.8kb mouse transcript, four exons. Multiple splice isoforms in human, 2 or 3 exons, ~2 or ~2.8kb. Most homology is towards 3' of transcripts (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/10731720\">Okutsu (2000)</a>)."], ["Conservation", "Human Igf2as contains a predicted ORF, however this is not present in mouse (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/10731720\">Okutsu (2000)</a>).\n\nAlso expressed and imprinted in pig (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19571260\">Bischoff (2009)</a>)."], ["Expression", "Imprinted, expressed from paternal allele (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/10731720\">Okutsu (2000)</a>). Igf2as generally retains imprinting in tumours even when Igf2 becomes bi-allelically expressed (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12702581\">Vu (2003)</a>). \n\nUbiquitously, but lowly, expressed in human adult and fetal tissues. 2 exon (has retained intron) isoform was specific to adult liver (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12702581\">Vu (2003)</a>). \n\nLike Igf2, Igf2as showed highly up-regulated expression in Wilms tumour samples compared to neighbouring normal kidney tissue. "], ["Name", "IGF2AS: Insulin-like growth factor 2 antisense \nPEG8: Paternally expressed gene 8"]]|
|20148|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Over-expression of Msx1as in-vitro results in the reduction of Msx1 protein in a dose-dependent manner (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12489151\">Berdal (2002)</a>). Msx1as is proposed to negatively regulate Msx1 during craniofacial and skeleton development. (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16157866\">Coudert (2005)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11390985\">Blin-Wakkach (2001)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12489151\">Berdal (2002)</a>)"], ["Characteristics", ">2 kb, spliced, complementary (antisense) to the region extending from of the 3' end of exon 2 to the middle of intron 1 of the Msx1 gene (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12489151\">Berdal (2002)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11390985\">Blin-Wakkach (2001)</a>)."], ["Conservation", "Msx1as RNA has been detected in mice, rats, and humans. The transcription initiation site for Msx1as RNA was located by primer extension in both mouse and human in an identical region, including a consensus TATA box present in a highly conserved 66-bp region at the 3' UTR of Msx1 (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11390985\">Blin-Wakkach (2001)</a>)."], ["Expression", "Msx1as transcript is expressed in mouse embryos at E9.5 before the initial steps of skeleton morphogenesis and cell differentiation, and continuously up to birth (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16157866\">Coudert (2005)</a>). Expressed in differentiated dental and bone cells, being up-regulated during osteoblast differentiation and in developing tooth, bone and limb bud  (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16157866\">Coudert (2005)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11390985\">Blin-Wakkach (2001)</a>, ID=\t12489151). Also detected in hair follicles and neural tube, tissues where Msx1 are expressed (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16157866\">Coudert (2005)</a>).\n\nInversely correlated with Msx1 during mouse dental and bone differentiation with the two genes also showing a complementary spatial expression pattern (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16157866\">Coudert (2005)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11390985\">Blin-Wakkach (2001)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12489151\">Berdal (2002)</a>).\n\nMsx1as transcript has also also detected by Northern blot analysis in dental epithelium and mesenchyme from a rat incisor (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11390985\">Blin-Wakkach (2001)</a>)."], ["Misc", "The Msx1as putative TATA box is conserved in Msx2 cDNA sequences, suggesting a more general regulation pathway of the Msx gene family (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11390985\">Blin-Wakkach (2001)</a>)."]]|
|20149|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Transcript(s) from the Meg9 locus bind to the PRC2 chromatin modification complex in mouse embryonic stem cells (mESCs) (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21172659\">Zhao (2010)</a>).\n\nAberrant repression of Meg9 and other maternally expressed lncRNAs from the DLK1-Dio3 imprinting cluster is present in most induced pluripotent stem cell (iPSC) lines and is responsible for the failure of iPSCs to form viable mice, with embryos dying mid-gestation (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20418860\">Stadtfeld (2010)</a>).\n\nSome Meg9 miRNAs have a known function, including one known to be important in brain development (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16421561\">Schratt (2006)</a>). Others are predicted to target Dlk1, a paternally expressed gene from the same imprinted locus (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19194500\">Hagan (2009)</a>)."], ["Name", "MEG9 - Maternally expressed 9\nMirg- MicroRNA-containing gene"], ["Characteristics", "Imprinted: Maternally expressed lncRNA from the Dlk1-Dio3 locus, downstream from Rian (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12796779\">Seitz (2003)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16309881\">Tierling (2006)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19194500\">Hagan (2009)</a>). Contains intronic miRNAs which are also maternally expressed (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12796779\">Seitz (2003)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15310658\">Seitz (2004)</a>).\n\nMirg suggested to be a processed form of Meg9. Northern blot analysis identified a number of transcripts from this locus from ~1kb (putative Mirg transcript) to ~5.5kb (longer than cloned Meg9 transcript) (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19194500\">Hagan (2009)</a>)."], ["Misc", "Currently unclear if there is any overlap of transcripts from Rian/MEG8 and MEG9/Mirg loci. RNA sequencing by <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20436462\">Guttman (2010)</a> found no evidence for overlap in mESCs, but there is imprinted transcription in the region between them with the same expression patterns (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16309881\">Tierling (2006)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19194500\">Hagan (2009)</a>).\n\nSequence given is EU616813.1 from mouse. Note that northern blotting has suggested longer (characterised) transcripts also exist."], ["Conservation", "Meg 9 is present in mammals. However the Meg9 host mRNA for the miRNAs has not been identified in each species.\n\nMeg9 microRNAs are mammalian specific (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15310658\">Seitz (2004)</a>)."], ["Expression", "Meg9/ Mirg show similar expression to other lncRNA from locus. Expressed in embryonic and extraembronic tissue but also found in adult skin and testis (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16309881\">Tierling (2006)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19194500\">Hagan (2009)</a>).\n \nThe large cluster of intronic miRNAs show a similar pattern of expression inlcuding in embryos and adult brain (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15310658\">Seitz (2004)</a>).  "]]|
|20077|;|Characteristics|;|0|;|1|;|0|;|[["Function", "Regulates genomic imprinting of a cluster of autosomal genes (Igf2r, Slc22a2 and Slc22a3) in cis, on mouse chromosome 17 (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11845212\">Sleutels (2002)</a>).  \n\nTruncation of Air disrupts imprinting not only of Igf2r but also the nearby non-overlapping genes Slc22a2 and Slc22a3, leading to mice with a lower birth weight (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11845212\">Sleutels (2002)</a>).\n\nAir RNA forms a \"cloud\" over the imprinted DNA locus, binding to chromatin. Recruits G9a histone methyltransferase to epigenetically silence Slc22a3 (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18988810\">Nagano (2008)</a>). Igf2r is not silenced by this mechanism.\n\nNb: Slc22a3 and Slc22a2 are only imprinted at a specific time point in placental development. Outside of this time point the Air \"cloud\"/ Air chromatin binding and repressive histone modification are not found on these gene loci (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18988810\">Nagano (2008)</a>). "], ["Characteristics", "108 kb (unspliced). Transcribed from an antisense promoter located in intron 2 of the Igf2r (insulin-like growth-factor type-2 receptor) gene (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/10802648\">Lyle (2000)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9338788\">Wutz (1997)</a>). \n\nAlso a number of spliced isoforms from 500bp to ~1.4kb (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16874305\">Seidl (2006)</a>).\n\nImprinted, expressed only from paternal allele (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9338788\">Wutz (1997)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/10802648\">Lyle (2000)</a>)."], ["Misc", "Nb: Genebank and NCBI Gene sequences for Air are all for the spliced mouse isoforms. See http://www.ncbi.nlm.nih.gov/gene/104103. UCSC browser link below is for transcript variant 3 which covers a similar length to the unspliced transcript."], ["Conservation", "All characterisation been carried out in mouse. Recently Air has been identified in human (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18789384\">Yotova (2008)</a>) but full length transcripts have yet to be characterised."], ["Names", "Antisense Igf2r RNA"], ["Expression", "Expressed during embryonic development, in the placenta (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9338788\">Wutz (1997)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/10802648\">Lyle (2000)</a>), adult brain, lung and heart (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16874305\">Seidl (2006)</a>).\n\nExpressed in glial cells of the developing brain but not in neurons, explains lack of Igf2r imprinting in these neurons. (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16037066\">Yamasaki (2005)</a>)\n\nUnspliced Air is unstable, localised to the nucleus. Spliced isoforms, found in nucleus and cytoplasm, are more stable (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16874305\">Seidl (2006)</a>)."]]|
|20079|;|Characteristics|;|0|;|1|;|0|;|[["Function", "In vitro over-expression of p15as/ANRIL RNA was originally demonstrated to induce epigenetic silencing of p15 gene expression (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18185590\">Yu (2008)</a>).\n\nRecently, ANRIL RNA was found to interact and regulate chromobox 7 (CBX7), a component of the Polycomb Repressor Complex 1 (PRC1), which methylates histone H3 lysine 27 to promote epigenetic silencing, and is also up-regulated in prostate cancer. Interaction occurs with a conserved chromodomain of CBX7 and is essential for the ability of PRC1 to repress the INK4b/ARF/INK4a locus and control cell senescence. (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20541999\">Yap (2010)</a>)"], ["Characteristics", "Present in multiple splicing isoforms (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19888323\">Folkersen (2009)</a>) (such as the CDK2BAS RefSeq sequence NR_003529.3 of ~3.9kb). Also detected as an unspliced transcript of 34.8 kb (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18185590\">Yu (2008)</a>), specified as p15AS, but which seems to correspond to an isoform with the first intron of CDK2BAS retained. Antisense to the tumor suppressor gene p15/CDKN2A. (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18185590\">Yu (2008)</a>)\n\nTraverses a noncoding region centromeric to CDKN2A, a region containing the INK4b/ARF/INK4a locus and implicated in a range of complex diseases including cancer (such as melanoma-neural system tumor syndrome), type 2 diabetes, periodontitis and coronary heart disease (see extensive reference list in Literature below, and <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20716961\">Popov (2010)</a> for a review).\n\nTranscript found to be quite unstable with a half-life >4 hr in human Hela cells (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/22369889\">Tani (2012)</a>)."], ["Expression", "Expressed in tissues and cell types affected by atherosclerosis. Increased levels of ANRIL are found in patients carrying the atherosclerosis risk haplotype expression, including in peripheral blood mononuclear cells, whole blood and atherosclerotic plaque tissue, and the levels were directly correlated with the severity of atherosclerosis (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20056914\">Holdt (2010)</a>). \n\nUp-regulated in prostate cancer (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20541999\">Yap (2010)</a>)."], ["Name", "ANRIL: Antisense noncoding RNA in the INK4 locus;\n\nCDKN2B-AS1: CDKN2B antisense RNA 1;\n\nP15AS: P15 antisense RNA"]]|
|20078|;|Characteristics|;|0|;|1|;|0|;|[["Misc.", "More than 200 pseudogenes reported (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11399078\">Kuryshev (2001)</a>)."], ["Characteristics", "200 nucleotide ncRNA (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/7684772\">Tiedge (1993)</a>) exapted from an Alu element (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/2444875\">Watson (1987)</a>). Transcribed by RNA polymerase III (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/8265590\">Martignetti (1993)</a>).\n\nThree structural domains, 5' that shares homology with Alu elements, a central A rich region and a 3' unique region (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/7684772\">Tiedge (1993)</a>). \n"], ["Conservation", "Anthropoid primates (monkeys, apes and humans) (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9847409\">Skryabin (1998)</a>).\n\nBC200, BC1 and G22 likely form a family of independently exapted repetitive elements which have evolved to carry out similar functions in different mammalian species (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12162957\">Muddashetty (2002)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17175535\">Khanam (2007)</a>). "], ["Expression", "Expressed predominantly in different regions of the brain. Also shows low level expression in testis but not in other normal tissues examined (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/2444875\">Watson (1987)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/7684772\">Tiedge (1993)</a>, <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11399078\">Kuryshev (2001)</a>). RNA sequencing of 11 human tissues confirmed up-regulation of expression in brain (hypothalamus) and low or no expression elsewhere (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20668672\">Castle (2010)</a>).\n\nDisregulated in cancer: expressed in a number of human tumours but not in corresponding normal tissue (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9422992\">Chen (1997)</a>). \n\nLink with aging and Alzheimer disease: BC200 expression decreases with aging but is upregulated in Alzheimer's disease (AD). In AD affected brain regions, expression increased with disease severity. RNA localisation showed intense perikaryal staining, showing build up of RNA in cell body (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17553964\">Mus (2007)</a>). \n\nLike BC1 ncRNA found in rodents, BC200 also suggested to localise to dendrites (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/7684772\">Tiedge (1993)</a>).  "], ["Function", "Binds several proteins including the signal recognition particle SRP9/14 heterodimer (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9605471\">Kremerskothen (1998)</a>), eukaryotic initiation factor 4A helicase (eIF4A) (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18316401\">Lin (2008)</a>) and Poly(A)-binding protein (PABP), binding to PABP requires the central A rich region (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12162957\">Muddashetty (2002)</a>).\n   \nInhibits translation in-vitro and in cultured cells similar to BC1.  BC200 binding to eIF4A inhibits it by uncoupling eIF4A ATPase activity from its helicase/ duplex unwinding activity (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18316401\">Lin (2008)</a>). Translational inhibition also involves BC200 binding to to PABP (<a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16154588\">Kondrashov (2005)</a>). "]]|
